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This thesis is dedicated to three patients:
A patient who tolerated a wearable sensor poorly, until it detected that
they were having a cardiac arrest and arguably dramatically improved
their future health. Thereafter they tolerated the sensor very well.
A patient who was very talkative before their operation, and died
tragically young a few days later despite wearing a wearable sensor.
A patient who probably didn’t need a wearable sensor, but ended up
practically dancing around the ward whilst wearing it, laughing and
joking with the staff.




Acutely-ill hospitalised patients are at risk of clinical deteriorations in health leading to adverse
events such as cardiac arrests. Deteriorations are currently detected by manually measuring
physiological parameters every 4-6 hours. Consequently, deteriorations can remain unrecog-
nised between assessments, delaying clinical intervention. It may be possible to provide earlier
detection of deteriorations by using wearable sensors for continuous physiological monitoring.
Respiratory rate (RR) is not commonly monitored by wearable sensors, despite being a sensitive
marker of deteriorations. This thesis presents investigations to identify an algorithm suitable
for estimating RR from two signals commonly acquired by wearable sensors: the electrocardio-
gram (ECG) and photoplethysmogram (PPG). A suitable algorithm was then used to estimate
RRs retrospectively from a physiological dataset acquired from acutely-ill patients to assess the
potential utility of wearable sensors for detecting deteriorations.
Existing RR algorithms were identified through a systematic review of the literature. A tool-
box of RR algorithms was created to facilitate comprehensive assessments of algorithms across
multiple datasets. This was used to assess the influence of technical and physiological factors on
respiratory signals extracted from the ECG and PPG, providing recommendations for wearable
sensor designs for RR estimation. An assessment of 95 RR algorithms using data from healthy
and hospitalised patients showed that the algorithms did not perform well enough for use with
acutely-ill patients. Therefore, a novel algorithm was designed specifically for use with wearable
sensors, providing improved performance.
The novel RR algorithm was used to estimate RRs retrospectively from wearable sensor data
acquired from 184 patients. The performances of algorithms to detect deteriorations from the
resulting wearable sensor data were similar to those used with routinely collected intermittent
data, suggesting that it is feasible to use wearable sensors to continuously assess the likelihood
of deterioration. However, the false alert rate increased when using wearable sensor data due
to the continuous, rather than intermittent, monitoring. Therefore, further work is required
to improve algorithms to detect deteriorations from wearable sensor data to provide clinically
useful alerts.
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Introduction
Acutely-ill hospitalised patients are at risk of deteriorations in health leading to adverse events
such as cardiac arrests, sepsis, and acute kidney injury. Adverse events such as these are
detrimental to patients as they increase morbidity and mortality, and prolong their length of
stay in hospital [12–14]. In addition, adverse events have a significant impact on healthcare costs
and resources. For instance, in the USA adverse events have been estimated to cost upwards of
US$17 billion per annum [15], and in Australia they have been estimated to account for 8% of
hospital bed days [16]. Furthermore, in the UK clinical negligence costs for the National Health
Service (NHS) totalled £769 million during 2008-2009 [17]. Therefore, any measures which
reduce the incidence of adverse events may improve patient outcomes and reduce healthcare
resource utilisation.
Many adverse events are preceded by measurable changes in physiology. Schein et al. pub-
lished landmark results in 1990 that 84% of patients “had documented observations of clinical
deterioration or new complaints” in the eight hours preceding cardiac arrest [18]. This finding
was subsequently supported by a study by Franklin et al. [19]. Physiological abnormalities
have also been observed in the hours prior to unplanned admissions to the Intensive Care Unit
(ICU) [20, 21] and preventable deaths [22]. Furthermore, in a study of electronic health record
(EHR) variables, it was found that 9 out of 14 predictors of cardiopulmonary arrests, unplanned
transfers to ICU, and death, were physiological (and at least 4 of the remaining 5 were directly
linked to physiology) [23]. The assumption that adverse events are preceded by changes in
physiology is also supported by expert opinion. In 2010 a consensus of international experts
found that most cardiac arrests and deaths are preceded by physiological parameters “lying
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outside . . . normal ranges” [24]. The overwhelming conclusion is that changes in physiology can
be observed during the hours prior to many adverse events.
It is widely accepted that the progression of deteriorations, and therefore the likelihood of
subsequent adverse events, can be reduced by recognising and acting on the accompanying
changes in physiology [25–27]. Currently, staff on general hospital wards identify deteriorations
through manual measurement of physiological parameters every 4-6 hours (such as heart rate
and blood pressure), from which an early warning score (EWS) is calculated indicating the
likelihood and severity of a deterioration [28]. The effectiveness of current practice is limited to
intermittent assessments since they have to be performed manually. This means deteriorations
can remain unrecognised until the next assessment, potentially delaying the clinical response by
several hours. In addition, the current manual assessments are time-consuming and inefficient.
It may be possible to address the shortcomings of manual and intermittent measurements by
using wearable sensors to monitor physiology continuously and automatically. Wearable sensors
for use in hospitals have traditionally been limited to providing electrocardiogram (ECG) based
heart rate and arrhythmia monitoring. Consequently their use has been confined to patients
at risk of arrhythmias. Recent developments in wearable sensor design and biomedical signal
processing techniques mean that it may now be possible to monitor a broader range of phys-
iological parameters using wearable sensors [29]. As a result, wearable sensors may now have
utility for the early detection of the wider range of deteriorations from which all acutely-ill
inpatients are at risk [30]. For example, wearable sensors can now monitor additional signals
such as the pulse oximetry (photoplethysmogram, PPG) signal, providing arterial blood oxygen
saturation (SpO2) monitoring. Furthermore, signal processing techniques for monitoring of the
respiratory, vascular, and autonomic systems have been developed in other settings, which could
be adapted for use with wearable sensors. Consequently, novel wearable sensors may be useful
for detecting not only cardiac deteriorations, but also those which manifest as changes in other
physiological systems.
Two additional steps are required to realise the potential of wearable sensors to provide clini-
cal benefit through detection of deteriorations. The first step concerns respiratory rate (RR),
which is a highly sensitive marker of deterioration [31]. Current methods for monitoring RR
using wearable sensors are either obtrusive or inaccurate [32]. Therefore, further development
and evaluation of RR monitoring techniques for use in wearable sensors is required. Secondly,
techniques for generating alerts of deteriorations need to be adapted for use with wearable
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sensors. Wearable sensor data is susceptible to artifact, due to poor sensor contact and move-
ment, and is also acquired during periods of activity. In contrast, intermittent physiological
measurements are checked for artifact by the measurer, and are acquired whilst patients are at
rest. Therefore, the techniques which have previously been used to identify deteriorations from
intermittent measurements may need to be refined for use with wearable sensor data. If these
issues can be resolved then there is potential for wearable sensors to improve patient safety
and quality of care, and reduce staff workload [33]. This is of particular importance since the
number of patients in hospital and severities of illnesses are increasing, whilst staffing levels are
decreasing [29, 34].
1.1 Thesis Goals
This thesis addresses the first step identified to realise the potential of wearable sensors: de-
veloping RR monitoring techniques for use in wearable sensors. The overall aim of this thesis
is:
To develop and assess the performance of techniques for continuous RR monitoring
using ECG and PPG signals for use in wearable sensors to detect deteriorations.
A deterioration is defined as an acute worsening of health, resulting in a transition to a physi-
ological state with an increased likelihood of a clinical adverse event [35].
Several goals were identified in order to achieve the overall aim as follows:
• To assemble a comprehensive physiological dataset using wearable sensors: A
comprehensive dataset was assembled containing wearable sensor data and labels of de-
teriorations suitable for development of algorithms to detect deteriorations. This dataset
included continuous ECG and PPG signals, from which RR could be estimated retrospec-
tively.
• To identify algorithms to estimate RR from the ECG and PPG from the lit-
erature, and methods used to assess their performance, to create a toolbox
of resources for algorithm assessments: Many algorithms have been proposed to
estimate RR from the ECG and PPG signals, which are commonly acquired by wearable
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sensors. These provide a convenient method for monitoring RR. However, a systematic re-
view of the literature found that these algorithms had not been comprehensively assessed.
Therefore, it was unclear which algorithm, if any, performed well enough for use in wear-
able sensors. A toolbox of algorithms and benchmark datasets was created to facilitate
comprehensive assessments of algorithm performances.
• To assess the influence of technical and physiological factors on respiratory
signals extracted from the ECG and PPG: It was not clear how technical and
physiological factors influence the performance of RR algorithms. Therefore, the quality
of respiratory signals extracted from the ECG and PPG was assessed under different signal
acquisition procedures and a range of physiological conditions to provide recommendations
for the design of wearable sensors incorporating RR algorithms, and for their clinical use.
• To assess the performance of RR algorithms for the ECG and PPG in healthy
subjects and hospitalised patients: A comprehensive assessment of existing RR algo-
rithms was performed to determine which, if any, were suitable for continuous monitoring
of acutely-ill patients using wearable sensors.
• To develop a novel algorithm for continuous RR monitoring: A novel RR algo-
rithm was designed specifically for use with acutely-ill patients and wearable sensors. This
algorithm was found to provide superior performance compared to existing RR algorithms.
• To assess the potential utility of wearable sensors for detecting deteriorations:
The potential utility of continuous RR monitoring using wearable sensors to detect dete-
riorations was assessed by using the novel RR algorithm to estimate RRs retrospectively
from the comprehensive physiological dataset assembled in the first goal. This provided
evidence to suggest that EWSs could be continuously updated using data acquired from
wearable sensors.
1.2 Thesis Outline
This thesis is structured as follows. Chapter 2 presents the clinical background, including
the current clinical practice for identifying deteriorations in ambulatory hospital patients, the
growing role of wearable sensors, and the steps required to realise the potential of wearable
sensors to improve identification of deteriorations. In Chapter 3 the data processing steps
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taken to assemble a comprehensive physiological dataset are described. The resulting dataset is
suitable for the development of algorithms to detect deteriorations. In Chapter 4 a systematic
review of RR algorithms is presented, followed by a toolbox of resources for assessment of RR
algorithms. Chapter 5 reports a study of the influence of technical and physiological factors on
the quality of respiratory signals extracted from the ECG and PPG, with implications for the
use of RR algorithms in wearable sensors. Chapter 6 presents a study of the performance of
RR algorithms across a range of datasets, culminating in the conclusion that no existing RR
algorithm performed well enough to be used for continuous RR monitoring of acutely-ill patients.
In Chapter 7 a novel RR algorithm is presented, designed specifically for monitoring acutely-ill
patients. In Chapter 8 the novel RR algorithm was used with the dataset presented in Chapter
3 to demonstrate the feasibility of continuous RR monitoring to detect clinical deteriorations
using wearable sensors. Finally, Chapter 9 presents a summary of the achievements of this
thesis, and directions for future work.
Chapter 2
Clinical Background
In this chapter the clinical background to this thesis is presented. Firstly, the clinical need for
identification of deteriorations is described. Secondly, an overview of current practice for phys-
iological assessment of ambulatory patients, and identification of deteriorations, is presented.
This is followed by an explanation of the potential role of wearable sensors in providing earlier
identification of deteriorations than current practice, and reducing staff workload. The current
evidence for the clinical benefit of multi-parametric wearable sensors is then reviewed. Finally,
the steps required to realise the potential of wearable sensors are described: (i) the need for
continuous, unobtrusive, RR monitoring; and, (ii) the need for sensitive and specific algorithms
to generate alerts of deteriorations from continuous wearable sensor data.
2.1 The Need for Early Identification of Deteriorations
There is no consensus on the definition of a clinical deterioration in the literature [36]. Deterio-
rations have been defined using four approaches: (i) adverse events contributed to by negligence;
(ii) defined clinical adverse events; (iii) the presence of physiological instability; and (iv) move-
ment to a clinical state which is associated with increased risk of defined clinical adverse events
[36]. In this work approach (iv) was used. A clinical deterioration was defined as an acute wors-
ening of health, resulting in transition to a physiological state with an increased likelihood of
a clinical adverse event. Examples of clinical adverse events include the development of sepsis,
acute kidney failure, respiratory failure, and cardiac arrest. This definition of a deterioration
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is particularly relevant to both patients and clinicians, since clinical adverse events result in
increased morbidity, mortality, and healthcare resource utilisation.
Acutely-ill hospitalised patients are at increased risk of deteriorations. Within this broad pa-
tient population, specific groups have a particularly high risk of deteriorations. For instance,
approximately 50 % of patients recovering from upper gastrointestinal surgery suffer from an
adverse event during their hospital stay [37]. In contrast, approximately 10 - 20 % of patients
recovering from cardiac surgery suffer an adverse event whilst in hospital [38, 39]. A large pro-
portion of adverse events (38.7 - 60.7 % in different patient groups) in post-operative patients
are potentially avoidable [39]. Therefore, there is a clinical need to identify deteriorations early
to prevent the subsequent adverse events which increase morbidity, mortality, and healthcare
costs.
Acutely-ill hospital patients suffer from a wide range of different types of adverse events [39, 40].
The relative importance of detecting deteriorations which are associated with each type of
adverse event is determined by several factors. Firstly, different types of adverse events have
different incidence rates in different populations. For instance, in a study of patients recovering
from coronary artery bypass graft (CABG) surgery, approximately 9 % suffered from congestive
heart failure, whereas only 1 % suffered from a stroke [40]. Secondly, the impact of each type of
adverse event on morbidity, mortality and quality of life varies [41]. For example, in this CABG
study the mortality rates associated with the two types of adverse events differed markedly, with
approximately 12 % of occurrences of congestive heart failure resulting in death, compared to
27 % of strokes. Thirdly, different types of deteriorations can be treated with differing success
rates. In this example, the treatments for the two deteriorations differed. The symptoms
of congestive heart failure can be treated by oxygen (or respiratory) therapy, and the use of
vasodilators and diuretics. In contrast, the treatments for strokes are less easily administered,
and often last far longer, including extensive rehabilitation programmes. The heterogeneity
in incidence, impact, and treatments of different types of deteriorations has an effect on the
relative importance of detecting each one.
It is important that deteriorations are identified early to improve patient outcomes and reduce
healthcare costs. In a study of inpatients from four surgical services approximately 6 - 12 %
of deteriorations resulted in death [39]. Furthermore, 20 - 45 % of these deaths were judged to
be potentially avoidable [39]. Therefore, timely identification and appropriate management of
deteriorations may decrease mortality. The importance of early identification of deteriorations
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was shown by a trial investigating the impact of hospital-wide medical emergency teams (METs)
[42], who attend to and manage deteriorating patients. The rate of cardiac arrests and unex-
pected deaths decreased as the proportion of early MET calls increased [43], suggesting that
early identification and management of deteriorating patients may indeed be associated with
improved outcomes. In addition, deteriorations have been shown to increase length of stay after
surgery [12], thereby increasing healthcare costs [13, 14]. Early identification of deteriorations
is beneficial for both patients and healthcare providers.
2.2 Physiological Monitoring of Ambulatory Inpatients
Acutely-ill hospital patients have their physiology measured regularly to assess their risk of dete-
rioration, since deteriorations are commonly accompanied by changes in physiology [18],[19],[20–
24]. In the UK seven physiological parameters are measured regularly in acutely-ill patients, as
listed in Table 2.1 [28]. These physiological parameters are typically measured every 4-6 hours,
although this can be decreased to once every 12 hours for patients not displaying any deranged
physiological parameters, or increased to every hour or even continuous monitoring for patients
displaying deranged physiology [28]. Physiological measurements are obtained using a monitor
which is typically wheeled from one patient to the next. The current practice of taking regu-
lar physiological measurements is designed to ensure that every acutely-ill patient is regularly
assessed for signs of deterioration, and has several benefits:
• Accuracy: Since measurements are taken by hand, the operator can assess the accuracy
of the measurements, quickly resolving the causes of any unreliable measurements, such
as poor sensor contact.
• Data coverage: The level of patient compliance with these physiological measurements
is extremely high, since an operator ensures that the measurements are successfully taken.
• Additional assessment: The operator has opportunity to observe additional factors
which may be indicative of deterioration, which cannot be measured electronically.
• Response: A clinical response can be easily initiated in response to the physiological
measurements, because these are immediately reviewed by the operator. The operator can
either initiate a response themselves (such as the administration of supplemental oxygen),
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Table 2.1: Physiological parameters measured intermittently during routine practice: The
listed parameters are measured every 4 - 6 hours in acutely-ill hospital patients to calculate the
National Early Warning Score (NEWS) [28]. Details of techniques (either electronic or manual)
which are commonly used to measure the parameters are provided.
Parameter Abbr. Measurement technique Electronic?
Heart rate HR A pulse oximeter is used to automatically esti-




SpO2 A pulse oximeter is used to automatically esti-




SBP A sphygmomanometer is used to automatically
estimate SBP. This involves application of a
blood pressure cuff around the upper arm.
X
Temperature temp A thermometer is used to estimate core temper-
ature. A variety of thermometers are in routine
use, including single-use oral thermometers, and
electronic tympanic thermometers.
X
Respiratory rate RR RR (the number of breaths per minute) is usu-
ally measured by manually counting chest wall
movements over a period of approximately 30 s.
7
Oxygen therapy O2 A binary variable indicating whether or not the




LOC A multinomial variable indicating the LOC with
the following categories: (i) Alert (fully awake),
(ii) Voice (responds to a voice stimulus), (iii)
Pain (responds to a pain stimulus), (iv) Unre-
sponsive (no response to voice or pain).
7
or can quickly inform another member of staff to trigger a more complex response (such
as a new pharmacological intervention).
Once a set of measurements have been obtained an additional step is taken to identify deteri-
orations. This is performed by calculating an early warning score (EWS), an aggregate score
calculated from physiological parameters, which indicates the presence and severity of a deteri-
oration. EWSs are designed to overcome the problem that no single parameter is all-important
for identification of deteriorations [44]. A simple formula is used in which each parameter is as-
signed a score indicating its level of abnormality, and these individual scores are summed to give
an aggregate score. The higher the aggregate score, the higher the likelihood of deterioration.
The regular use of a standardised National Early Warning Score (NEWS) to assess acutely-ill
hospital patients was mandated in the UK in 2012 [28]. The methodology for calculating the
NEWS is displayed in Table 2.2. This score has been found to outperform previously proposed
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Table 2.2: Calculation of the National Early Warning Score (NEWS): Seven physiological
parameters (defined in Table 2.1) are measured, and a score is assigned to each. The NEWS is
then calculated as the sum of these individual scores [28]. Definitions of LOC categories: A -
alert, V - responds to voice, P - responds to pain, U - unresponsive.
Parameter Score assigned to individual parameter
3 2 1 0 1 2 3
HR ≤ 40 41-50 51-90 91-110 111-130 ≥ 131
SpO2 ≤ 91 92-93 94-95 ≥ 96
SBP ≤ 90 91-100 101-110 111-219 ≥ 220
temp ≤ 35.0 35.1-36.0 36.1-38.0 38.1-39.0 ≥ 39.0
RR ≤ 8 9-11 12-20 21-24 ≥ 25
O2 Yes No
LOC A V, P, or U
EWSs when used to identify patients at risk of cardiac arrest, unexpected ICU admission, and
death [45]. EWSs have also been integrated into worldwide clinical practice [46].
The performances of EWSs are the subject of debate. On one hand, EWSs have been shown
to correlate with important patient-centred endpoints such as levels of intervention [47], higher
hospital mortality [47, 48], length of stay [48], and to be a better predictor of cardiac arrest than
individual parameters [49]. Furthermore, they have resulted in clinical response at lower levels
of physiological abnormality [50]. On the other hand, it has not been shown conclusively that
the use of EWSs translates to improved patient outcomes [51]. For instance, in 2003 a study
of the use of an EWS to triage medical admissions did not find any impact on outcomes [31].
In 2007, there was “little evidence of reliability, validity and utility” of EWSs [52], particularly
as the majority of 33 different EWSs discriminated poorly between survivors and non-survivors
[53]. Reassuringly, since then the NEWS has been recommended for use across the NHS, and
has been shown to outperform the 33 previously tested EWSs [45]. Nonetheless, there may still
be scope to improve the performances of EWSs.
2.3 The Potential Role for Wearable Sensors
The use of wearable sensors (hereafter also defined as wireless) to monitor human physiology
began in 1961 when the first human in space, Yuri Gagarin, was continuously monitored by
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doctors on earth [29]. By 1969 the technology had developed to allow simultaneous monitoring
of multiple astronauts during the first moon-landing mission. By the 1980s wearable sensors
had been successfully translated into hospital use in intensive and acute care units [54].
Since the 1980s the role of wearable sensors in hospitals has been largely confined to cardiac
monitoring. Their routine use is dominated by electrocardiogram (ECG) monitoring, which is
indicated for specific patient groups in hospital [55]. Wireless ECG monitoring is typically used
to facilitate mobilisation when patients are not sufficiently ill to require more intensive, tethered
monitoring. Possible settings include intensive and coronary care units, cardiac telemetry wards,
and less routinely, post-cardiac surgery units, the surgical recovery room, and the emergency
department [56].
Wearable sensors are currently used to identify abnormal heart rhythms. A wide range of
rhythms can be identified in real-time, such as: inefficient arrhythmias including atrial fibrilla-
tion; life-threatening arrhythmias such as bradycardia and ventricular tachycardia; and asystole.
Indeed, the use of wearable sensors for identification of life-threatening dysrhythmias has been
shown to improve patient outcomes. Recent studies have found telemetry (remote monitoring,
typically of the ECG) to be associated with improved survival to hospital discharge following
in-hospital cardiac arrest [57, 58]. The mechanism underlying this improvement may be that
the use of telemetry allowed earlier defibrillation, which increased the likelihood of survival
to hospital discharge [59]. This illustrates how wearable sensors are currently used to trigger
restorative, rather than preventative, treatments.
There is a desire to use wearable sensors in a preventative manner for early detection of the dete-
riorations which precede adverse events. Currently, clinical deteriorations of acutely-ill patients
are detected through manual physiological assessments. However, this is limited to intermit-
tent assessments, meaning deteriorations can remain unrecognised until the next assessment
exposing the patient to delays in time-sensitive interventions. The use of wearable sensors cou-
pled with an intelligent notification system may facilitate earlier detection of deteriorations,
since they could provide continuous physiological assessments. Indeed, in some cases they are
currently being used for this purpose, rather than solely for detection of dysrhythmias [60], de-
spite only being able to monitor a minority of physiological parameters such as HR and SpO2.
However, studies have demonstrated only minimal, or no, improvement in patient outcomes
associated with the use of wearable sensors for detection of deteriorations [56, 61–63]. This
is because traditional wearable sensors are designed to identify dysrhythmias based on ECG
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monitoring, but are ill-equipped to identify the multi-parametric physiological changes that in-
dicate deteriorations. Furthermore, there is a low frequency of cardiac arrests or dysrhythmias
amongst patients monitored by telemetry [61–63], meaning that wearable sensors will have lim-
ited impact unless a wide range of deteriorations can be detected. There are also unintended
consequences of using wearable sensors in this way. They may provide a false sense of security
[30] and result in alarm fatigue due to a high false alarm rate [64]. Overall, the evidence suggests
that the use of traditional ECG-based wearable sensors for detecting deteriorations is far from
ideal, as summarised in [65].
Recent developments have rendered wearable sensors much more suitable for detection of dete-
riorations. Firstly, novel wearable sensors can now be used to monitor a much broader range of
physiological parameters than traditional wearable sensors [29]. Table 2.3 lists those parame-
ters which can be measured by wearable sensors which are available for clinical use in hospitals.
These include the five routinely measured ‘vital signs’ (HR, RR, SpO2, SBP and temp), and
ECG-based analyses. This demonstrates that it is technically possible to monitor the five vital
signs using a wearable sensor, as well as parameters indicative of cardiac function. Secondly,
wearable sensors are being made less obtrusive, making them more acceptable to patients. For
example, wrist-worn and patch-style sensors are now being trialled for use in hospitals, such as
the sensor shown in Figure 2.1 [66, 67]. Thirdly, algorithms for assessing the quality of phys-
iological signals can now be implemented on wearable sensors to ensure that only parameters
estimated from high quality signals are reported (such as HRs estimated from the ECG) [67].
Fourthly, the battery life of wearable sensors has increased up to five days [68], reducing the
workload associated with battery replacement. Fifthly, wearable sensors can now be operated
on a hospital’s Wi-Fi network, rather than requiring a bespoke wireless network [69]. Finally,
novel data fusion algorithms for identification of deteriorations from multi-parametric data have
been developed [70], increasing the reliability of identifications of deteriorations [71]. As a re-
sult, the role of wearable sensors may no longer be largely confined to cardiac monitoring in
patients perceived to be at risk of dysrhythmias [30]. Instead, they may have utility for the
early detection of deteriorations which precede adverse events.
An additional, related application for wearable sensors is to reduce the workload associated with
manual physiological assessments. Considerable workload is created by 4 - 6 hourly assessments
since on a general hospital ward there are several patients per member of staff, and each manual
assessment takes several minutes. It may be possible to use wearable sensors to safely reduce the
frequency of manual assessments in patients deemed to be at low risk of deterioration. A process
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Table 2.3: Parameters which can be measured using wearable sensors
Parameter Sensor(s) Methodology
Vital Signs
HR ECG or pulse
oximeter
Heart rate (HR) can be measured from either the ECG or
PPG by detecting individual heart beats in the signals.
This is commonly achieved by using a QRS detector (e.g.
[72, 73]), or pulse peak detector (e.g. [74]).
SpO2 pulse oximeter Arterial blood oxygen saturation (SpO2) can be measured
using a pulse oximeter, commonly situated at either the
finger or ear. The acceptability of pulse oximeters is im-
proving with the design of more comfortable sensors, such
as a miniaturised Velcro finger strap sensor [75].
RR ImP, InP or ac-
celerometer
Several techniques have been developed for monitoring
respiratory rate (RR), although none is used ubiquitously.
RR can be extracted from: inductance plethysmography
(InP) signals acquired from a strain gauge in a chest
band [76]; impedance pneumography (ImP) signals ac-
quired using two ECG electrodes [69]; and recently an
accelerometer has been used to monitor respiratory move-
ments on the abdomen [77]. Although not in clinical use,
methods are being developed for estimation of RR from
a gyroscope, the ECG, and the PPG [78–80].
BP sphygmoman-
ometer
Some novel wearable sensors include a sphygmomanome-
ter for blood pressure (BP) measurement [77].
temp thermometer Surface temperature (temp) can be measured in wearable
sensors using a thermometer sited at various locations




ECG Arrhythmia and dysrhythmia alarms are routinely pro-




ECG Novel wearable sensors provide measurements of ECG
morphology such as ST duration and QT elevation [83].
such as that illustrated in Figure 2.2 could be used to achieve this. In this process, patients
who have a low enough NEWS at a manual assessment would have the next manual assessment
conducted 12 hours later unless their wearable sensor detected a change in physiology. If a
change in physiology was detected by the wearable sensor, then a manual assessment would
be conducted immediately. This process is based on current guidelines for determining the
frequency of assessments in [28], in which the frequency is reduced to 12 hourly in patients who
are assessed to be at minimal risk of deteriorations, as indicated by a NEWS of zero. If it is
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Figure 2.1: A wrist-worn wearable sensor: Nonin Medical’s WristOx2 R© 3150 measures heart
rate (HR), arterial blood oxygen saturation (SpO2), and the photoplethysmogram (PPG) con-
tinuously. Source: [5] (CC BY 4.0, DOI: 10.5281/zenodo.166546)
possible to safely reduce the frequency of manual assessments in low risk patients using this
approach, then it could result in a considerable reduction in workload.
2.4 Current Evidence for the Clinical Benefit of Wearable Sen-
sors
Wearable sensors must satisfy two key requirements to confer clinical benefit in the broad
population of acutely-ill patients:
1. Data coverage: Wearable sensors must provide a sufficiently high real-time data cover-
age, where the data coverage is defined as the proportion of time for which high quality
data are available. Achieving high data coverage in an ambulatory population is not
straightforward for several reasons. These include: the presence of artifact due to move-
ment or poor sensor contact; the discomfort of wearing sensors for prolonged periods;
and, minimal capacity for both clinicians and patients to troubleshoot any problems, since
clinicians already have busy workloads, and patients are often unfamiliar with wearable
sensors.
2. Multi-parameter monitoring: Wearable sensors must acquire a sufficiently comprehen-
sive set of signals and parameters to be able to detect the physiological changes indicative
of deteriorations. Although a broad set of parameters are measured during intermittent
observations (Table 2.1), it is difficult to acquire such a comprehensive set from wear-
able sensors. This is due to: the increased burden on the patient of wearing multiple
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Figure 2.2: Using wearable sensors to reduce staff workload: This process could be used
to reduce the workload associated with manual physiological assessments. An initial manual
assessment is taken to determine whether a patient is at sufficiently low risk of deterioration,
as indicated by a NEWS < thresh. Low risk patients are continuously assessed for changes in a
subset of physiological parameters using wearable sensors. If a change is detected then a manual
assessment is triggered; otherwise, the delay between manual assessments is 12 hours, reducing
workload.
transducers (such as both a pulse oximeter and a set of ECG leads); the increased power
requirements and consequent shortening of battery life when using multiple transducers;
and, the difficulty of acquiring some parameters accurately and unobtrusively, such as RR.
If wearable sensors satisfy these requirements, resulting in a high enough data capture rate for
a sufficiently comprehensive set of physiological signals and parameters, then they may confer
clinical benefit.
Surprisingly few studies have been conducted using multi-parametric wearable sensors in hos-
pitals, as summarised in Table 2.4. Those studies that have been conducted are subject to the
shortcomings of using short monitoring periods and small sample sizes, as illustrated in Figure
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Duration of monitoring [hours]
Number of
patients
Figure 2.3: The shortcomings of studies of wearable sensors: Most studies of multi-parametric
wearable sensors (represented by dots) have either monitored patients for short periods (typically
24 hours or less), or have enrolled few patients (typically less than 50). The studies shown are
detailed in Table 2.4. It was assumed that the patients monitored “until discharge” in [85] were
monitored for 120 hours (five days).
2.3. Evaluations of wearable sensors must be conducted over a similar time-scale to that for
which they would be used in practice. Acutely-ill patients may stay in hospital for several days
or weeks. However, all except one of these studies monitored patients for less than 26 hours on
average, limiting the relevance of their findings with regard to patient acceptance of the sensors.
Furthermore, evaluations must be adequately powered (i.e. have a sufficiently large sample
size) to assess inter-subject variability in feasibility, and to identify clinical benefit given that
only a small minority of patients are likely to deteriorate. However, only three studies enrolled
more than 50 patients. This suggests that further research is required to assess the technical
functionality and clinical benefit of wearable sensors.
Existing studies provide insight into the technical feasibility of acquiring data from wearable
sensors in hospitals. Half of the studies identified in Table 2.4 reported packet reception ratios
or data coverage rates, and are listed in Table 2.5. The packet reception ratios indicate the
proportion of data transmitted from a wearable sensor which were successfully received. The
reported packet reception ratios of over 95 % suggest that it is feasible to transmit and receive
data from wearable sensors in the hospital setting. Indeed, in one study, Chipara et al. found
that service intervals (periods of time for which transmissions were continuously received) lasted
a median of 17.7 minutes, with 90 % of subsequent outage intervals (periods of time for which
transmissions were not received) lasting 1.4 minutes or less [86]. Therefore, the challenges
associated with transmitting wearable sensor data in a hospital, such as obstacles in wards, a
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Table 2.5: Studies of wearable sensors which reported data acquisition rates: Studies reported
packet reception ratios (the proportion of data packets transmitted from a wearable sensor which
were successfully received) and data coverage rates (the proportion of time for which valid data
were acquired). * indicates that multiple devices were tested.




Orphanidou et al. [66] ECG - 97
pulse ox - 88
Chipara et al. [86, 87] pulse ox 99.7 ≈ 80.9
Ko et al. [33] pulse ox 95.4 -
Ko et al. [89] pulse ox 98.3 -
Lopez et al. [90] accelerometer
≈ 99 -
ECG, thermometer
Bonnici et al. [75] ECG - 56.1, 38.8 *
pulse ox - 18.7, 56.1, 9.9 *
changing environment due to movements of people and equipment [33], and transmission within
close proximity to the human body, do not appear to preclude the use of wearable sensors.
Evidence for the feasibility of using wearable sensors to acquire physiological measurements
from hospital patients is less conclusive. Three studies reported the data coverage rate, the
proportion of time for which valid data were acquired. Data can be rendered invalid by sensor
disconnection, poor sensor connection or motion artifact. A wide range of data coverage rates
have been reported for both ECG and pulse oximetry sensors, ranging from 19 to 97 % (see
Table 2.5). This is likely to be indicative of the user acceptability of wearable sensors, since
sensors may be removed by patients or staff if they are too burdensome. Whilst some studies
have reported acceptability feedback from both patients and clinicians, none of these studies
have monitored patients for over 24 hours [33, 88, 91]. It should be noted that the highest
data coverage rates were achieved when monitoring patients for ≤ 4.0 hours [66]. In contrast,
the lower data capture rates reported in [75, 86, 87] were achieved when monitoring patients
for approximately 24 hours. This suggests that the acceptability of wearable sensors, and
therefore the data capture rates, may be associated with the time for which patients have worn
the sensors. Therefore, further research is required to determine whether the use of wearable
sensors for prolonged monitoring is acceptable to patients.
Evidence for the clinical benefit of wearable sensors is sparse. The utility of wearable sensors
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for arrhythmia detection has been reported [88, 91], although a high false alarm rate for critical
arrhythmias has also been reported [84]. Only minimal evidence is currently available to support
the hypothesis that wearable sensors can be used to detect deteriorations other than arrhythmias
and result in changed patient outcomes. For instance, Kisner et al. reported that the use of a
wearable pulse oximeter, coupled with a protocol for initiating supplementary oxygen therapy
if the SpO2 fell below 90 %, reduced the incidence of atrial fibrillation in patients recovering
from a coronary artery bypass graft [85]. There are two reasons for a lack of evidence for
the clinical benefit of wearable sensors. Firstly, very few studies have been conducted on the
topic. Secondly, development of wearable sensors has focused largely on the hardware required
to acquire streams of clinical data. However, simply acquiring data will not have an impact
unless it is appropriately processed, providing decision support to clinicians. The next section
will discuss how software for processing of wearable sensor data could be designed to realise the
potential of wearable sensors.
2.5 Realising the Potential of Wearable Sensors
The key to realising the potential of wearable sensors for detecting deteriorations is found in the
development of techniques to process and synthesise the continuous data to provide clinically
useful and actionable outputs. This section provides the clinical background to the contributions
of this thesis towards realising the potential of wearable sensors.
2.5.1 Development and evaluation of techniques for continuous, unobtrusive
RR monitoring
RR has been found to be a highly sensitive marker of deteriorations [93]. For instance, cardiac
arrests are preceded by abnormal RRs [18, 49, 94–96]; elevated RR can indicate respiratory
dysfunction [97]; and, both elevated and reduced RRs (≥ 20 and < 6 breaths per minute, bpm)
are predictors of mortality [22, 98, 99]. RR has been shown to be a particularly important
indicator of deterioration. For instance, it has been observed to be the best discriminator of
patient risk [31] and the best single variable predictor of cardiac arrest [49]. Furthermore, it
has been found to be highly predictive of resuscitation events and death (odds ratio, OR (95%
CI) = 9.1 (7.12 - 11.59) for RR > 24 bpm) [23], and of in-hospital mortality (OR (95% CI) =
3.18 (2.89 - 3.50) for RR > 22 bpm). Thus, there is much evidence that manual, intermittent
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measurements of RR are highly sensitive markers of deteriorations, suggesting that RR has an
important role to play in the detection of deteriorations using wearable sensors.
Current methods for taking individual and continuous measurements of RR are far from ideal,
despite the clinical importance of RR. In current clinical practice individual measurements are
usually taken by manually counting the chest movements associated with individual breaths
over a period of approximately 30 - 60 s [100]. This practice is time-consuming, inaccurate
[32], and poorly carried out [101–104]. Electronic methods for monitoring RR continuously are
also susceptible to criticism, being obtrusive and inaccurate [32]. For instance, three methods
are currently employed in wearable sensors to monitor RR: impedance pneumography (ImP),
inductance plethysmography (InP), or an accelerometer. ImP is the least obtrusive of these
methods since it consists of measurement of variations in thoracic impedance with respiration
through injection of a high frequency voltage into the thorax at ECG electrodes [105]. However,
ImP has been found to be imprecise, with 95% limits of agreement between reference RRs and
ImP-derived RRs reported as ± 11.9 bpm and -9.9 - 7.5 bpm [32, 106]. These errors are large
considering that a normal RR range is approximately 12 - 20 bpm. The use of InP is limited
by the cumbersome nature of the chest bands which are required to hold a strain gauge against
the thorax. Chest bands have been observed to be too uncomfortable for prolonged monitoring
[66]. Until recently the use of accelerometers was confined to experimental devices [107], and
their performance remains unclear. Therefore, there is an urgent need to develop a method for
continuously and unobtrusively monitoring RR using wearable sensors.
A potential solution is to estimate RR from the ECG or PPG signals. Both signals are modu-
lated by respiration as shown in Figure 2.4, providing opportunity to estimate RR from them.
Furthermore, most wearable sensors monitor at least one of the ECG and PPG signals, since
they are required to measure HR, and the PPG is required to measure SpO2. Therefore, esti-
mation of RR from the ECG or PPG would allow RR to be monitored without the need for
any additional sensors, providing a valuable marker of deterioration. Over 100 algorithms have
been proposed in the literature to estimate RR from the ECG and PPG [10]. However, it is not
clear which of these algorithms provides the best performance, nor whether any of these algo-
rithms perform sufficiently well for use in wearable sensors. This is because previous comparison
studies have compared only a small number of algorithms [10] (see for example [108–113]). In
addition they have often evaluated algorithms on data acquired from mechanically ventilated
patients whose respiratory mechanics are different to those of ambulatory patients. Therefore, a
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Figure 2.4: Modulation of the pulse oximetry (PPG) signal by respiration: Stroke volume
varies during respiration due to changes in intrathoracic pressure and venous return. This causes
amplitude modulation of the PPG signal. Other modulations of the PPG are also caused by
respiration, as detailed in Section 4.2.
comprehensive evaluation of existing algorithms is required to identify the best algorithm, and
determine whether its performance is sufficient for use in wearable sensors.
2.5.2 Identification of deteriorations from wearable sensor data
The second step in the processing of wearable sensor data is to generate alerts of deteriorating
patients which can be used to trigger clinical actions. There has been much research into EWSs
for identification of deteriorations from intermittent measurements. However, only minimal re-
search has been conducted into techniques for detecting deteriorations from continuous wearable
sensor data. Two techniques are in clinical use with wearable sensors. The first technique is
to use an EWS to detect deteriorations with the continuous data provided by wearable sensors.
This approach is now clinically available in the IntelliVue Guardian Solution (Philips Medizin-
Systeme GmbH, Böblingen, Germany) [77], which can be customised to use any desired EWS
algorithm [114]. Secondly, novelty detection algorithms are being used to assess the likelihood
of deterioration using wearable sensor data. For instance, the VisensiaTM system, designed
by Tarassenko et al. and commercialised by OBS Medical Ltd (Abigndon, UK), uses novelty
detection methods to quantify the level of abnormality of a set of physiological parameters,
indicating deteriorations [115]. These two techniques are now explained in further detail.
The use of an EWS to assess the likelihood of deterioration is a benchmark method for converting
physiological data into clinically meaningful alerts. However, EWSs are designed for use with
high quality data obtained from patients at rest during intermittent physiological assessments.
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In contrast, wearable sensor data present additional challenges due to the increased likelihood
of low quality data, and the possibility of data being acquired during physical activity. Both
scenarios result in the physiological inputs to an EWS not being representative of a patient’s
true physiology when at rest. Furthermore, EWSs typically require inputs which are not pro-
vided by wearable sensors, meaning that additional inputs from the previous set of intermittent
measurements are required, which may no longer be accurate. Therefore, the straightforward
use of an existing EWS to synthesise wearable sensor data cannot be presumed to be an optimal
solution. Modifications to existing EWSs may be needed, such as a requirement that elevated
EWSs be sustained for a certain period before raising an alert to avoid false alerts due to tran-
sient, unrepresentative input data. However, an advantage of the use of EWSs is that they are
already familiar to hospital clinicians due to their widespread use.
The second technique of using novelty detection algorithms to identify deterioration is more
easily adapted for use with wearable sensor data. The VisensiaTM system consists of a multi-
variate probability density function (PDF) learnt from a historical dataset. An alert is triggered
when the probability associated with a set of measurements is below an empirically-optimised
threshold. The system was originally trained using continuous monitoring data [115]. Therefore,
it is likely that the model is more robust to the potentially unrepresentative data provided by
wearable sensors. In addition, the model was generated using statistical methods, unlike EWSs
which usually contain an element of expert opinion [116]. Therefore, the system could easily be
re-trained for use with wearable sensor data. Furthermore, the PDF can be generated from any
desired set of numerical inputs. Consequently, this approach is suitable for use with wearable
sensors which only provide a subset of the routinely measured physiological parameters. It is
also suitable for patient-population specific monitoring, since a new PDF could be generated for
each patient population (although this is not currently implemented). In addition, this approach
may facilitate analysis of physiological variability, since the variability in each parameter, and
the variability in their relationships, is captured by the PDF.
Techniques to identify deteriorations from wearable sensor data should be designed with the
following three requirements in mind. Firstly, they must provide sensitive alerts of deterio-
rations. Secondly, the alerts must provide sufficiently earlier warning of deteriorations than
current practice to be clinically advantageous. Thirdly, the positive predictive value (PPV) of
alerts (the proportion of alerts which are true) must be sufficiently high to avoid alarm fatigue.
The problem of alarm fatigue arises where staff have to respond to an overly high false alert
rate. Previous studies of wearable sensors have identified extremely high false alert rates [64],
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which has potential to desensitise staff to alarms, cause mistrust of the equipment, and result in
a lack of response to true alarms [117–119]. Further research is required to determine whether
either of the approaches described meets these three requirements, or whether novel techniques
are required.
2.6 Final Remarks
Acutely-ill hospitalised patients are at risk of deterioration, defined as an acute worsening in
health, resulting in transition to a physiological state with an increased likelihood of a clini-
cal adverse event. Current practice for identification of deteriorations is based on intermittent
physiological assessments, which are performed by hand at 4 - 6 hourly intervals. Recent devel-
opments in wearable sensors mean that they may now have a role in improving the detection
of deteriorations, and reducing the workload associated with manual physiological assessments.
The continuous data provided by wearable sensors may facilitate earlier identification of changes
in physiology, personalised alerting, and analyses of physiological variability. However, very few
studies have investigated the use of multi-parametric wearable sensors in hospitals. Most pre-
vious studies have been limited by low sample sizes or a short monitoring duration. Therefore,
evidence for the feasibility of using wearable sensors to monitor hospitalised patients for pro-
longed periods is lacking, and evidence for the clinical benefit of wearable sensors is even more
sparse. Consequently, further research is required before wearable sensors can be used for de-
tection of deteriorations in hospital patients.
Two steps towards realising the potential of wearable sensors for detecting deteriorations have
been identified. Firstly, a technique is required for continuous and unobtrusive RR monitoring
using wearable sensors. This is because RR is a sensitive marker of deteriorations, yet current
methods for monitoring RR using wearable sensors are highly obtrusive or inaccurate. Secondly,
a technique is required to identify deteriorations from multivariate, noisy, wearable sensor data.
Two existing techniques are now in clinical use: EWSs and novelty detection algorithms. How-
ever, it is not clear whether they perform well enough to meet the three requirements of a
technique to identify deteriorations: sensitivity, advanced warning, and a high PPV. The re-
mainder of this thesis presents investigations into continuous RR monitoring techniques for
use with wearable sensors. In Chapter 8 a RR algorithm is used with algorithms to detect
deteriorations to assess the utility of wearable sensors for detection of deteriorations.
Chapter 3
Assembling a Physiological Dataset
This chapter describes the processes undertaken to assemble a comprehensive physiological
dataset acquired from 226 adult patients. Firstly, the clinical trial in which the data were col-
lected is summarised. This is followed by descriptions of the processes for data preparation
(preparation specific to this particular trial) and quality assessment (identification and elimi-
nation of unreliable continuous data). A detailed description of the dataset is then provided.
Finally, the utility of the dataset for assessing the utility of wearable sensors is evaluated.
3.1 The Feasibility and Efficacy of Continuous In-Hospital Pa-
tient Monitoring (LISTEN) Trial
The Feasibility and Efficacy of Continuous In-Hospital Patient Monitoring (LISTEN) Trial
was an observational study in which acutely-ill patients were monitored continuously using
wearable sensors. Its primary aim was to determine whether wearable sensors could be used
to provide earlier warning of deteriorations than standard practice. Secondary aims included
assessments of the feasibility and clinical utility of using wearable sensors to monitor hospital
patients continuously, and to develop novel early warning algorithms for use with wearable
sensors. A highly comprehensive physiological dataset was acquired during the trial, including
electrocardiogram (ECG) and photoplethysmogram (PPG) data from wearable sensors, making
it particularly suitable for this work. The trial was approved by the Bloomsbury Research
Ethics Committee (reference 12/LO/0526), and was carried out at Guy’s and St Thomas’ NHS
Foundation Trust, London, UK (National Clinical Trial no. 01549717) between November 2012
24
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and January 2014. Continuous physiological data were acquired throughout patients’ post-
surgical hospital stays, as well as routine health record data. Furthermore, labels of adverse
events (defined in Table 8.1) were added retrospectively. Consequently, the dataset is a highly
comprehensive record of the physiology of a set of acutely-ill hospital patients, both in terms of
the frequency and breadth of measurements.
The patient population chosen for the trial was that of adult patients recovering in hospital
after major cardiac surgery, which had both advantages and disadvantages. The advantages
stemmed from the relative ease of acquiring continuous physiological data from this population.
Firstly, it was possible to equip all of the wards on which these patients would typically stay with
continuous monitoring equipment, since the patients typically followed a narrow and predictable
clinical pathway. Secondly, all of the study wards already used continuous monitoring equipment
when clinically indicated. Therefore, ward staff were familiar with the equipment, making it
easier to use continuous monitoring equipment with the study patients. However, there were
two key disadvantages. Firstly, the incidence of deteriorations in this population is low (in
comparison to high-risk surgical cohorts). Approximately 10-20% of patients recovering from
cardiac surgery suffer from a deterioration during their hospital stay [38, 39], and their hospital
mortality rate is approximately 3% [120]. In contrast, approximately 50% of patients recovering
from major gastrointestinal surgery suffer from a deterioration [37]. Secondly, clinical staff
could not be blinded to the continuous physiological data, since the monitoring equipment was
already in routine clinical use. Therefore, it may have helped staff to identify deteriorations
earlier, prompting clinical interventions which would otherwise not have been carried out.
Patients recovering from major cardiac surgery are at risk of a wide range of adverse events.
The adverse events which can be expected after coronary artery bypass graft (CABG) surgery,
a common type of cardiac surgery [120], have been reported in [40]. Several organ systems
are affected by these events. For instance, the heart is affected by congestive heart failure and
other cardiac events; the cardiovascular system is affected by bleeding and hypotension; the
respiratory system is affected by pneumonia, respiratory compromise, and pneumothorax; and
the kidneys are affected by renal dysfunction. Consequently, the physiological manifestations of
the deteriorations preceding these events can be expected to differ greatly with different types
of event. For instance, cardiac deteriorations are commonly manifested as abnormalities on
the ECG. In contrast, respiratory deteriorations primarily impact vital signs such as RR and
SpO2, whereas cardiovascular deteriorations primarily impact HR and BP. Since each type of
deterioration may affect a different organ system, and manifest differently, it may be necessary
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Table 3.1: The typical clinical pathway of patients participating in the LISTEN trial whilst
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to design algorithms to detect individual types of deteriorations, or groups of deteriorations
which manifest similarly.
Patients in this trial typically stayed in two distinct clinical settings with differing capabilities
for continuous physiological monitoring: critical care and the ambulatory ward. Patients were
initially treated in a level 1 critical care ward following surgery, known as an intensive care
ward. They were then cared for in a level 2 critical care ward, known as a high dependency
ward. Finally, they stayed in a level 3 ambulatory ward until hospital discharge. The first two
settings, the level 1 and 2 critical care wards, used static bedside monitors (IntelliVue MP70
monitor, Philips Medical Systems, Andover, MA, USA) for continuous physiological monitoring.
The physiological signals monitored were lead II ECG, finger PPG, impedance pneumography
(ImP), arterial blood pressure (ABP) signals (although ABP was rarely monitored in the level
2 ward), central venous pressure (CVP), and occasional additional ECG leads. In contrast, in
the level 3 ambulatory ward static monitors were no longer used, and instead wearable sensors
(IntelliVue TRx M4841 telemetry monitors, Philips Medical Systems) were used, which only
provided continuous monitoring of ECG and PPG signals. Further details of the signals and
parameters are provided in Table 3.1. As a result of the reduced monitoring capabilities on
the ambulatory ward, the only continuous physiological signals available throughout patients’
recoveries were ECG and PPG, and the only continuous parameters were HR and SpO2.
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Continuous monitoring data, which consisted of physiological signals, parameters and monitor-
ing alarms, were acquired from the bedside monitors and the wearable sensors using BedMaster
data acquisition software (v.4.1.12, Excel Medical Electronics, Jupiter, FL, USA). The software
associated data with the monitor from which they were recorded, rather than with a particu-
lar patient. Therefore, the times at which patients were being monitored by each monitor were
manually recorded in the electronic Case Report Form (eCRF) to allow the data associated with
each patient to be identified. The data were recorded in a proprietary format, and converted
to Extensible Markup Language (XML) format using the BedMaster software. They were then
converted to Matlab R© format using bespoke software.
The acquisition of intermittent physiological measurements also varied between clinical settings.
In the level 1 and 2 critical care wards observations were routinely recorded in an Electronic
Health Record (EHR), and could be exported to a text file for subsequent processing. However,
in the level 3 ambulatory ward observations were routinely recorded on paper notes. In an at-
tempt to capture these electronically we introduced new vital signs monitors (CVSM 6000, Welch
Allyn, UK) to the ward for the trial. This allowed the user to optionally send measurements
directly from the monitor to an EHR, in addition to the routine use of paper notes. However,
this did not provide a comprehensive record of the intermittent measurements on its own, since
many measurements were not sent from the monitor to the EHR. Therefore, measurements from
the ambulatory ward were dual-transcribed from both the electronically transmitted data and
the paper notes, to obtain as complete a dataset as possible. The intermittent measurements
will serve two purposes in this thesis. Firstly, they will be used to calculate benchmark early
warning scores (EWSs), which will be used as comparators when evaluating novel algorithms for
detection of deteriorations. Secondly, they will be used as inputs to novel algorithms, supple-
menting the continuous data with additional vital signs which are not monitored continuously,
such as temperature.
Three further types of data were recorded. Firstly, fixed variables, i.e. those which do not
change during a patient’s hospital stay, were manually recorded in the eCRF. These included
demographic data and operation details. They may have utility as inputs to early warning
algorithms to stratify patients into groups [121]. Secondly, laboratory test results were auto-
matically recorded in an EHR as part of routine care. They were retrospectively exported as
text files. They may also be useful inputs to early warning algorithms since algorithms have
recently been developed which incorporate laboratory values in addition to traditional vital sign
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inputs resulting in improved performance [122]. Thirdly, adverse events were identified retro-
spectively from each patient’s notes by an expert and recorded in the eCRF. Best estimates of
the times of events were recorded, as well as the times at which they were identified by clinical
staff. These labels are essential for this work since they provide the response variable against
which early warning algorithms can be trained and assessed.
For further details of the LISTEN Trial the reader is referred to [35, 123].
3.2 Data Preparation
The first stage of dataset curation was to perform the data preparation tasks which were specific
to this particular dataset. The aim was to convert the raw data files into a Prepared Dataset
on which analyses can be performed. The following tasks were performed:
• Fixed variables: Age, gender, ethnicity, operation type and operation duration were
extracted from the eCRF. Ethnicities were grouped as: Asian, Black, White, or Other.
Operation types were grouped as: bypass, valve, bypass and valve, or other.
• Events: The following events were extracted from the eCRF: the wards which a patient
stayed on; the times at which patients were admitted to and discharged from each ward;
the times at which patients were provided with a wearable sensor; and the type and times
of any withdrawals from the trial. In addition, the times at which patients stayed in
critical care, an ambulatory ward, and the study ward (the ambulatory ward on which
patients were provided with wearable sensors) were extracted.
• End-points: The types and times of adverse events were extracted from the eCRF, as
well as the following additional end-points: re-admission to critical care; hospital discharge
(regardless of survival status); and discharge from hospital alive.
• Laboratory test results: The majority of laboratory tests gave a result in either a
numerical or a categorical value, whereas a small minority of results were in free-text
format. Those tests which had numerical or categorical results were extracted from the
raw text files. Both the times of tests and the results were extracted. Tests with free-text
results were not exported.
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• Intermittent physiological measurements: Intermittent physiological measurements
were extracted from EHR exports (corresponding to critical care) and dual-transcribed
spreadsheet files (ambulatory ward). Most sets of measurements contained the five vital
signs (HR, SpO2, SBP, temp and RR) and O2. In addition, measurement sets collected
in critical care contained the heart rhythm and ventilator settings.
• Continuous monitoring data curation: Any continuous monitoring data with either
implausible timestamps (e.g. 01-Jan-1970), or physiologically implausible values (e.g.
values > 1× 109 ), were identified as erroneous and discarded.
• Continuous monitoring alarms: Continuous monitoring alarms were categorised ac-
cording to: (i) whether they were physiological; (ii) the input signal; (iii) type (such
as ‘threshold limit breached’); and (iv) level of severity (as provided by the monitoring
equipment).
• Timestamps: All timestamps were adjusted to be relative to the time at which the
patient left the operating theatre. Times were measured in seconds (except for the times
of physiological signals, which were measured in milliseconds).
• Formatting: All data were imported into Matlab R© format (.mat). This provided effi-
cient data storage, and ensured that all the data were accessible for analysis via a single
software platform.
• Correction of continuous monitoring data timestamps: The timestamps of contin-
uous monitoring data were sometimes incorrect, perhaps due to latencies in data transmis-
sion prior to timestamping. This resulted in sections of data being shifted in time, resulting
in data gaps and simultaneous data, as illustrated in Figure 3.1(a). A bespoke algorithm
was designed and implemented to correct the timestamps. This resulted in correction of
the timestamps of many of the shifted sections, as demonstrated in Figure 3.1(b). The
results of using the algorithm are summarised in Table 3.2. The key advantage of using
the algorithm is that it increases the number of segments which contain continuous data,
allowing additional parameters to be derived from the waveforms. Further details of the
algorithm are available in [35].
The Prepared Dataset is designed to be an accessible representation of the raw data from the
LISTEN trial, following essential data curation processes. It is useful for a small set of analyses
which require all the data, regardless of its quality. For instance, the primary aim of the
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Figure 3.1: Correction of continuous monitoring data timestamps: Errors in timestamps
resulted in simultaneous data at some times, and missing data at others, as shown in (a).
A bespoke algorithm was implemented to correct for erroneous timestamps, as shown in (b).
Figure and caption adapted from [35].
Table 3.2: Performance of the timestamp correction algorithm: the proportion of data points,
and continuous data segments, available for analysis are shown before and after using the
timestamp correction algorithm. The key benefit of the algorithm is the increased percentage
of continuous data segments available for signal processing. Assessed using the first 24 hours of
heart rate data acquired from each subject after admission to critical care following surgery.
Proportion available [%], med (lower - upper quartiles)
Before algorithm After algorithm
Data points 94.2 (91.3 - 98.0) 95.3 (92.4 - 99.0)
10 s segments 90.5 (88.7 - 92.0) 94.6 (91.4 - 98.0)
30 s segments 85.9 (83.8 - 88.6) 93.2 (89.6 - 96.1)
60 s segments 82.0 (77.8 - 85.0) 91.2 (87.2 - 94.0)
LISTEN trial was to assess the feasibility of using wearable sensors for continuous monitoring.
The Prepared Dataset should be used for analyses such as this. However, most analyses are best
conducted using only those data which are of high quality. As such, they should be conducted
on the Processed Dataset. This is an enhanced version of the Prepared Dataset in which data
deemed to be of low quality have been discarded. The processing steps performed to obtain the
Processed Dataset from the Prepared Dataset are now described.
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3.3 Quality Assessment
The second stage of dataset curation consisted of eliminating unreliable continuous monitoring
data from the Prepared Dataset. Unlike intermittent physiological measurements, continuous
monitoring data are recorded without verification by a clinician. Therefore, they are susceptible
to inaccuracies due to factors such as movement artifact and poor sensor contact, making quality
assessment particularly important. Several methods have been proposed in the literature to
identify artifactual data [114]. In this section the methods used to identify and eliminate low
quality continuous data are described. The use of quality assessment methods ensured that
only high quality continuous data were retained in the Processed Dataset. All data other than
continuous monitoring data were simply carried forward from the Prepared Dataset to the
Processed Dataset.
Quality assessment was performed by calculating signal quality indices (SQIs) for ECG, PPG,
ABP and ImP signals. SQIs are metrics derived from a physiological signal which indicate
its quality. In this work SQIs were calculated for the ECG and PPG after segmentation into
windows of 10 s duration [124]; for the ABP using 20 s windows [125]; and for ImP using
32 s windows (as described in Section 4.6.2). A range of measurements indicative of signal
quality were derived from each signal and each window. The quality of each window was then
determined through comparison of the measurements to empirical threshold values, indicative
of the boundaries between low and high quality. Low quality windows of signal were discarded,
as were any parameters derived from these windows (such as SBP values derived from a window
of ABP signal). The quality assessment process is helpful for avoiding false alarms in early
warning algorithms, which are often caused by parameters being inaccurately derived from
artifactual signal data [126]. An example is provided in Figure 3.2, where false bradycardia and
desaturation alerts were triggered by low quality data, which were eliminated through quality
assessment. The signal processing steps involved in calculation of SQIs are now described.
The first step towards calculation of SQIs was to detect heart beats in the ECG, PPG and ABP
signals, and breaths in the ImP signal. Beat detection was performed on the ECG using the QRS
detector proposed by Pan, Tompkins and Hamilton [72, 73]. Two implementations of this QRS
detector were used. Firstly, the implementation that was used in the original SQI algorithms
was used to facilitate SQI calculation [124]. However, since this implementation has not been
rigorously tested and is not publicly available, a second implementation, rpeakdetect.m, was
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Figure 3.2: Quality assessment of PPG-derived numerics. The pulse rate (PR) and arterial
blood oxygenation (SpO2) numerics provided by the clinical monitor are shown. It appears that
the patient desaturated at approximately 35 and 70 mins, and that the pulse rate dropped at
40 mins. However, quality assessment of the PPG waveform from which these numerics were
derived revealed that the numerics coloured in pink were of low quality, indicating that these
derangements were not physiological, but artifacts of low quality data.
used for all other purposes besides SQI calculation [127]. Similarly, PPG SQI calculation was
performed using the three-point peak detector used in the original SQI algorithms [124]. For
all other purposes the Incremental Merge Segmentation algorithm proposed in [74] was used
for beat detection. This particular implementation was written by M. Pimentel [128]. Beat
detection in the ABP signal was performed using the pulse onset detector described in [129],
which was implemented in the code accompanying [125]. A modification of this code was used
for both SQI calculation and other purposes. Breath detection in the ImP signal was performed
using the count-orig method, which was originally proposed for use with respiratory signals
derived from the ECG [109]. This consists of: (i) detrending the signal; (ii) detecting peaks and
troughs; (iii) defining a threshold as 0.2 times the 75th percentile of peak values; (iv) ignoring
peaks with an amplitude below this threshold; and, (v) identifying valid breaths as consecutive
peaks separated by only one trough with an amplitude less than zero.













Figure 3.3: Template-matching for signal quality assessment: ECG and PPG signals were
segmented into windows, and the correlation between individual beats (thin grey lines) in a
window and the window’s average beat template (thick red line) was calculated. If the correla-
tion was below an empirically determined threshold then the segment was deemed to be of low
quality, as described in [124]. (a) and (b) show high quality windows, whereas (c) and (d) show
low quality windows. Figure and caption adapted from [10].
The second data processing step was to perform signal quality analysis on the continuous signals.
Signal quality analysis of the ECG and PPG signals was performed using the template-matching
algorithms proposed in [124]. The algorithms consist of two parts. Firstly, the HR and the beat-
to-beat intervals are derived from the heart beat annotations. These are compared to a series
of thresholds to determine whether the timings of the annotated heart beats are physiologically
plausible. Secondly, a template beat is calculated as the average of each individual beat. The
correlation between each individual beat and this template is calculated, and compared to an
empirical threshold indicating the minimum acceptable correlation. If a window fails any of these
tests then it is deemed to be of low quality. The template-matching process is demonstrated
in Figure 3.3. These algorithms were chosen since they were designed for use with ambulatory
data.
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Signal quality analysis of the ABP signal was performed using the algorithm proposed in [125].
This consisted of deriving a range of metrics for each beat, and assessing whether they are
physiologically plausible. The metrics included the systolic, diastolic and mean arterial blood
pressures, and the beat duration. If any metric was outside of a pre-specified range of physio-
logically plausible values then that beat was deemed to be of low quality. If a window contained
any low quality beats, then it was deemed to be of low quality. This algorithm is based on
the assumption that physiologically plausible ABP signals can be described by a fixed set of
metrics. Unlike the ECG and PPG SQIs, it does not adapt to an individual patient’s signal
morphology.
The remaining signal for which a SQI was required was the ImP (respiratory) signal. Signal
quality assessment techniques for use with respiratory signals are far less established than those
for use with cardiac signals. Therefore, a novel signal quality index (SQI) for the ImP signal
was developed and assessed, as described in Section 4.6.2. This SQI completed the set of SQIs
required to assess the quality of all of the signals from which routinely used vital signs are
derived.
3.4 Dataset Description
A total of 229 subjects were enrolled into the LISTEN Trial. Three subjects subsequently with-
drew consent so were excluded from any analyses. The demographic characteristics of the 226
remaining subjects are summarised in Table 3.3. A total of 201 subjects (89%) remained in
wards where physiological data could be acquired continuously throughout their stay. Further-
more, 200 subjects (89%) were provided with a wearable sensor for 3.7 (2.6 - 5.2) days. The
physiological dataset acquired from these subjects is presented as two distinct datasets. The
Prepared Dataset is the dataset after completion of the data preparation described in Section
3.2, but before any of the data processing described in Section 3.3. The Processed Dataset is the
dataset after completion of the additional processing described in Section 3.3. These datasets
are described in this section to facilitate evaluation of the dataset for future research. Firstly,
an evaluation of the utility of the dataset for this thesis is presented in Section 3.5. Secondly,
the description in this section will allow future researchers to evaluate the utility of the dataset
for their own research.
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Table 3.3: Demographic characteristics of the 226 LISTEN subjects who underwent surgery
Characteristic
Age [yrs], median (lower - upper quartiles) 67.5 (60.0 - 76.0)






Operation Type, no. (%)
Bypass 71 (31.4)
Valve 111 (49.1)
Bypass and Valve 36 (15.9)
Operation Duration [hrs], median (lower - upper quartiles) 3.4 (2.8 - 4.2)
The LISTEN data is presented as the Prepared Dataset and the Processed Dataset since the
two datasets are suitable for different types of research. The Prepared Dataset is designed to
contain all of the recorded data, with the exception of nonsensical data, regardless of its quality.
Consequently, it has the advantage of containing additional continuous signals which were not
quality assessed, such as central venous pressure (CVP) and additional ECG leads, and their
accompanying parameters. However, it has the disadvantage that the continuous physiological
data have not been quality assessed. This dataset is designed for either: (i) the experienced
analyst who wishes to process the data using their own methods, or (ii) research which requires
‘real-world’ data, as opposed to solely high quality data. The Processed Dataset is designed to be
used for analyses which require only high quality data. It requires minimal pre-processing, since
any low quality continuous physiological data have already been eliminated. It is designed for
use by novices, and is particularly suitable for use with supervised machine learning algorithms
since it is structured to facilitate extraction of predictor and response variables. A selection of
end-points are provided, giving a choice of response variables. Figure 3.4 shows an example of
the data available for a single patient in the Processed Dataset. All data other than continuous
physiological signals and numerics are identical in the two datasets.
The data coverage rates for the continuous data were limited by the settings in which the data
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Figure 3.4: A summary of a LISTEN subject’s processed data: Fixed variables (such as
demographics) are shown at the top, followed by labels of adverse events. The times at which
the patient was in critical care (CC), on the ambulatory ward (Amb), and being monitored
by a wearable sensor (Tele) are then shown. This is followed by the times of laboratory tests
(Labs), and then each of four vital signs: heart rate (HR), arterial blood oxygenation (SpO2),
respiratory rate (RR) and systolic blood pressure (SBP). Continuous data is shown in small
dots, whereas intermittent measurements are shown as larger dots with a black outline.
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Table 3.4: Data coverage rates of continuous data in the Processed Dataset. Definitions:
prop: Proportion of time for which data were acquired [%], median (lower - upper quartiles);
lag : Time until next measurement [median hrs], median (lower - upper quartiles).
Variable
Entire Dataset Critical Care Ambulatory



















































































































were recorded. Continuous data could only be recorded from subjects whilst they were staying
on study wards, i.e. those equipped with data acquisition equipment. Out of the 226 subjects,
25 (11.1%) stayed on a non-study ward at least once during their hospital stay. These subjects
stayed on non-study wards for a median (lower - upper quartiles) of 43.2 % (26.5 - 59.7) of their
hospital stay. In addition, only a subset of the continuous variables available in critical care
could be acquired in the ambulatory setting as described in Section 3.1. The data coverage rates
of the continuous data in the Processed Dataset are summarised in Table 3.4. These are shown
firstly for the entire dataset, and then broken down according to critical care and ambulatory
settings.
Several aspects of the continuous data coverage rates are useful for informing the design of
algorithms for use with wearable sensors. Firstly, only the ECG and PPG signals were available
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Figure 3.5: Changes in data coverage in the 24 hours before severe adverse events on the
ambulatory ward: in (a) the coverage of continuous data decreased in the time before adverse
events; whereas in (b) the coverage of intermittent physiological observation data increased in
the time before deteriorations, as shown by a reduced time between consecutive observations.
Dashed lines show median values for all other observations. Severe adverse events were defined
as death, cardiac arrest and critical care readmission.
in the ambulatory setting. Of these, the data coverage rates for the ECG were substantially
higher than those for the PPG. The numerics derived from the ECG and PPG signals (HR,
PR and SpO2) had similar data coverage rates to the signals from which they were derived.
Secondly, in this setting the PPG was rarely acquired at times when the ECG wasn’t acquired:
the PPG was recorded for 31.4 (11.1 - 48.4) % of the time that ECG was recorded, and the
ECG was recorded for 95.7 (87.7 - 99.0) % of the time that PPG was recorded. Therefore, any
algorithms which can use either the ECG or the PPG, such as for estimation of HR, should
prioritise using the ECG due to its improved data coverage. Furthermore, there would be little
benefit to allowing an algorithm to switch between the ECG and PPG interchangeably, since this
would only provide a minimal improvement in data coverage. Thirdly, the data coverage on the
ambulatory ward varied with the progression of deteriorations: the data coverage of continuous
data decreased as shown by a reduction in the proportion of time for which it was acquired
(Figure 3.5(a)), whereas the frequency of intermittent physiological observations increased, as
shown by a reduction in the time between observations (Figure 3.5(b)). This may reduce the
advanced warning of deteriorations which can be provided by wearable sensors.
It is also helpful to consider how the window duration used for analysis of continuous signals
affects the expected time between consecutive windows of continuous data. Most algorithms
would benefit from a longer duration of data to provide more accurate parameter estimation.
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Figure 3.6: The impact of signal window duration on the frequency of available windows: (a)
and (b) show how the time between consecutive windows of continuous ECG and PPG signals
is impacted by the window duration. Gaps between segments of high quality continuous data
mean that the time between consecutive high quality windows decreases as the duration of
windows increases. This results in a compromise between the duration of data used in signal
processing algorithms, and the frequency with which parameters can be estimated.
Table 3.5: The impact of signal window duration on the frequency of available windows. The
median time between consecutive windows is provided for typical window durations used for
signal processing algorithms. Results expressed as median (lower - upper quartiles).
Window
duration [s]
Median time between consecutive windows [mins]
ECG PPG
15 3.34 (1.50 - 11.17) 2.00 (1.18 - 4.00)
30 6.43 (3.00 - 13.63) 3.25 (2.00 - 6.17)
60 9.58 (4.33 - 17.67) 5.00 (3.00 - 9.52)
90 11.29 (5.33 - 21.91) 6.83 (4.02 - 13.08)
120 11.45 (6.87 - 24.12) 8.83 (5.17 - 18.00)
300 20.17 (11.33 - 39.71) 23.08 (11.67 - 54.23)
However, increasing the required window duration has the disadvantage of also increasing the
time between consecutive windows, due to gaps in the data. Figures 3.6 (a) and (b) show how the
time between consecutive windows increases with increased ECG and PPG window duration. It
is clear that an increase in the window duration used by an algorithm will dramatically reduce
the frequency with which parameters could be derived, since the time between consecutive
windows is greater. Results for specific candidate window lengths are shown in Table 3.5. These
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Table 3.6: Data coverage rates of intermittent physiological measurements. Definitions:
freq : Frequency of measurements per day, median (lower - upper quartiles);
lag : Time until next measurement [median hrs], median (lower - upper quartiles).
Variable
Entire Dataset Critical Care Ambulatory





















































































results suggest that it may be possible to estimate parameters sufficiently frequently when using
longer window durations. For instance, a window duration of 120 s would allow parameters to
be estimated multiple times per hour, which is often enough to detect physiological changes
indicative of deteriorations.
The data coverage rates of the intermittent physiological measurements are provided in Table
3.6. The five routinely measured vital signs (HR, SpO2, RR, SBP and temp) were each measured
approximately once every four hours on the ambulatory ward. DBP was also measured at the
same frequency, although it may not be widely measured at other institutions since its inclusion
in routine physiological measurements is not mandated [28]. MAP was not recorded on the paper
charts, but only through the occasional electronic transmission of measurements to the electronic
health record (EHR), explaining its low frequency of measurement. It may well be helpful to
include the five routinely measured vital signs in algorithms for detection of deteriorations,
since they were measured frequently enough to identify changes in physiology associated with
deteriorations. Furthermore, the use of intermittent temp and SBP values may be particularly
beneficial since these parameters are not available from the processed wearable sensor data.
The data coverage rates of the biochemistry results are provided in Table 3.7. The most fre-
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Table 3.7: Data coverage rates of biochemistry results. Definitions:
freq : Frequency of measurements per day, median (lower - upper quartiles);
lag : Time until next measurement [median hours], median (lower - upper quartiles).
Variable
Entire Dataset Critical Care Ambulatory
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Table 3.8: Number of patients experiencing each of the most frequent types of adverse clinical
event in the ambulatory setting, n (%)
Adverse event Entire Dataset Critical Care Ambulatory
Atrial fibrillation 77 (34.1) 50 (22.1) 28 (12.4)
Cardiac pacing 107 (47.3) 84 (37.2) 26 (11.5)
Critical care readmission 11 (4.9) 0 (0.0) 11 (4.9)
Sepsis 26 (11.5) 17 (7.5) 9 (4.0)
Pleural drain 13 (5.8) 8 (3.5) 6 (2.7)
Cardiac failure 10 (4.4) 5 (2.2) 5 (2.2)
Return to surgery 18 (8.0) 15 (6.6) 4 (1.8)
Deep wound infection 6 (2.7) 2 (0.9) 4 (1.8)
Cardiac arrest 6 (2.7) 3 (1.3) 3 (1.3)
Altered mental state 21 (9.3) 18 (8.0) 3 (1.3)
Acute kidney injury 101 (44.7) 99 (43.8) 2 (0.9)
quently measured biochemistry values in the ambulatory ward were measured 0.4 (0.3 - 0.6)
times per day, resulting in a median expected lag time until the next measurement of approxi-
mately 36 hours (1.5 days). Since deteriorations are expected to progress over periods of hours
rather than days, routinely measured biochemistry values are unlikely to be beneficial for detec-
tion of deteriorations. Nonetheless, it has previously been observed that the use of biochemistry
results can improve algorithms for detection of deteriorations [130].
Table 3.8 lists the the most common types of adverse clinical events in the ambulatory setting.
The rate of adverse events in this patient population was low, as expected. The most common
adverse events in the ambulatory setting were the onset of paroxysmal atrial fibrillation (occur-
ring in 28 patients) and the need for cardiac pacing (26). However, neither of these are suitable
candidates for predicting using multi-parameter wearable sensors since they can be readily de-
tected from the ECG, and any precursory changes in physiology are likely to be confined to the
ECG. In contrast, critical care readmission (11), sepsis (9), return to surgery (4), and cardiac
arrest (3) are suitable candidates for prediction since they are more likely to be manifested
across a range of physiological parameters. The low rates of adverse events mean that any
predictive algorithms trained on this dataset should be hypothesis generating, and should be
re-trained and validated on larger datasets. In addition, a technique such as cross validation
should be used to maximise the contributions of the patients who experienced adverse events.
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3.5 Dataset Evaluation
In this section the utility of the LISTEN Dataset for designing algorithms to detect deteriorations
is evaluated.
The LISTEN Dataset is a valuable resource for assessing the utility of wearable sensors. It
contains data collected from 226 patients, 200 of whom were provided with a wearable sensor
for 3.7 (2.6 - 5.2) days. In contrast, similar datasets acquired in previous studies have been
limited by either the wearable sensors being worn for short periods (typically 24 hours or less),
or collecting data from a small number of patients (typically less than 50), as described in
Section 2.4. Consequently, this dataset can be used for relatively robust analyses over a large
number of patients, and over a length of time which is comparable to that of their expected
usage.
The LISTEN Dataset contains all the variables which could be acquired routinely in the clinical
setting in which the study was conducted, as detailed in Table 3.1. In addition to the routine
monitoring, patients wore a wearable sensor for the entirety of their recovery on an ambulatory
ward. In contrast, only a minority of patients wear a wearable sensor routinely. This facilitated
capture of ECG and PPG signals throughout patients’ hospital stays, making this a uniquely
comprehensive record of the physiology of hospital patients recovering from cardiac surgery. In
addition, all of the signals and parameters which are routinely monitored in critical care were
captured. However, the dataset cannot be considered to be fully comprehensive since some
other wearable sensors provide additional monitoring of activity, RR and temp, which are not
available in this dataset. Nonetheless, it has the advantage that all of the variables acquired can
be monitored in routine clinical practice, ensuring that any novel techniques developed based
on continuous monitoring of these variables could be implemented in practice.
The inclusion of routinely acquired intermittent physiological measurements, and labels of ad-
verse events, ensures that the dataset is highly suitable for developing and evaluating algorithms
for detection of deteriorations. The intermittent measurements can be used to derive bench-
mark EWSs, allowing novel algorithms for detection of deteriorations to be compared to current
practice. In addition, the labels of adverse events can be used to classify data from each patient
to train algorithms.
The data coverage rates are those which can be expected in a real-world clinical setting (Table
3.4). The highest data coverage rate was given by the ECG in both critical care and ambulatory
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settings. Therefore, it should be the primary choice of signal for analyses which can be performed
using several signals, such as RR estimation and heart rate variability (HRV) analysis, which
could use either the ECG or the PPG. The PPG signal had a relatively low data coverage rate,
which should be considered when evaluating the usefulness of deriving novel parameters from
the signal. The data coverage rates tended to be much higher in critical care. Therefore, it may
be advantageous to develop techniques on the critical care data, and use the ambulatory data
to test their performance.
The LISTEN Dataset has been pre-processed using several trial-specific processing procedures,
ensuring that future users can begin analyses quickly without having to perform pre-processing
to clean up the data. Four continuous signals were quality assessed, reducing the inaccuracies in
the numerics derived from them. This is particularly important in the ambulatory setting where
motion artifact and poor sensor contact are common. A novel SQI was developed for use with
the ImP signal, allowing users to have confidence in both the RRs and the timings of individual
breaths derived from this signal. This facilitates analyses which require accurate breath timings,
such as respiratory rate variability analyses [131], and those which require precise RRs, such
as the use of ImP-derived RRs as a reference for the assessment of algorithms to estimate RR
from the ECG and PPG [4]. In contrast, other comparable datasets containing continuous
physiological data, such as the MIMIC Database acquired using static monitors in critical care
[132], require substantial pre-processing before analyses can be conducted. This makes the
LISTEN Dataset ideal for rapid analyses without the need for considerable pre-processing.
The data acquisition procedures used to collect the LISTEN Dataset were not perfect, leading
to missing, and in some cases, erroneous data. Approximately one third of the patients who
wore a wearable sensor asked to have it removed before the end of their hospital stay [123]. In
addition, technical malfunctions of the data acquisition system led to gaps in the continuous
monitoring data of several hours or even days on occasion. Furthermore, the intermittent
physiological measurements were acquired by transcription from handwritten charts, which were
sometimes illegible. Data gaps such as these mean that some subjects may not contribute data
to particular analyses. Future users should also be aware of the limitations of the monitoring
equipment and data acquisition software. These included: (i) sampling frequencies of 125 Hz,
potentially inhibiting particular analyses such as HRV analyses; (ii) varying, unknown timing
offsets between the ECG and PPG signals, inhibiting pulse transit time calculations; and, (iii)
the acquisition of signals using the amplitude scaling applied by the ward staff, potentially
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reducing the resolution of signals. Nonetheless, the acquired signals and parameters represent
those which can be reasonably collected during current clinical practice.
The patient population for this trial was chosen to facilitate relatively high data coverage rates.
However, there were several disadvantages to using this population. Firstly, the group of subjects
was relatively homogeneous since each patient’s critical illness was caused by cardiac surgery.
In contrast, medical inpatients can be admitted because of a range of illnesses, meaning that
any findings may not be generalisable beyond cardiac patients. However, findings may still have
ramifications since over 30,000 patients undergo cardiac surgery in England and Wales each
year [120]. Secondly, since of all the subjects had undergone cardiac surgery, their physiology
may have been deranged due to the after-effects of the operation, making it difficult to differ-
entiate between derangements indicative of deteriorations, and those due to surgery. Thirdly,
all physiological measurements acquired were available to clinicians in real-time, so would have
prompted changes in treatment thus altering both physiology and end-points from their natural
courses. The impact of this could have been reduced by selecting a patient population which
does not receive continuous ambulatory monitoring as part of routine care.
3.6 Final Remarks
This chapter has described the processes for, and results of, assembling a physiological dataset
with which to test the hypothesis of this thesis. The LISTEN Dataset is a highly comprehensive
physiological dataset containing data acquired from patients recovering from major cardiac
surgery in hospital. The data is presented as two datasets: the Prepared Dataset, which is
designed to contain all of the data acquired, after elimination of nonsensical data; and the
Processed Dataset, which has been subject to quality assessment. The Processed Dataset is
recommended for most analyses, unless real-world data is required, in which case the Prepared
Dataset should be used.
The LISTEN Dataset contains continuous physiological monitoring data acquired from critical
care using static bedside monitors, and the ambulatory setting using wearable sensors. Contin-
uous ECG and PPG signals are available throughout, with additional ImP and ABP signals in
critical care. In addition, intermittent physiological measurements, biochemistry results, demo-
graphics and labels of adverse events are provided. Furthermore, EWSs can be derived from
the intermittent measurements, acting as benchmark algorithms for detection of deteriorations.
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Initial analyses of the dataset provided guidelines for the design of algorithms to detect deteri-
orations when using this dataset:
• Only ECG and PPG signals were available from wearable sensors. Therefore, algorithms
for use in the ambulatory setting should use these signals and the numerics derived from
them (HR, PR and SpO2).
• The ECG was captured for a greater proportion of the time than the PPG. Furthermore,
the PPG was only rarely captured at times when the ECG was not, meaning that the
ECG should preferably be used for algorithms where possible.
• Data coverage rates of continuous monitoring data decreased before severe adverse events,
which may impair the detection of deteriorations.
• The use of shorter windows (e.g. 30 s) of signals to estimate additional parameters, such
as RR, is beneficial for increasing the frequency of available windows. However, the use
of longer windows (e.g. 120 s) would still allow additional parameters to be estimated
multiple times per hour, potentially providing early detection of deteriorations.
• The five routinely measured vital signs (HR, RR, SpO2, BP and temp) were the only
intermittent measurements which were measured frequently enough to be expected to be
of use in algorithms for detection of deteriorations.
• The adverse events which occurred most often in the dataset, and which are expected to be
manifested across multiple physiological parameters are: cardiac arrest, sepsis, readmission
to critical care, and return to surgery.
The LISTEN Dataset has the advantage of being a real-world dataset, although its generalis-
ability to other acutely-ill patient populations is potentially limited. It has the advantage that
it contains variables which can be routinely acquired from hospital patients. This means that
any algorithms developed using the dataset could be applied in current practice. Furthermore,
since the data was collected across long monitoring periods from a high number of patients, the
data coverage rates are those which could be expected in clinical practice. However, the dataset
has the disadvantage that it contains data solely from patients recovering from cardiac surgery.
Therefore, any findings may not be generalisable beyond this population. In addition, this pop-
ulation suffered from a relatively low rate of adverse events, meaning algorithms developed on
this dataset may need to be re-trained and validated on other datasets.
Chapter 4
Estimating Respiratory Rate from
the Electrocardiogram and
Photoplethysmogram: a Systematic
Review and Toolbox of Resources
This chapter presents a systematic review of algorithms to estimate respiratory rate (RR) from
the electrocardiogram (ECG) and photoplethysmogram (PPG) signals. It starts by describing
the rationale for estimating RR from the ECG and PPG. This is followed by an explanation of the
physiological basis for estimating RR from the ECG and PPG. The methodology for a systematic
review of the literature is then presented. The results of this review are presented focusing on
the systematic search process, the characteristics of the included publications, the techniques
used for RR algorithms, and the methodologies used to assess RR algorithms. A discussion
provides a critical review of the state of the literature, culminating in the identification of key
limitations which should be addressed in future research. Finally, a toolbox of resources to aid
research into RR algorithms is presented consisting of: (i) novel datasets for assessment of RR
algorithms, (ii) a novel signal quality index (SQI) for use with the impedance pneumography
(ImP) signal, and (iii) a set of benchmark RR algorithms. These resources are being made
publicly available at: http://peterhcharlton.github.io/RRest.
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4.1 Rationale
RR is an important physiological parameter which provides valuable diagnostic and prognostic
information. It is frequently measured in acutely-ill hospital patients since it is a highly sensitive
marker of deteriorations, as detailed in Sections 2.2 and 2.5. It is also widely used in many other
clinical scenarios, such as: in emergency department screening of both children [133] and adults
[134]; in the identification of pneumonia [135] and sepsis [136]; as a marker of hypercarbia [104]
and pulmonary embolism [137]; and, for prognosis in the ICU [138]. RR is usually measured by
manually counting chest wall movements, which is time-consuming, inaccurate [32], and poorly
carried out [101, 102, 104], as described in Section 2.5. In addition, RR monitoring is not widely
incorporated into wearable sensors. Therefore, there is an unmet clinical need for an automated,
electronic method for measuring RR. If an unobtrusive method could be developed then it may
have utility both for taking intermittent measurements, and for continuous monitoring using
wearable sensors.
A potential solution is to estimate RR from a non-invasive signal which is modulated by respi-
ration and is easily measured. Two such signals are considered in this review: the ECG and the
PPG. The ECG is measured for a short period of time during screening for heart disorders. It is
also monitored continuously in high acuity settings such as the intensive care unit or coronary
care unit, and in hospital patients at risk of dysrhythmias [56]. In addition, wearable sensors
often monitor the ECG. Indeed, some recently developed sensors incorporate ECG monitor-
ing into a chest-worn patch, providing continuous single-lead ECG monitoring over a period of
several days in a highly unobtrusive manner [81]. The PPG is routinely measured in a wide
range of clinical settings to obtain arterial blood oxygen saturation (SpO2) and pulse rate (PR)
measurements. In addition, the PPG is continuously monitored in critically-ill patients, and
can also be monitored continuously in ambulatory patients using wearable sensors. Further-
more, non-contact video-based technology is being developed for continuous PPG monitoring
in a wide range of clinical scenarios, without the need for any equipment to be attached to the
patient [139]. Therefore, both the ECG and PPG signals are widely available. In addition,
they are both modulated by respiration, making them a highly attractive means of obtaining
unobtrusive, electronic RR measurements. Furthermore, they were both acquired throughout
the LISTEN Trial (Section 3.4), meaning that techniques for estimation of RR from the ECG
and PPG could be used to derive RR from the continuous data in the LISTEN dataset.
Chapter 4. Estimating Respiratory Rate: Review and Resources 49
 
No       
mod      
PPG
BW       
AM       
FM       
ECG
Figure 4.1: Respiratory modulations of the ECG and PPG: Both the ECG and the PPG are
subject to three respiratory modulations: baseline wander (BW), amplitude modulation (AM)
and frequency modulation (FM). Source: [10] (CC BY 3.0, DOI: 10.1088/0967-3334/37/4/610)
Over 100 algorithms have been proposed to estimate RR from the ECG or PPG [10]. However,
the literature surrounding these algorithms has not been synthesised. Consequently, it is difficult
to identify all of the algorithms which have been proposed, and to determine which, if any, RR
algorithm is most suitable for clinical use.
A systematic review was undertaken to establish: (i) the techniques used to estimate RR; (ii)
the methodology used to assess RR algorithms; and, (iii) the reported performances of RR
algorithms.
4.2 Physiological Basis for Respiratory Rate Algorithms
Algorithms to estimate RR from the ECG and PPG are based on extraction of one or more respi-
ratory modulations from the signals. Both the ECG and PPG exhibit three types of respiratory
modulation as illustrated in Figure 4.1: baseline wander (BW), amplitude modulation (AM)
and frequency modulation (FM). RR can be estimated from the ECG or PPG by extracting a
signal which is dominated by one or more of these modulations. For instance, a low-pass filter
could be used to extract the low frequency respiratory modulation due to BW. The resulting
signal could then be used to estimate RR through spectral analysis.
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Table 4.1: Physiological mechanisms of ECG and PPG respiratory modulation. For a compre-
hensive treatment see [79] and [140]. Source: [7] (CC BY 3.0, DOI: 10.1088/1361-6579/aa670e)
Modulation ECG PPG
BW
Beat morphology is influenced
during respiration by two
mechanisms: (i) changes in
thoracic impedance, and (ii)
changes in the orientation of the
electrical axis of the heart relative
to ECG electrodes [79].
Changes in tissue blood volume
caused by: (i) transmitted changes
in intrathoracic pressure; and (ii)
vasoconstriction of arteries during
inhalation, transferring blood to
more central veins [144].
AM Stroke volume is reduced during in-
halation due to changes in intratho-
racic pressure, affecting pulse ampli-
tude [140].
FM FM is the manifestation of respiratory sinus arrhythmia (RSA) [145] which
causes heart rate to increase during inspiration and decrease during exhala-
tion. It is caused by at least three mechanisms: (i) changes in intrathoracic
pressure during inhalation stretch the sino-atrial node, increasing heart rate
(HR); (ii) increased vagal outflow during exhalation reduces HR; and (iii)
reduced intrathoracic pressure during inhalation decreases left ventricular
stroke volume, causing a baroreflex-mediated increase in HR [146].
Several physiological mechanisms are responsible for the respiratory modulations of the ECG
and PPG. They have been reported previously in [79] and [140], and are summarised in Table
4.1. The mechanisms which cause BW and AM differ between the ECG and PPG, whereas
a single mechanism causes FM in both signals. The mechanisms are not fully understood.
However, it is clear that the strength of any particular respiratory modulation can be affected
by a range of factors. For instance, respiratory sinus arrhythmia (RSA, which causes FM) and
chest wall expansion (which is linked to BW and AM) both diminish with age [141], [142], [143],
[10]. The strength of a modulation may affect the reliability of RR estimates which can be
derived from that modulation.
4.3 Methods
4.3.1 Approach
Publications containing algorithms for estimation of RR from the ECG and PPG were identified
systematically using the following methodology. Firstly, it was decided that publications would
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be eligible for inclusion if they described: (i) an algorithm which operated on either the single-
lead ECG signal or the single-channel PPG; and (ii) an algorithm for estimation of either
RR or breath-to-breath intervals. Publications were excluded if they met one of the following
exclusion criteria: (i) they were written in a language other than English; (ii) no full text was
available (after contacting authors where possible); or, (iii) they were patents. Secondly, an
initial, pragmatic search was performed for publications containing algorithms meeting these
criteria. Thirdly, the titles of the publications identified during the pragmatic search were
analysed to determine a search strategy for use in a systematic search. Fourthly, a systematic
search was conducted using the following online databases: PubMed, Scopus, IEEE Xplore, and
Google Scholar. Finally, publications containing algorithms meeting the inclusion criteria were
identified through screening of titles, followed by full publications.
4.3.2 Determining a search strategy
The initial pragmatic search yielded a total of 90 qualifying publications. This allowed a search
strategy to be determined as follows. Inspection of the publication titles revealed three common
themes: (i) the process of respiration; (ii) a mathematical process; and, (iii) description of the
input signal. Words which occurred in at least 5% of the publication titles were sorted into
one of these three categories, or deemed to be irrelevant. This yielded 27 keywords: three
in the respiration category; 15 in the mathematical process category; and nine in the input
signal category. A total of 76.7% of the titles contained at least one of the keywords from each
category. Therefore, a search strategy was devised consisting of three search terms (one for
each category), in which publication titles had to contain at least one keyword from each search
term to be included. The next step was to eliminate keywords which did not add value to the
search strategy, to increase the specificity of the search. A total of 10 keywords did not add
value to the search strategy, as demonstrated by there being no reduction in the sensitivity of
the search strategy (from 76.7%) when each was individually omitted. Omission of all 10 only
slightly reduced the sensitivity of the search strategy to 75.6%. Therefore, this was chosen as
the search strategy to be used in a systematic search. The final keywords are listed in Table
4.2. These were used to perform a systematic search on the 12th and 13th August 2016. Both
publications identified through the systematic search and those identified through the initial
pragmatic search were screened against the inclusion and exclusion criteria.
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Table 4.2: Systematic review search terms. To be included, publication titles had to contain




S1 Respiration breathing, respiration, respiratory
S2 Mathematical process derivation, derived, estimation, extraction, methods,
rate, rates















































  303  Irrelevant title 
  50    Didn’t estimate RR 
  36    Didn’t use single-lead ECG or 
single-channel PPG 
  13    Not in English 
  9      No full text available 
  2      Patents 
 
 
Figure 4.2: Identification and screening of publications describing respiratory rate (RR) algo-
rithms showing: the number of publications identified by the searches, screened, excluded and
included in the final analysis.
4.4 Results
4.4.1 Search and screening
The results of the identification and subsequent screening of publications are summarised in
Figure 4.2. The search identified 553 publications. These were screened against the inclusion
and exclusion criteria, leading to exclusion of 413 publications. Most excluded publications were
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Table 4.3: The utility of databases searched in a systematic review of respiratory rate (RR)
literature. Definitions: No. pubs - number of publications included in the final analysis; No.
unique pubs - number of publications included in the final analysis which were unique to this
database; Sen - sensitivity; PPV - positive predictive value.
Database No. pubs No. unique pubs Sen [%] PPV [%]
Google Scholar 36 7 25.7 10.7
IEEE Xplore 59 2 42.1 48.8
PubMed 48 2 34.3 29.4
Scopus 91 4 65.0 29.7
Manual Search 90 31 64.3 100.0
deemed to be irrelevant based on their titles. In addition, many articles were excluded because
they did not present algorithms to estimate RR. These articles often presented methods for
extracting a respiratory signal from the ECG or PPG, without estimating RR from that signal.
A total of 140 publications were included in the final analysis: [10, 80, 108–113, 147–278]
Statistics describing the utility of each database are presented in Table 4.3. The most compre-
hensive database was Scopus, which contained nearly two thirds of the publications included
in the final analysis (shown by its sensitivity of 65.0 %). Approximately one third of the re-
sults retrieved from Scopus were included in the final analysis (shown by its positive predictive
value, PPV, of 10.7 %). The least comprehensive database was Google Scholar, which returned
only 25.7 % of the included publications, and only approximately one tenth of its results were
included (shown by its PPV of 10.7 %). It is notable that the manual search strategy missed
35.7 % of the publications included in the final analysis, and the automated search strategy
consisting of the four electronic databases missed 22.1 % of the included publications.
4.4.2 Characteristics of included publications
The included publications were published between 1991 and 2016. Only three were published
in the seven years following the initial publication in 1991. Since 1999, the rate of publication
has risen steadily up to the present rate of approximately 16 publications per year, as shown
in Figure 4.3. Approximately half of the included publications (72 out of 140, 51.4 %) were
presented at conferences. Most of the remaining publications were journal articles (63, 45.0 %).
The remainder were theses (5, 3.6 %).
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Year








Figure 4.3: The number of publications describing respiratory rate (RR) algorithms published
each year: This histogram illustrates how the number of publications describing RR algorithms











Figure 4.4: The stages of a respiratory rate (RR) algorithm. Dashed stages are optional.
4.4.3 Respiratory rate algorithms
During the review of RR algorithms it was observed that they consisted of up to five stages,
as illustrated in Figure 4.4. The role of each stage is as follows. Extract Respiratory Signal(s)
consists of extracting one or more time series dominated by respiratory modulation. Fuse Signals
is an optional stage in which multiple respiratory signals can be fused to give one respiratory
signal in either the time or frequency domain. Estimate RR(s) consists of estimating a RR
from a window of a respiratory signal. Fuse RR Estimates is an optional stage used to fuse
multiple RR estimates to obtain one final estimate. Quality Assessment can be used at various
stages throughout an algorithm to reject or mitigate against imprecise estimates. The signal
processing steps which have been used in the literature at each stage are now described.
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Figure 4.5: Extraction of a respiratory signal from the ECG or PPG: ECG (upper plot) and
PPG (lower plot) signals and extracted respiratory signals (grey) are shown on the left. The
corresponding frequency spectra are shown on the right. The frequency spectra of the raw
ECG and PPG signals are dominated by the cardiac frequency content at 1.2 Hz. In contrast,
the frequency spectra of the extracted respiratory signals are dominated by respiration at 0.3
Hz, which is approximately the RR provided by simultaneous ImP measurement (shown by the
dashed line). Respiratory signals were extracted from amplitude modulation (AM) of the ECG
and PPG.
4.4.3.1 Extracting respiratory signals
ECG and PPG signals are primarily cardiac in origin, with secondary respiratory modulations
of much lower magnitudes. Therefore, the first stage of an RR algorithm is extraction of a
respiratory signal, i.e. a time series dominated by respiratory modulation, from which RRs
can be much more easily estimated. Figure 4.5 shows examples of respiratory signals extracted
from the ECG and PPG. The frequency spectra demonstrate that the extracted respiratory
signals are dominated by respiratory modulation. Techniques for extraction of a respiratory
signal fall into two categories: either feature-based or filter-based techniques. Feature-based
extraction of a respiratory signal consists of the extraction of a time series of beat-by-beat
feature measurements (such as the amplitude of each QRS complex). Filter-based extraction
consists of filtering the raw signal to attenuate non-respiratory frequency components (such
as band-pass filtering the PPG to extract a respiratory signal exhibiting BW). The individual
processing steps used for each approach are shown in Figure 4.6, and are now described.
Processing steps common to both feature- and filter-based techniques
The first and final steps of the extraction of respiratory signals are common to both feature- and
filter-based techniques. The first step is the elimination of very low frequency (VLF) components
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Respiratory Signal 
Raw Signal  
Elimination of very low frequencies 
Filter-based extraction of 
respiratory modulation 
Elimination of very high 
frequencies 
Beat detection 
Extraction of feature 
Measurements 
Fiducial point identification 
Re-sampling at a regular 
frequency 
Elimination of non-respiratory frequencies 
Feature-based Filter-based 
Figure 4.6: Processing steps for extraction of a respiratory signal: The steps required to
extract a respiratory signal using the two possible approaches: (a) Feature-based respiratory
signals are extracted by constructing a time series of beat-by-beat feature measurements (on
left); (b) Filter-based respiratory signals are extracted by filtering the raw signal to produce a
signal in which the non-respiratory frequency components of the raw signal are attenuated (on
right). Dashed lines indicate optional steps.
of the PPG and ECG, i.e. those at sub-respiratory frequencies. VLFs are eliminated using a
finite-impulse response high-pass filter such as: a median filter [168, 240, 244]; subtraction of
a baseline trend calculated using a linear or polynomial fit [177, 226], or using measurements
of the baseline at a specific point in the cardiac cycle (such as the baseline shortly before the
QRS complex [225], or the midpoints between successive R waves [150] in the ECG). A cut-off
frequency of 0.03-0.05 Hz is typically chosen [226, 256, 257, 264]. This stage is not required if the
ECG or PPG monitoring device removes VLFs prior to output. The subsequent processing steps
for extraction of respiratory signals then differ depending on whether a feature- or filter-based
technique is being used, until the final step which is common to all techniques. The final step is
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the elimination of frequency components outside of the range of plausible respiratory frequencies.
Band-pass filtering is used to eliminate non-respiratory frequencies with cut-offs at either end
of the range of plausible respiratory frequencies [113, 153, 168, 198, 238]. Several ranges of
plausible respiratory frequencies have been proposed in the literature, with no consensus on
the optimal range. Furthermore, the range may need to be adjusted according to the patient
population, particularly for paediatrics [279]. Indeed, some algorithms use a range with varies
according to age [280], or a range which adapts to the HR [108, 231, 232, 267, 281]. As a
guideline, Karlen et al. used a conservative range of 4 - 65 breaths per minute (bpm) [80].
The steps of elimination of VLFs before extraction of a respiratory signal, and elimination of
non-respiratory frequencies after extraction of a respiratory signal, help to avoid erroneously
identifying spurious frequency content as the RR. The intermediate steps for extraction of a
respiratory signal differ according to whether a feature- or filter- based technique is being used,
and are now described.
Filter-based techniques for extraction of respiratory signals
Filter-based techniques for extraction of a respiratory signal are performed in a single step.
Several techniques have been proposed, as listed in Table 4.4.
Processing steps specific to feature-based extraction of respiratory signals
Feature-based extraction of respiratory signals consists of five processing steps. Three of these
steps are common to all feature-based techniques, with the two remaining steps changing ac-
cording to the technique being used.
The first of these five steps is the elimination of very high frequency (VHF) noise by low-pass
filtering to improve the accuracy of beat detection and feature measurements. Higher cut-off
frequencies are used for the ECG (e.g. 40, 75, or 100 Hz [159, 187, 257]) than the PPG (e.g. 10
or 35 Hz [113, 187]), to retain the high frequency content of the QRS complex. In addition, the
ECG is particularly susceptible to power-line interference [283], which may be eliminated using
an additional band-stop filter. Whilst a fixed filter is commonly used, an adaptive filter (which
adapts to the noise content) has also been used [198, 284, 285]. Commercial monitoring devices
typically remove VHFs prior to signal output, similarly to VLFs.
Next, feature-based techniques require the detection of individual beats. ECG beat detection is
typically performed by identifying QRS complexes, from which the R-waves can be identified.
Approaches for identifying QRS complexes include: threshold beat detection [187]; adaptive
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Table 4.4: Filter-based techniques for extraction of respiratory signals. Techniques used in
this thesis are indicated by *
Abbr. Technique
XA1* BW: Band-pass filter to eliminate frequencies outside the range of plausible respi-
ratory frequencies using a digital filter [214].
XA2* AM: The maximum amplitude of the continuous wavelet transform within plausible
cardiac frequencies (approx. 30-220 beats per minute) [282].
XA3* FM: The frequency corresponding to the maximum amplitude of the continuous
wavelet transform within plausible cardiac frequencies [282].
XA4* BW, AM, FM: Filter using the centred-correntropy function [110].
XA5 Decimation, consisting of detrending the signal, low-pass filtering to eliminate fre-
quencies higher than respiration, and re-sampling at a reduced sampling frequency
[108] of 1 - 2 Hz [177].
XA6 AM, FM: Estimate instantaneous amplitudes and frequencies using the Teager-
Kaiser energy operator [263].
XA7 Use empirical mode decomposition to identify the oscillation modes within a signal,
and extract a respiratory signal as the sum of the IMFs indicative of respiration
[254].
XA8 FM: Calculate instantaneous frequencies using variable frequency complex demod-
ulation [164].
XA9 AM, FM: Decompose signal using the discrete wavelet transform to reconstruct the
detail signal at a predefined decomposition scale [157].
XA10 Extract respiratory oscillation using principal component analysis by detecting pe-
riodicity using singular value decomposition to identify periodicity [222].
threshold beat detection using the first derivative of the ECG [72, 73]; a combination of meth-
ods using adaptive threshold detection and the curve length transform [111]; and, wavelet
transform methods [286]. The adaptive threshold, curve length and wavelet methods have all
been evaluated on the benchmark MIT/BIH arrhythmia database, achieving sensitivities and
PPVs for beat detection of over 99.5%, as described in [72, 73], [287] and [286, 288, 289] respec-
tively. Once QRSs have been detected, R-waves can be identified. They have been identified
as the maximum ECG value between consecutive QRS onsets [191], or more specifically, as the
maximum value within a certain time of the detected QRS (e.g. within 20 ms [159]). PPG
beat detection is similarly performed by identifying cardiac pulses, from which pulse peaks can
be identified. Methods of identifying cardiac pulses include: band-pass filtering to eliminate
non-cardiac frequencies (e.g. 0.5-2.0 Hz), followed by peak detection [186]; threshold beat de-
tection using the first derivative of the PPG [250]; the Incremental-Merge Segmentation (IMS)
algorithm [74, 80]; and, identifying regions for pulse peaks using a simultaneous ECG signal
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Table 4.5: Feature-based techniques for extraction of respiratory signals. Techniques used in
this thesis are indicated by *
Abbr. Technique
XB1* BW: mean amplitude of troughs and proceeding peaks [10].
XB2* AM: difference between the amplitudes of troughs and proceeding peaks [80].
XB3* FM: time interval between consecutive peaks [237], [80].
XB4* BW: mean signal value between consecutive troughs [112].
XB5* BW, AM: peak amplitude [80].
XB6* BW, AM: trough amplitude [112].
XB7* FM: QRS duration [244]. Q and S waves were identified as the minima immediately
before and after the R wave [112].
XB8* AM, FM: QRS area [256], defined as the integral of the ECG between Q and S waves
after subtraction of a baseline linearly interpolated between Q and S waves.
XB9* BW: Kernel principal component analysis using a radial basis function, with the
variance of the Gaussian kernel determined by maximising the difference between
the first eigenvalue and sum of the remainder [291].
XB10* FM: PPG pulse width estimated using a wave boundary detection algorithm [199].
XB14 Calculate the kurtosis between adjacent peaks [174].
XB15 Difference between durations of the upslope and downslope of the PPG [265].
[113, 198, 236, 241, 290]. Pulse peaks are then identified as the maximum PPG value between
consecutive cardiac pulse onsets [186, 191].
The third and fourth steps are specific to the particular feature-based technique being used.
Many techniques require identification of additional fiducial points beyond simply R-waves and
pulse peaks. These points are usually identified using heuristic rules. Once the required fiducial
points have been identified, measurements of features which vary with respiration are obtained
from the time-amplitude co-ordinates of the fiducial points. Several features have been used, as
summarised in Table 4.5.
The fifth step specific to feature-based extraction of respiratory signals is to re-sample the
respiratory signal at a regular sampling frequency. This is necessary since signals obtained
from beat-by-beat feature measurements are irregularly sampled (once per beat), whereas the
subsequent elimination of non-respiratory frequencies is conducted using filtering techniques
which require a regularly sampled signal. Often linear [80, 268] or cubic spline interpolation
[198] is used. More complex methods include: Berger’s algorithm, designed for use with an
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FM signal [292], and used in [80, 191]; the Integral Pulse Frequency Modulation model, also
designed for use with FM signals [293], and used in [254]; and, the discrete wavelet transform
[244]. Respiratory signals are typically re-sampled at 4-10 Hz, completing the processing steps
specific to feature-based extraction of respiratory signals.
Additional approaches
Two additional approaches have been proposed which are not based on the physiological mech-
anisms described earlier in Section 4.2: the use of pulse transit time (PTT) and the electromyo-
gram (EMG). PTT can be estimated from the time interval between the R-wave and subsequent
PPG pulse onset [149, 187], or between the R-wave and the time at which the PPG pulse has
risen by 50% of its amplitude [198]. It has been suggested that this varies with respiration,
possibly due to changes in pulse wave velocity induced by respiration [294]. It has been sug-
gested that an EMG signal can be extracted from the high frequency content (> 250 Hz) of
the ECG exhibiting the activation of the diaphragm and intercostal muscles during respiration
[185]. However, neither of these signals can be extracted from the LISTEN Dataset described
in Chapter 3, due to the low sampling frequency (125 Hz) of its signals, and the changing time
alignment between the ECG and PPG. Therefore, they are not considered any further.
4.4.3.2 Fusing respiratory signals
The second stage of RR algorithms is the fusion of multiple respiratory signals to provide one
respiratory signal from which RR can be estimated. Multiple respiratory signals arise in two
scenarios. Firstly, multiple respiratory signals can be extracted simultaneously from one patient,
either by using both the ECG and PPG, or by using multiple methods for extracting respiratory
signals. Secondly, a respiratory signal can be segmented into several (often overlapping) time
periods, and the signals within each time period treated as individual respiratory signals. In
each scenario, fusion is conducted in either the time or the frequency domain, depending on the
domain in which the subsequent RR estimation component functions. Methods for performing
fusion of multiple respiratory signals are listed in Table 4.6. This stage is optional, and is one
of two ways in which multiple respiratory signals can be used to increase the robustness of RR
estimates, the other being the fusion of RR estimates derived from multiple signals.
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Table 4.6: Techniques for fusion of respiratory signals
Abbr. Technique
Frequency domain, MA1 to MA6
MA1 Spectral-averaging [256]: Calculate the individual power spectra of multiple respi-
ratory signals, and then find the average power spectrum.
MA2 Peak-conditioned spectral-averaging [113, 198]: only spectra which are sufficiently
peaked are included in calculation of the peak-conditioned average power spectrum.
To qualify: (i) a spectrum must contain a peak within a confidence interval around
the previous RR estimate with a magnitude ≥ 85% [113] (formerly ≥ 75% [198])
of the largest peak in the spectrum; (ii) at least a certain proportion of the power
within this confidence interval must lie in a narrower interval centred on the largest
peak within this confidence interval.
MA3 Cross time-frequency analysis [236]: Use the smoothed pseudo Wigner-Ville distri-
bution to estimate time-frequency spectra between two signals.
MA4 Time-frequency coherence [236]: used to measure the degree of coupling between
two signals.
MA5 Vector autoregressive (AR) modelling [217]: The poles of multiple AR models (one
for each respiratory signal) are calculated. Only those poles which are common to
both models, and which fall within the range of plausible respiratory frequencies,
are used to extract a respiratory signal.
MA6 Temporal spectral averaging [113, 198]: Calculate an averaged frequency spectrum
from overlapping periods of a respiratory signal.
Time domain, MB1 and MB2
MB1 Point-by-point multiplication [197].
MB2 Use of a neural network to identify periods of inhalation and exhalation [149, 186].
4.4.3.3 Estimating respiratory rate
The third component of RR algorithms is the estimation of RR. The input to this component
is a single respiratory signal, and the output is an estimate of RR. The techniques used for
this component act in either the time or frequency domain. Time-domain techniques involve
detecting individual breaths in a respiratory signal. The RR is then calculated as the mean
breath duration. Frequency domain techniques mostly involve calculating a frequency spectrum,
from which the RR is identified as the frequency corresponding to the maximum spectral power
in the range of plausible respiratory frequencies. The techniques are listed in Table 4.7. These
techniques are used to estimate RR from a window of a respiratory signal, such as a 32 s
window. The RR estimation component may be the last in a RR algorithm. However, two
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Table 4.7: Techniques for RR estimation. Techniques used in this thesis are indicated by *
Abbr. Technique
Frequency-based, EF1 to EF7
EF1* Fast Fourier Transform spectral analysis [80].
EF2* Auto-regressive spectral analysis [259] using model order 8 [237].
EF3* Auto-regressive spectral analysis using the median spectrum for model orders 2-20
[295].
EF4* Auto-regressive all-pole modelling (order 8), with the highest magnitude pole se-
lected as the respiratory pole [177].
EF5* Auto-regressive all-pole modelling (order 8), with the lowest frequency pole selected
as the respiratory pole [108].
EF6* Find periodicity using the autocorrelation function [109].
EF7* Spectral analysis using the Welch periodogram [199].
EF8 Spectral analysis using the short-time Fourier transform [253].
EF9 Use Gaussian process regression to estimate periodicity [242].
Time domain breath detection, ET1 to ET5
ET1* Breath detection by peak detection [280].
ET2* Breath detection by positive gradient zero-crossing detection [186].
ET3* Breath detection by combined peak and trough detection [281]: elimination of peaks
less than the mean, and troughs greater than the mean; elimination of peaks (and
troughs) within 0.5s of the previous peak (or trough); elimination of peaks (and
troughs) which are immediately followed by a peak (or trough).
ET4* Breath detection using Count-orig [109]: detrend; detect peaks and troughs; define
a threshold as 0.2 times the 75th percentile of peak values; ignore peaks with an
amplitude below this threshold; identify valid breaths as consecutive peaks separated
by only one trough with an amplitude less than zero.
ET5* Breath detection using Count-adv [109]: detrend; detect peaks and troughs; define a
threshold as 0.3 times the 75th percentile of amplitude differences between consecu-
tive extrema; eliminate the pair of extrema with the smallest amplitude difference if
this is below the threshold; repeat until no more pairs can be eliminated; remaining
peaks represent breaths.
further components can optionally be used to improve the robustness of RR estimates, and are
now described.
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Table 4.8: Techniques for fusion of respiratory rate estimates. Techniques used in this thesis
are indicated by *
Abbr. Technique
Modulation, FM1 to FM4
FM1* Smart Fusion [80]: RRs estimated from BW, AM and FM respiratory signals
(XB1,2,3) are quality assessed. If their standard deviation is ≤ 4 then RR is es-
timated as the mean, otherwise no RR is output.
FM2* Spectral peak-conditioned averaging [199]: Frequency spectra calculated from BW,
AM and FM respiratory signals (XB1,2,3) using the Welch periodogram (FT7) are
fused to give a mean spectrum. Only those spectra for which a certain proportion
of spectral power is contained within a frequency range centred on the frequency
corresponding to the maximum spectral power are included (a modification of the
reported method). RR is estimated as the frequency corresponding to the maximum
power in the mean spectrum.
FM3* Pole Magnitude Criterion [237]: The respiratory pole is chosen as the highest mag-
nitude pole obtained from auto-regressive spectral analysis of BW, AM and FM
respiratory signals (XB1,2,3).
FM4* Pole Ranking Criterion [238]: The pair of highest magnitude poles obtained from
auto-regressive spectral analysis of BW, AM and FM respiratory signals (XB1,2,3)
with the greatest pole ranking criterion (PRC) is selected. PRC = mi,j/dθi,j
2, where
mi,j = (mi +mj) /2 and dθi,j = |θi − θj |, for i, j = 1, . . . , N , where N is the number
of poles calculated. θ and m are the pole angles and magnitudes respectively. RR
is estimated from the mean frequency corresponding to the selected pair.
Temporal, FT1
FT1 Temporal smoothing [113]: estimated RRs, RRest, are smoothed to give the final
RR, RRi, using RRi = 0.2RRest + 0.8RRi−1.
4.4.3.4 Fusing respiratory rate estimates
Techniques for fusion of multiple RR estimates can be used to improve the robustness of a
final RR estimate. They can be separated into two categories: modulation, or temporal fusion
techniques. Modulation fusion techniques consist of fusing RR estimates derived from the same
window of input signal using different modulations. For instance, simultaneous estimates derived
from respiratory signals indicative of AM and FM have been fused to provide a single output.
Temporal fusion techniques involve fusing RR estimates derived from a single respiratory signal,
over different windows. For instance, when continuously monitoring RR during exercise testing
previous RR estimates can be fused with the current RR estimate to improve robustness. The
techniques which have been proposed for fusion of RR estimates are described in Table 4.8.
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4.4.3.5 Quality assessment
Quality assessment is an optional component of RR algorithms, which can be performed at
any stage of an algorithm. Quality assessment techniques used in RR algorithms fall into
two categories: signal quality indices (SQIs) and RR estimate quality indices (RQIs). SQIs
are used to identify segments of ECG or PPG data of low quality. Low quality segments are
typically rejected based on the assumption that RR estimates derived from them are likely to
be inaccurate [80]. RQIs are used to assess the expected accuracy of estimated RRs and reject
any estimates which are expected to be inaccurate.
Several SQI techniques have been used in RR algorithms to avoid estimating RRs from low qual-
ity input data. SQIs based on template matching, described in Section 3.3, have been commonly
used in RR algorithms. These involve construction of a template of average beat morphology,
and calculation of the correlation between individual beats and the template. A signal segment
is deemed to be of high or low quality by comparing the average correlation coefficient over that
segment to an empirically-determined threshold. Another common approach is to use Hjorth
parameters as SQIs [241, 296]. Hjorth parameters quantify the quality of oscillatory signals
[297]. The highest quality is achieved by a signal consisting of a single oscillatory component,
and the lowest quality by a signal which has a uniform frequency spectrum (i.e. white noise). If
the Hjorth mobility, an estimate of a signal’s central frequency, is not a plausible HR, then the
signal is deemed to be of low quality. If the Hjorth complexity, an estimate of a signal’s half-
bandwidth, is small this indicates a strongly oscillatory signal. Conversely, if it is greater than
an empirical threshold (e.g. 8 Hz), this indicates a non-oscillatory, and therefore low quality,
signal [298]. An alternative approach is to search for any beat-by-beat characteristics which are
indicative of low quality input signals. Beat-to-beat intervals [80, 280, 281], pulse amplitudes
[80] and clipped pulses [80] have been used to identify segments of low quality input signal.
SQIs are commonly used to identify and reject low quality input data in critical care [114], so
many techniques are borrowed from this literature.
Several quality assessment techniques have been developed specifically for RR algorithms which
assess either the extracted respiratory signals or the RR estimates. Similarly to ECG and
PPG signal quality assessment, Hjorth parameters [111] and breath-to-breath intervals [280]
have been used to assess the quality of respiratory signals. In the frequency domain, it has
been proposed that if the ratio of the magnitude of the respiratory peak to that of the next
highest peak is below a cut-off threshold, then the respiratory signal should be identified as
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Table 4.9: Characteristics of RR algorithms assessed in the literature. Definition: PTT -
pulse transit time
Characteristic Category No. publications (%)
Input Signal ECG 71 (50.7)
PPG 79 (56.4)
ECG and PPG 1 (0.7)
PTT 6 (4.3)
Window duration (s) < 30 3 (2.1)
30-59 30 (21.4)
60-89 33 (23.6)
≥ 90 7 (5.0)
unknown 67 (47.9)




≥ 16 2 (1.4)
low quality [191]. The quality of RR estimates has been assessed by estimating three estimates
simultaneously using the three respiratory modulations [80]. If the range of the estimates is
small, then they are deemed to be of high quality.
4.4.4 Respiratory rate algorithm assessment methodologies
The characteristics of the RR algorithms assessed in the literature are provided in Table 4.9.
Research into RR algorithms has been divided between the use of ECG and PPG signals as the
input signal (used in 50.7 % and 56.4 % of publications respectively). Very few publications have
assessed algorithms which use both the ECG and PPG (0.7 %), or the pulse transit time (PTT)
as inputs (4.3 %). The duration of input signal used to estimate a single RR was most commonly
between 30 and 90 s, although the duration was not reported in 46.4 % of publications. Very few
publications conducted large scale comparisons of algorithms, shown by only 5 publications (3.6
%) containing comparisons of more than ten algorithms, and only 2 (1.4 %) comparing more
than 15 algorithms. Approximately half of publications (46.4 %) assessed the performance of
only one algorithm.
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The characteristics of the datasets used to assess the performances of RR algorithms are pro-
vided in Table 4.10. The majority of publications used datasets containing data from young
adults (63.6 %). In contrast only 30.0 % of publications used data from elderly adults. Most
publications used data from healthy subjects (70.7 %). The most frequently used patient pop-
ulation was critically-ill patients (24.3 %), whereas only 5.7 % of publications used data from
acutely-ill patients. Similarly, the data used in most publications were acquired during spon-
taneous breathing (77.1 %). Few publications assessed the performance of RR algorithms on
ambulatory data (11.4 %). The duration of recordings used to assess RR algorithms varied
greatly from < 10 mins to several hours. Nearly a quarter (23.6 %) of studies did not report
the duration of recordings used.
At least some of the data used in most assessments (74.3 %) is not publicly available. A total
of 11 publicly available datasets have been used to assess the performance of RR algorithms,
as detailed in Table 4.11. The publicly available datasets tend to be relatively small, with only
three datasets containing data from more than 50 subjects. All of the datasets contain ECG
signals, whereas only six out of eleven contain PPG signals. A range of respiratory signals were
used to estimate reference RRs across these datasets. Data in five of the datasets, including
the four largest datasets, were collected from critically-ill patients who may either be breathing
unassisted or with the aid of a mechanical ventilator. Only three datasets contained data from
sick patients outside of the critical care setting, all of which were recorded during sleep apnea
assessments. Despite the public availability of 11 datasets with which to assess RR algorithms,
only one publication has used more than 2 datasets [155]. Note that the VORTAL dataset has
not been included here since it is described in Section 4.6.
The methods used to assess algorithm performance are summarised in Table 4.12. A range
of equipment was used to acquire reference RRs, measurement of air flow or pressure, and
impedance pneumography (ImP), being most common (each used in 22.1 % of publications).
The type of reference RR equipment was not reported in 17.9 % of studies. A range of algorithms
were used to obtain reference RRs from reference respiratory signals. However, often there was
no assessment of the performance of these algorithms, making it difficult to know whether
errors in RR estimates derived from the ECG and PPG were solely due to poor RR algorithm
performance, or contributed to by inaccuracies in the algorithms used for obtaining reference
RRs. Two notable exceptions were [109] and [10]. In [109] several algorithms for obtaining
reference RRs were compared, and the time domain ET4 and ET5 methods were found to be
“the only serious candidates”, with frequency domain spectral methods (EF1, EF2) and an
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Table 4.10: Characteristics of the datasets used to assess RR algorithms in the literature.
Characteristic Category No. publications (%)
Age of subjects (years) 0 - 0.1: Neonate 3 (2.1)
0.1 - 17: Paediatric 16 (11.4)
18 - 39: Young adult 89 (63.6)
40 - 69: Middle-aged adult 46 (32.9)
≥ 70: Elderly adult 42 (30.0)
Level of illness Healthy 99 (70.7)








Included ambulatory data? Yes 16 (11.4)
No 134 (95.7)
Unknown 1 (0.7)
Recording time (mins) 1-10 50 (35.7)
11-20 20 (14.3)
21-59 9 (6.4)
≥ 60 28 (20.0)
Unknown 33 (23.6)
Dataset publicly available? Yes 60 (42.9)
No 104 (74.3)
Number of datasets used 1 122 (87.1)
2 17 (12.1)
3 1 (0.7)
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Table 4.12: Methods used to assess RR algorithm performance in the literature.
Characteristic Category No. publications (%)









Statistics Error statistic 71 (50.7)
Breath detection statistic 25 (17.9)
Bias and LOA 18 (12.9)
Correlation 8 (5.7)
Coverage Probability 2 (1.4)
None 28 (20.0)
Unknown 3 (2.1)
Conflict of interest? Yes 1 (0.7)
No 139 (99.3)
autocorrelation method (EF6) performing poorly. In [10] (which arose from this review) a time
domain breath detection algorithm was used, and its performance was quantified by comparing
the reference RRs provided by the algorithm to those obtained through manual annotation of
a subset of the data.
Similarly, a wide range of statistics were used to assess RR algorithm performance. The most
common group of statistics were based on the errors in estimated RRs (used in 50.7 % of
publications), including the mean (absolute) error, root mean squared (normalised) error, and
the percentage error. Statistics indicating the reliability of breath detection were used in 17.9
% of publications. These included statistics such as sensitivity, specificity, false negative and
false positive rates. The limits of agreement method [309], consisting of the systematic bias and
limits of agreement within which 95% of errors are expected to lie, was used less often (12.9 %).
Only one publication reported a conflict of interest.
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4.5 Discussion
This review has presented a comprehensive synthesis of the literature on algorithms to estimate
RR from the ECG and PPG. A total of 140 publications were included in the review following
a systematic search of four online databases. This demonstrates both the importance of the
topic to the research community, and the potential utility of a comprehensive review to future
researchers. This review builds on previous reviews of algorithms for use with the ECG [79] and
PPG [280, 281, 310]. The results of the review are now discussed.
4.5.1 Search and screening
The methodology used to conduct this review differed from previous reviews of the topic, which
consisted of manual search strategies. In contrast, this review used a combination of manual
and systematic search strategies, ensuring a highly comprehensive search. The systematic search
strategy was designed based on the results of an initial manual search, allowing the search terms
to be optimised for identification of relevant literature. This resulted in a relatively high PPV for
the identified publications of 25.3 %, indicating the proportion of publications identified based
on their title which were included. In addition to the manual search, four electronic databases
were searched, providing a comprehensive survey of the literature. The most comprehensive
search database was Scopus, which identified 91 included publications, including 65.0 % of
the publications which were included. IEEE Xplore had a high PPV of 48.8 %, indicating
its usefulness for quick, initial searches. However, it only identified 42.1 % of the included
publications. Google Scholar had low sensitivity and PPV values (25.7 and 10.7 % respectively),
and only provided 7 unique publications. The manual search strategy was highly important since
31 (22.1 %) of the included publications were only identified by the manual search and not any
of the electronic databases. It was, however, by far the most time-consuming search. The search
strategy used was not only beneficial because of its comprehensiveness, but has the additional
advantage that it can be easily updated in the future.
4.5.2 Characteristics of included publications
This review demonstrated that research into the estimation of RR from the ECG and PPG
is both a recently developed and rapidly growing field. The earliest included publication was
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published in 1991. Since then the rate of publication has increased greatly, and continues to
grow. Currently there are approximately 16 new publications describing RR algorithms per
year. This highlights the need for frequent updates of this review, which are facilitated by the
systematic search strategy.
4.5.3 Respiratory rate algorithms
This review presented a generalised structure of RR algorithms which can be used to facilitate
in-depth assessments of algorithm performance. Algorithms were found to consist of up to five
stages, as summarised in Figure 4.4. Two of the stages are compulsory: extraction of respiratory
signal(s), and estimation of RR(s). The remaining three stages are optional. An algorithm can
be constructed by selecting an interchangeable technique for use at each stage of the algorithm.
This framework is a novel approach to decomposing RR algorithms into their constituent parts,
which allows the multitude of different algorithms described in the literature (over 100) to be
described concisely. It will also facilitate assessment of the influence of the technique used at
each stage on algorithm performance. Some algorithms contain modifications, or additions, to
the orthodox techniques listed for use at each stage. For instance, techniques for estimation of
RR based on autoregressive modelling often require specification of the model order. Several
approaches have been proposed to select an appropriate model order, including: (i) the use of a
pre-specified model order [108, 237, 280]; (ii) analysis of the respiratory signal using Rissanen’s
minimum description length method [110, 311, 312] or the Akiake criteria [111]; or (iii) the
optimal parameter search (OPS) criterion [203–205, 271]. Therefore, the techniques listed in
the generalised structure do not capture all of the potential subtleties of algorithms. However,
this structure has the great benefit of providing a manageable way to implement and assess the
many algorithms proposed in the literature.
The extraction of respiratory signals was performed using two approaches: feature- and filter-
based approaches. Feature-based techniques extract one measurement of the influence of res-
piration on the input signal for each heart beat. In contrast, filter-based techniques extract a
continuous signal. The benefit of the feature-based approach is that a specific influence can be
measured. For instance, the change in QRS amplitude due to movement of the ECG electrodes
with respect to the heart’s electrical axis can be measured directly, without any confounding
from P- or T-waves. In contrast, filter-based techniques make no distinction between the differ-
ent components of the ECG or PPG signals, and therefore do not measure a specific influence.
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However, the feature-based approach has the disadvantage of only taking a measurement of the
influence of respiration once per heart beat. If the HR is less than twice the RR, then this may
inhibit RR estimation by the Nyquist-Shannon sampling theorem [313]. Conversely, the filter-
based approach provides a continuous signal, potentially allowing estimation of RRs when the
HR is less than twice the RR. It is not yet clear which approach provides superior performance,
or whether the optimal choice of approach varies between patient populations. Furthermore,
it is not clear which technique for extracting a respiratory signal provides the highest quality
signal (i.e. that which correlates most closely with a reference respiratory signal), and whether
this also varies between patient populations.
The fusion of multiple respiratory signals to provide one, more robust signal, has received rela-
tively little attention in the literature. Time domain methods have received little consideration
since their conception in 2003 [186]. Frequency domain methods have been used in a few publi-
cations, and often have the benefit of incorporating a quality assessment step, for instance only
including respiratory signals whose frequency spectra meet certain criteria.
Estimation of RRs was performed using techniques operating in either the time or the frequency
domain. Time domain techniques consist of the identification of individual breaths. These
techniques have the benefit of being able to estimate RRs when the respiratory pattern is
not stationary. However, they are susceptible to erroneous breath detection due to abnormal
morphology in a respiratory signal. On the other hand, frequency domain techniques require
the respiratory pattern to be quasi-stationary, but are less susceptible to transient noise on the
respiratory signal. Similarly to feature- and filter-based approaches to extracting a respiratory
signal, it is not yet clear whether either approach for estimation of RRs provides superior
performance.
The fusion of multiple RR estimates has been proposed as a method to increase the robustness
of RR estimates [80, 237, 238]. However, these techniques have not been tested widely across
different datasets, so it is not clear whether this optional component consistently improves
algorithm performance. The techniques fall into two categories: modulation and temporal
fusion. Modulation fusion is conducted by fusing individual estimates derived from multiple
respiratory signals, whereas temporal fusion consists of fusing sequential estimates from a single
respiratory signal. Therefore, temporal fusion may not be suitable for use with wearable sensors
since there may be gaps between consecutive segments of high quality data.
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A range of quality assessment techniques have been proposed. However, no individual technique
has been commonly used across several publications, highlighting the experimental nature of
these techniques. Recent work has compared the performances of several techniques for assess-
ment of respiratory signal quality, although this work is still ongoing [154, 155].
4.5.4 Respiratory rate algorithm assessment methodologies
The 140 included publications used a wide range of methodologies for assessment of RR al-
gorithms. Research has been split almost equally between using the ECG and PPG as input
signals. This demonstrates the potential clinical utility of using each input signal, as well as the
need to compare algorithm performances when using each input signal. The duration of input
signals used to estimate RR ranged between 30 and 90 s in most assessments. This reflects a
compromise between, on the one hand, reducing the time required for assessments and ensur-
ing that the true RR remains stable during the measurement period, and on the other hand,
increasing the measurement duration to obtain more precise estimates.
The focus of RR algorithm assessments appears to have been on the assessment of novel algo-
rithms, rather than comparisons of performances of existing algorithms. This is demonstrated
by approximately half of the publications assessing the performance of only one algorithm. In
contrast, only two publications (one of which arose from this work) compared the performance
of more than 15 algorithms. Consequently, it is difficult to determine from the literature which
algorithms perform best.
The datasets used to assess RR algorithms were often acquired from subjects who are not rep-
resentative of acutely-ill, ambulatory patients who would be monitored with wearable sensors.
Assessments were often conducted using data from young, healthy subjects. A smaller propor-
tion used data from ventilated patients or subjects breathing in time with a metronome, whose
respiratory mechanics could not be presumed to be similar to those of spontaneously breathing
patients. In contrast many hospital patients are elderly, and therefore have stiffer arteries, more
frequent ectopic beats, and co-morbidities which may affect the performance of RR algorithms.
Only a few publications (8, 5.7 %) used data from acutely-ill patients. This is likely to be
because it is difficult to acquire reference RR measurements in acutely-ill, ambulatory patients,
and also because none of the publicly available datasets contain data from acutely-ill patients
outside of critical care.
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4.5.5 Future Research Directions
This review identified three key limitations of previous assessments of RR algorithms which
should be addressed in future research. Firstly, prior to this review there were no compre-
hensive comparisons of RR algorithms. The performances of 30 algorithms were compared in
one publication [278], whilst the only other publication to have compared more than 15 RR
algorithms arose from this review [10]. This demonstrated the urgent need for a comprehensive
assessment of RR algorithms to determine whether any algorithm performs sufficiently well for
use in wearable sensors. Secondly, most of the assessments used data from populations which
are not necessarily representative of acutely-ill patients. Therefore, it is not known whether RR
algorithms could be expected to perform at the same level when used for monitoring hospital
patients using wearable sensors. Thirdly, it is unclear whether the reference RRs used in many
publications were reliably obtained, since the algorithms used to obtain them were often not
assessed. This may have resulted in the observed performances of RR algorithms being worse
than their true performances due to inaccuracies in reference RRs. The impacts of these three
limitations on future research are now discussed.
Comprehensive assessments of algorithms are currently hindered by the lack of publicly avail-
able algorithm implementations. The publications identified were written by 101 first authors,
indicative of the wide range of skills and knowledge used to design the algorithms. Therefore,
a substantial amount of effort is required to implement the algorithms for assessment. An al-
ternative approach which would not require implementation of the different algorithms would
be to perform a meta-analysis of existing studies. However, several factors make this difficult
including: poor reporting of study methodology; the use of different statistical methods to
assess algorithms; the use of data from several populations ranging from healthy subjects to
critically-ill patients; the potential for different algorithm implementations between studies; and
the potential range of accuracies of reference RRs. Therefore, a publicly available toolbox of
algorithms is required to facilitate comprehensive assessments.
Assessments of the utility of algorithms for use with wearable sensors are hindered by a lack of
datasets acquired from acutely-ill patients. None of the 11 publicly available databases contain
data from acutely-ill patients outside of the critical care setting. Therefore, additional datasets
are required to assess the potential performance of algorithms in this setting.
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It is essential that the reference RRs used to evaluate RR algorithms are reliable. However, there
has been little research into the techniques used for obtaining reference RRs [237]. Consequently,
it is not clear how accurate reference RRs are, and also whether the technique used to obtain
reference RRs biases the performance metrics towards particular methods for estimating RR
from the ECG and PPG. These are important considerations since inaccuracies in reference
RRs will result in the performances of RR algorithms appearing to be poorer than they truly
are. Several methods have been used previously to obtain reference RRs, although none are
ideal. These include: manual annotation of individual breaths [80]; using a time domain breath
detection algorithm to identify individual breaths [109, 204]; using two methods for estimating
RR, and only outputting a reference RR at times when the two methods agree within a specified
tolerance (e.g. two frequency domain techniques [154], or a time domain and a frequency
domain technique [4, 237]). However, none of these methods is without its limitations. Manual
annotations are time-consuming and not easily reproducible [109]. The use of a time domain
algorithm may bias the analysis towards RR algorithms which use a time domain RR estimation
technique. The use of two methods to estimate RR from the reference signal may result in
excessive exclusion of windows, since those windows on which only one of the two methods
provides an accurate reference RR will be excluded. It may not be possible to develop a perfect
technique for obtaining reference RRs which is free from any of these limitations. However,
further research should be based on an informed choice of technique, allowing its limitations
and possible influence on the results to be appreciated.
Despite the extensive research into RR algorithms, none have yet been widely adopted into
clinical practice. However, clinical devices are now available which incorporate RR algorithms.
CovidienTM have developed an RR algorithm for use with the PPG which can be incorporated
into their patient monitors. This is likely based on the algorithm they have previously reported
and assessed in healthy volunteers and hospitalised patients [147, 148]. The device has been
independently assessed [260], although it is not yet clear whether it is suitable for widespread
clinical use. In addition, Philips Healthcare (Andover, MA, USA) have conducted studies
investigating the estimation of RR from the ECG [151, 153, 176, 183–185]. The availability of
clinical devices containing an RR algorithm makes it substantially easier to assess RR algorithms
prospectively in a range of clinical settings, although such research is limited to the algorithm
implemented in the device.
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4.6 RRest: Respiratory Rate Estimation Resources
This section presents the development of three resources to address the three limitations of
RR algorithm assessments described above: a lack of datasets from acutely-ill patients; the
need to ensure that reference RRs are reliable; and, a lack of publicly available algorithm
implementations. These resources are designed for two purposes. Firstly, they are used in
the remainder of this thesis to assess RR algorithms for retrospective use with the wearable
sensor data in the LISTEN Dataset. Secondly, they are being made publicly available, enabling
researchers to evaluate novel algorithms, and to perform their own assessments of RR algorithms.
4.6.1 Datasets for Assessment of RR Algorithms
The range of datasets publicly available for assessment of RR algorithms is not sufficient to
determine whether RR algorithms perform well enough for use with wearable sensors. The
publicly available datasets which have previously been used to assess RR algorithms (listed in
Table 4.11) are not ideal for two reasons. Firstly, the available datasets were recorded from
three patient populations, none of which is entirely representative of acutely-ill patients who
would wear wearable sensors. These are: (i) critically-ill patients; (ii) healthy subjects; and, (iii)
subjects being assessed for chronic obstructive sleep apnoea. Critically-ill patients often require
organ support which may impact the respiratory, cardiovascular and autonomic nervous systems,
artificially altering their physiology. For instance, patients may require mechanical ventilation
which provides positive pressure during inhalation (rather than the usual negative pressure
provided by thoracic expansion). They may also require positive or negative inotropic agents
which increase or decrease the strength of heart muscle contraction respectively. Critically-
ill patients may also be subject to pathologies such as sepsis which reduce autonomic nervous
system functionality [314]. Conversely, healthy subjects may have improved organ function when
compared to acutely-ill patients. Finally, sleep apnoea markedly changes respiratory dynamics,
making it unrepresentative of acutely-ill patients. Secondly, only in vivo datasets are available,
making it difficult to ensure that algorithms have been reasonably implemented, since when
using in vivo datasets it is difficult to determine whether poor algorithm performance is due
to a lack of respiratory modulation of the ECG and PPG signals, or due to poor algorithm
implementation. Therefore, there is a need for additional datasets for initial verification of RR
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algorithm implementations, and subsequent assessment of the performances of RR algorithms
in subjects who are similar to the target population of acutely-ill patients.
In the remainder of this section six novel datasets are described which have been assembled to
facilitate the assessment of RR algorithms for use in wearable sensors. These have been designed
to allow the influences of individual physiological and technical factors on RR algorithms to be
assessed. The datasets are summarised in Table 4.13.
RRest-synth: a dataset of idealised synthetic signals
Currently it is not possible to verify algorithm implementations on an idealised dataset. Rather,
algorithms are implemented and tested on real-world datasets. This approach makes it difficult
to perform robust comparisons of algorithms, since it is difficult to determine whether poor
performances of algorithms are due to intrinsic flaws in the algorithmic techniques, or simply
due to flawed implementations of the algorithms. The RRest-synth Dataset was designed to
overcome these difficulties. The dataset contains simulated ECG and PPG signals covering a
range of heart rates (HRs) and RRs. Three signals are provided for each combination of HR and
RR, each exhibiting either baseline wander (BW), amplitude modulation (AM), or frequency
modulation (FM). The exemplary signals shown in Figure 4.1 are taken from this dataset.
The signals were simulated based on mathematical descriptions of ECG and PPG signals in the
presence of the three respiratory modulations: BW, AM and FM. This builds on previous work
by Pallás-Areny et al., who described a mathematical formulation for AM of the ECG [315].
They assumed that if the ECG (here extended to the PPG), denoted x(t), is assumed to be




Vn cos(nωct+ Φn) , (4.1)
where the periodic signal consists of n sinusoidal components of amplitude Vn, ωc is the constant
cardiac angular frequency (frequency, f = 2πωc), and Φn is a phase shift [315]. This describes
the ECG or PPG in the absence of any respiratory modulation.
The manifestation of BW on the unmodulated signal can be modelled by assuming that the res-
piratory modulation is sinusoidal, at constant respiratory angular frequency ωr with amplitude
Ar, and that it obeys the superposition principle. Therefore, an ECG or PPG signal influenced
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Vn cos(nωct+ Φn) +Ar cos(ωrt+ Φr) , (4.2)
where Φr is the respiratory phase shift.
The manifestation of AM can be modelled through time domain multiplication of the amplitude
of the unmodulated signal by a respiratory modulation (the latter being always positive). The
respiratory modulation is characterised by an oscillation of maximum amplitude modulation





Vn cos(nωct+ Φn) · (1 + ∆V cosωrt) . (4.3)
The manifestation of FM can be modelled by modulating the instantaneous cardiac angular
frequency, ωci(t), at the respiratory frequency, giving
ωci(t) = ωc + ∆α sin(wrt) , (4.4)
where ∆α is the maximum angular displacement. The instantaneous phase angle of the FM












cos(wrt)] + Φn) . (4.6)
The dataset was generated as follows. An exemplary beat for the ECG and PPG signal was
acquired from a young subject. The time values of these beats were interpolated so that each
beat lasted 1 s. These were then repeated 210 times, giving a simulated signal lasting 210 s. This
signal was then modulated according to the descriptions of the three respiratory modulations
listed above, producing three separate signals. This process was repeated for a range of HRs
(30 - 200 beats per minute) and RRs (4 - 60 breaths per minute). When the HR was varied,
the RR was fixed at 20 bpm. When the RR was varied, the HR was fixed at 80 bpm. This
provided a total of 192 signals, each sampled at 500 Hz.
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The RRest-synth Dataset serves two purposes. Firstly, it allows one to determine whether an
RR algorithm has been implemented reasonably (i.e. whether it estimates RR accurately in
ideal simulated signals). Secondly, it allows one to assess the limitations of RR algorithms, such
as whether they perform accurately in the presence of different types of respiratory modulation,
and whether their performance is dependent on the underlying HR or RR.
RRest-ideal: a dataset of young healthy subjects before, during and after exercise
It is useful to assess the performance of RR algorithms on data from healthy subjects as well
as patients, to determine their best possible performance in the absence of pathophysiology.
Despite five publicly available datasets containing data from healthy subjects, none of these are
ideal for this purpose. Only one of these five contains PPG signals, which were recorded from
eight subjects. Therefore, a novel dataset acquired from healthy subjects is required to assess
the performance of RR algorithms on both ECG and PPG signals.
The RRest-ideal Dataset contains data acquired from 39 young healthy subjects aged 18 -
39 years old as part of the VORTAL study (National Clinical Trial 01472133) [10]. Ethical
approval for the study was obtained from the London Westminster Research Ethics Committee
(11/LO/1667). Data were acquired for approximately 10 mins at rest in the supine position,
followed by 2 mins walking on a treadmill, followed by several minutes running (until the
subject’s HR reached 85 % of their age-predicted maximum [316]), followed by a further 10
mins at rest whilst recovering from the exercise.
Therefore, the RRest-ideal Dataset is useful for two purposes. Firstly, it facilitates assessment
of the performance of algorithms in ideal conditions. Secondly, it can be used to assess the
impacts of walking and running on RR algorithm performances.
RRest-healthy: a dataset of young and elderly healthy subjects at rest
Several technical and physiological factors may influence the performance of RR algorithms, as
described in Chapter 5. These include technical factors such as the use of high fidelity recording
equipment (as opposed to clinical monitors), signal sampling frequency, the use of the ECG
or PPG as the input signal, and the location of PPG measurement (e.g. ear or finger); and
physiological factors such as age, gender, RR and HR. The technical factors may influence the
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design of wearable sensors, whilst the physiological factors may influence the choice of clinical
settings in which RR algorithms are used.
The RRest-healthy Dataset is designed to facilitate investigation of the influence of each of these
factors on the performances of RR algorithms. It contains data acquired from 41 young healthy
subjects aged 18 - 39 years old, and 16 elderly healthy subjects aged over 70 years old, as part
of the VORTAL study [7]. A 10 minute recording was acquired from each subject whilst laid
supine. Subjects who had co-morbidities or were receiving medications that might significantly
affect the functioning of the cardiac, respiratory and autonomic nervous systems were excluded.
Data were acquired simultaneously using a range of sensors. High fidelity laboratory (lab)
equipment was used to acquire lead II ECG, finger PPG, ear PPG, and oral-nasal pressure
signals. The lab equipment consisted of a 1902 amplifier, a Power 1401 analogue-to-digital
converter and Spike2 v.7.09 acquisition software (all Cambridge Electronic Design, Cambridge,
UK). Finger and ear PPGs were transduced using MLT1020FC and MLT1060EC infra-red re-
flection plethysmographs respectively (AD Instruments, CO Springs, New Zealand). Oral-nasal
pressure was transduced using an Ultima Dual Airflow differential pressure transducer (Braebon
Medical Corporation, Kantata, ON, Canada) connected to a P1300 Pro-Flow oral-nasal can-
nula (Philips Respironics, Murrysville, PA, USA). Signals were sampled at 500 Hz. In addition,
clinical equipment was used to simultaneously acquire Lead II ECG and finger PPG signals.
The signals were monitored using an IntelliVue MP30 clinical monitor (Philips Medical Sys-
tems, Boeblingen, Germany) and captured using ixTrend acquisition software (v.2.0.0 Express,
Ixellence GmbH, Wildau, Germany) at 500 Hz and 125 Hz, respectively.
The RRest-healthy Dataset is used in the investigation presented in Chapter 5, where additional
details such as demographic characteristics are provided.
RRest-acute: a dataset of acutely-ill patients recovering from cardiac surgery
The RRest-acute Dataset is designed to facilitate assessment of the performances of RR algo-
rithms in acutely-ill patients. Approximately 20 mins of data were acquired from each of 108
patients recovering from major cardiac surgery as part of the LISTEN Trial (National Clinical
Trial 01549717). The data were acquired during the last eight hours of patients’ stays in critical
care prior to being discharged to an ambulatory ward where most were monitored using wear-
able sensors. Therefore, the physiology of the patients can be expected to be similar to that
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which would be encountered when monitoring acutely-ill patients using wearable sensors. To be
eligible, patients had to be in sinus rhythm, and not paced, excluding patients with arrhythmias
or receiving external pacing.
RRest-afib: a dataset containing recordings during sinus rhythm and atrial fibril-
lation
The RRest-afib Dataset is designed for assessment of the influence of atrial fibrillation (AFib) on
RR algorithms. The data, consisting of paired 20 min recordings of periods of AFib and sinus
rhythm, was extracted from the LISTEN Dataset. All patients in the dataset were assessed
for eligibility using heart rhythm labels documented in the routine clinical records. To be
eligible, patients had to be in AFib for a sustained period, and in sinus rhythm for a separate
sustained period, during the 24 hours of their critical care stay immediately prior to discharge
to an ambulatory ward. A total of 20 patients were eligible according to the heart rhythm
labels. Of these, five patients were removed because the labels were found to be inaccurate
upon inspection. Therefore, RRest-afib contains 30 recordings, consisting of a recording during
AFib and a recording during sinus rhythm, from 15 patients.
The reliability of the data labels was also assessed through analysis of the ECG R-R intervals
in the dataset. This was achieved using a previously reported method for detecting AFib from
R-R intervals [317]. This method quantifies the variability of R-R intervals by plotting the
durations of the R-R intervals in each 128 s against the difference between consecutive R-R
intervals. The plot is divided into a 25 ms resolution grid, and the number of non-empty cells
(NECs, 25 × 25 ms cells) is calculated. Higher numbers of NECs demonstrate greater levels of
variability, associated with AFib. The results, shown in Figure 4.7, show a marked difference
in the variabilities of R-R intervals between the two groups.
RRest-vent: a dataset containing recordings shortly before and after extubation
The final dataset, RRest-vent, is designed to facilitate assessment of the impact of mechanical
ventilation on RR algorithms. It consists of data acquired from 59 LISTEN Trial patients at
three points during their recovery from surgery: shortly before disconnection from a ventilator;
shortly after disconnection from a ventilator; and, shortly before discharge from critical care
to the ambulatory ward. At each time point approximately 20 mins of data were acquired.










Figure 4.7: RRest-AFib Dataset verification: This shows the difference between the variabili-
ties of the R-R intervals in the sinus rhythm recordings and atrial fibrillation (AFib) recordings.
The distributions (median, lower and upper quartiles) of the NECs (a measure of variability of
R-R intervals) are shown for each set of recordings. As expected, the AFib recordings exhibit
a much greater level of variability than the sinus recordings.
This dataset will not be used to help directly with the assessment of algorithms for use with
wearable sensors, since acutely-ill patients who may wear wearable sensors are not mechanically
ventilated. Instead, assessment of the impact of mechanical ventilation on RR algorithms will
contribute towards an understanding of whether the results of previous studies of RR algorithms
in mechanically ventilated patients are representative of those which would be obtained during
unassisted breathing.
4.6.2 A Signal Quality Index for the Impedance Pneumography Signal
One finding of the review was the need for further research into methods for obtaining reference
RRs, as detailed in Section 4.5.5. All publicly available datasets for assessment of RR algorithms
include a reference respiratory signal from which reference RRs can be obtained (Table 4.11),
although only one (CapnoBase) contains reference RRs. Therefore, an algorithm is usually
required to obtain reference RRs from the reference respiratory signal. Several algorithms have
been proposed for this purpose as described in Section 4.5.5, although these each have significant
limitations. An alternative approach would be to use a signal quality index (SQI) to discard
segments of low quality reference respiratory signals, ensuring that only segments of high quality
respiratory signals are used to obtain reference RRs. Indeed, this approach has been widely used
to obtain high quality parameters from the ECG, PPG and ABP signals, as demonstrated in
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Figure 4.8: Impedance (ImP) signal quality assessment: A novel SQI algorithm was designed
to assess the quality of ImP signal segments. On the left, two segments are shown with dots
indicating detected breaths. On the right, the corresponding breath templates (red) and indi-
vidual breaths (grey) are shown. The upper segment is of low quality, as indicated by a low
correlation coefficient (R2) of 0.54. The lower segment is of high quality, as indicated by a high
R2 of 0.97.
Section 4.4.3.5. However, SQIs have not yet been thoroughly developed for use with respiratory
signals. A SQI has been previously proposed for use with the ImP signal [318]. However, when
used for RR estimation it was reported to result in a relatively large mean error of 3.2 ± 4.6
bpm. Furthermore, it did not perform adequately in initial testing on this dataset. This section
describes the development of a novel SQI for use with the ImP signal, and subsequent assessment
of its performance.
The novel SQI was developed by adapting the approach proposed by Orphanidou et al. for
cardiac signals in [124]. This approach consists of three steps. Firstly, individual respiratory
cycles are detected in the signal (i.e. heart beats in the original implementation). Secondly, the
timings of the individual cycles are assessed for physiological plausibility. For instance, in the
original implementation all beat-to-beat intervals had to be less than 3 s in duration. Any signal
segments with implausible cycle timings were deemed to be of low quality. Thirdly, template-
matching was used to assess the similarity of the signal at each cycle as shown in Figure 4.8. If
the correlation between the average cycle’s morphology, and each individual cycle’s morphology,
was high enough then the signal segment was deemed to be of high quality.
A range of criteria for assessing the plausibility of breath-to-breath timings were trialled, re-
sulting in the following algorithm:
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1. Pre-process the ImP signal: The following steps were taken: low pass filter to remove
frequency content above 1 Hz (60 bpm) using a Tukey window to avoid edge effects;
downsample to 5 Hz; normalise to give a mean of 0 and standard deviation of 1; invert
and remove any linear trend.
2. Detect individual breaths: The Count-orig method (ET4) was used to detect breaths,
as described in Table 4.7. This allows individual breaths to be labelled as either valid
(high quality), or invalid (low quality).
3. Assess plausibility of breath timings: Three criteria were used: (i) the normalised
standard deviation of breath durations had to be < 0.25 to permit only a small variation
in the durations of detected breaths; (ii) the proportion of breath durations > 1.5, or <
0.5, times the median breath duration had to be < 15 % to prevent errors due to outlying
breath durations; (iii) >60 % of the window duration had to be occupied by non-outlying
breaths. Any window which did not satisfy these three criteria was deemed to be of low
quality.
4. Assess similarity of breath morphologies: The morphologies of individual breaths
had to be highly correlated, as demonstrated by a mean correlation coefficient between
individual breath morphologies and a template breath of ≥ 0.75.
5. Calculate RR: If a window was deemed to be of high quality then the reference RR was
calculated as the mean duration of the valid breaths in that window.
The performance of the SQI was assessed using the RRest-vent Dataset. This dataset was
chosen to allow the performance to be assessed in three settings: ventilated in ICU, unassisted
in ICU, and shortly before discharge from critical care to the ambulatory ward. The assessment
was performed in two steps. Firstly, the ability of the SQI to discriminate between high and low
quality signal segments was assessed. To do so, ImP signal segments were manually labelled as
high or low quality, where a high quality was only given if the annotator was confident that they
could accurately identify all the breaths in that segment. A total of 1801 signal segments were
annotated (each of 32 s duration, totalling 16 hours of signals). These comprised approximately
10 mins of data from 34 subjects in each of the three clinical settings. Secondly, the accuracy and
precision of reference RRs obtained using the SQI were assessed. To do so, individual breaths
were annotated in those windows deemed to be of high quality by the SQI. These were used to
calculate reference RRs to compare with those calculated by the SQI. In addition, a benchmark
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method for identifying high quality respiratory signal segments, and obtaining reference RRs
was implemented and assessed. The method chosen was the agreement SQI, used in [4, 237].
It consists of estimating RR from the respiratory signal using two independent methods, one
in the time domain and one in the frequency domain. If the two estimates agree to within
± 2 bpm then the window is deemed to be of high quality, and the reference RR is calculated
as the mean of the two estimates. The two methods used were ET4 and EF7.
Results detailing the performance of both the novel ImP SQI, and the agreement SQI, are
provided in Table 4.14. The results show the improved performance of the ImP SQI compared to
the agreement SQI, across all performance metrics and all clinical settings. The key advantages
of the ImP SQI were as follows. Firstly, it was able to provide better discrimination between
high and low quality signal segments. It provided an increased sensitivity of 74.0 % compared to
48.6 % across all clinical settings, showing that more of the segments identified as high quality
were truly of high quality. It also provided an increased specificity of 88.0 % compared to
81.7 %, showing that a greater proportion of the segments identified as low quality were indeed
of low quality. Secondly, the ImP SQI provided more accurate and precise reference RRs than
the agreement SQI. This is shown by a bias (95 % confidence interval, CI) of 0.0 (-0.1 - 0.1) bpm
for the ImP SQI, compared to -1.1 (-1.7 - 0.6) bpm across all settings. This indicates that there
was no systematic mean error between the reference RRs calculated by the ImP SQI and the
manually determined reference RRs. In contrast, the agreement SQI tended to under-estimate
the manually determined reference RRs by 1.1 bpm. In addition, the precision (2SD) of the
ImP SQI was 1.9 (1.4 - 2.4) bpm, compared to 7.9 (5.8 - 9.9). Since 95 % of the errors are
expected to lie within ± 2SD of the bias, a smaller precision indicates improved performance
[309]. These results are in keeping with previous work, which found that time domain techniques
should be used to obtain reference RRs from respiratory signals [109]. These results compare
favourably with previous analyses of RRs obtained from the ImP signal, which have found that
ImP-derived RRs can have 2SD values of > 8 bpm [32].
The results suggest that the performance of the ImP SQI is not only an improvement on the
previous methodology, but also sufficient for the assessment of RR algorithms. This is shown
by a reasonably high proportion of high quality windows (74.0 %) being correctly identified.
In addition, the reference RRs obtained from those windows identified as high quality were
highly accurate and precise. The CP2 and iCP5 metrics demonstrate this further. The ImP
SQI achieved a CP2 of 97.8 %, indicating the proportion of reference RRs obtained which had
an error of < 2 bpm. In addition, it achieved an iCP5 of 0.0 %, indicating that no reference
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Table 4.14: The performances of the novel impedance pneumography (ImP) signal quality
index (SQI), and the agreement SQI. Performances were assessed across the three clinical set-
tings in the RRest Dataset. Discriminatory performance was assessed using the sensitivity and
specificity of the SQI for identification of high quality signal segments. The performance of the
SQI for estimation of RRs was assessed using the bias and limits of agreement (2SD), coverage
probability (CP2, proportion of values within 2 bpm of the reference value), and inverse cov-
erage probability (iCP2, proportion of values differing by more than 5 bpm from the reference
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iCP5 [%] 3.8 7.1 3.8 1.6
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RRs had an error of > 5 bpm. The robustness of these analyses are demonstrated by the total
number of high quality windows over which the reference RRs were assessed, which was 407
for the ImP SQI. Given its high performance, the ImP SQI will allow more robust conclusions
to be drawn from assessments of the performance of RR algorithms. It will allow differences
between RRs estimated using ECG- or PPG-based RR algorithms, and reference RRs, to be
largely attributed to poor RR algorithm performance, rather than poor reference RRs.
4.6.3 A Toolbox of RR algorithms
A key shortcoming of previous research into RR algorithms is the lack of benchmark implemen-
tations of algorithms. A toolbox of RR algorithms was designed and implemented to facilitate
comprehensive assessments of RR algorithms. Similarly to the novel datasets described above,
this toolbox has been used for the studies presented in this thesis, and is being made publicly
available at http://peterhcharlton.github.io/RRest ensuring that future researchers can
use standardised implementations of RR algorithms.
The toolbox is designed to evaluate the performance of a wide range of RR algorithms on
different datasets. It consists of five main parts:
• RR algorithms: Estimation of RRs from ECG and PPG signals using all possible com-
binations of the implemented techniques listed in Tables 4.4, 4.5, 4.7, and 4.8;
• Reference RR estimation: Estimation of reference RRs from either a reference respi-
ratory signal, or annotations of breath timings, or simultaneous RR measurements.
• Signal quality assessment: Assessment of the quality of ECG and PPG signals using
the algorithms described in Section 3.3;
• Respiratory signal quality assessment: Assessment of the quality of respiratory sig-
nals extracted from ECG and PPG signals;
• Statistical evaluation: Evaluation of the performance of RR algorithms using a range
of statistics.
The toolbox is designed to meet the wide range of needs of future researchers. It can be
used with a range of datasets, as it is compatible with all of the novel datasets described in
this chapter, and is also accompanied by scripts to re-format the MIMIC-II, CapnoBase, and
Chapter 4. Estimating Respiratory Rate: Review and Resources 89
Fantasia datasets for compatibility. This facilitates multi-dataset assessments of RR algorithms
covering a range of patient populations. Most parts of the toolbox contain implementations of
several analytical methods, allowing the user to use methods of their preference. For instance, a
total of 31 interchangeable techniques have been implemented for use at different RR algorithm
stages. Reference RRs can be estimated using a range of methods, including the agreement SQI
and novel ImP SQI described above. Three methods for assessment of the quality of respiratory
signals are provided. Five statistical metrics are automatically calculated for users to evaluate
algorithms. Researchers wishing to use the toolbox are directed towards a tutorial written to
allow the novice to quickly start using it [6], and the manual available on the project website.
Contributions of additional algorithms are welcomed.
The implementations of the 370 toolbox algorithms were assessed using the RRest-synth Dataset.
Each technique implemented for extraction of respiratory signals (XA1 to XA4 and XB1 to XB10),
and for estimation of RRs (EF1 to EF7 and ET1 to ET5), was considered to be successfully im-
plemented if over half of the algorithms containing that technique were acceptably accurate.
Acceptably accurate was defined as an absolute error of ≤ 1 bpm for at least 50 % of the simu-
lated signals for any of the three modulations, on either the ECG or PPG. The threshold of 50
% was chosen to ensure that algorithms which performed well for a subset of the trialled HR
and RR combinations were not excluded.
The EF5 and XB10 techniques were found not to be acceptably accurate. EF5 performed poorly
at RRs outside of 12 - 20 bpm, which may be due to its bias towards identifying lower frequencies
as the RR. XB10 variably detected the end of the PPG pulse as either the time of the minimum
immediately before the diastolic peak, or the time of the diastolic peak, causing inaccuracies.
After exclusion of these techniques 314 algorithms remained for further analyses.
4.7 Final Remarks
Many wearable sensors do not currently monitor RR, despite its importance for early detection
of deteriorations. One potential solution is to estimate RR from the ECG or PPG, both of which
are commonly monitored by wearable sensors. In this review a systematic search strategy was
used to identify 140 publications describing algorithms to estimate RR from the ECG and PPG.
The review provides a summary of the proposed algorithms and a synthesis of the methodologies
used to assess them. The results led to the identification of three key limitations of previous
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assessments of RR algorithms for assessing their potential utility for incorporation into wearable
sensors to monitor acutely-ill patients:
• Previous assessments of RR algorithms have mostly been conducted on data acquired from
populations which cannot be considered to be representative of acutely-ill patients;
• The reliability of reference RRs used in most assessments was not assessed, meaning
the performances of RR algorithms were potentially reported as being poorer than they
actually were; and
• No standardised implementations of algorithms are publicly available, making it difficult
to conduct large-scale comparisons of algorithms.
These limitations were addressed by creating a toolbox of resources. The toolbox consists of:
novel datasets including some from acutely-ill patients; a novel signal quality index for obtaining
reference RRs from the ImP signal; and a toolbox of benchmark RR algorithms. These resources
will be used to conduct analyses in the remainder of this thesis, and are being made publicly
available for other researchers at: http://peterhcharlton.github.io/RRest.
Chapter 5




This chapter presents a study to assess how technical and physiological factors influence the
quality of respiratory signals extracted from the electrocardiogram (ECG) and photoplethys-
mogram (PPG). Quality was assessed using the correlation between an extracted respiratory
signal and the reference respiratory signal. The following technical factors were assessed: PPG
measurement site (either the ear or finger); signal acquisition equipment type (either high fi-
delity laboratory equipment, or routine clinical equipment); type of input signal (ECG or PPG);
and, signal sampling frequency. The following physiological factors were assessed: age, gender,
respiratory rate (RR) and heart rate (HR). Recommendations based on the results are provided
regarding wearable sensor designs for RR estimation, and clinical applications.
5.1 Introduction
A fundamental step in estimation of RR from the ECG and PPG is the extraction of a respiratory
signal: a signal dominated by respiration. In the review of RR algorithms (Section 4.4.3), it was
found that respiratory signals can be extracted from the ECG and PPG using either feature- or
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Figure 5.1: Extraction of respiratory signals using exemplary feature- and filter-based tech-
niques. Respiratory signals have been extracted from the PPG using a feature-based technique
in which pulse peak amplitudes are extracted, and a filter-based technique using the amplitude
of the continuous wavelet transform. In this study the quality of extracted respiratory signals
was assessed by calculating the correlation between each extracted respiratory signal and the
reference respiratory signal. Source: [7] (CC BY 3.0, DOI: 10.1088/1361-6579/aa670e)
filter-based techniques, as illustrated in Figure 5.1. The processes for extraction of respiratory
signals are demonstrated in Figure 5.2. This figure illustrates extraction of respiratory signals for
each of the three idealised types of respiratory modulation of the ECG and PPG: baseline wander
(BW), amplitude modulation (AM), and frequency modulation (FM) [10]. If the amplitude of
the respiratory signal is too small compared to underlying noise, then the signal may not be
distinguishable from the noise, preventing the precise estimation of RR. Thus, any factors which
reduce the amplitude of respiratory modulations may result in reduced respiratory signal quality,
affecting the estimation of RR from these signals.
The aim of the study presented in this chapter was to determine how the quality of respiratory
signals is affected by technical and physiological factors which may be encountered in the clinical
setting. Technical factors are those which are fixed during device design, such as the choice of
anatomical site at which to measure the PPG. It is important to understand the influence of
technical factors to optimise device design. In contrast, physiological factors cannot be controlled
for. The influences of physiological factors, such as age, can inform decisions on whether or not
particular RR algorithms are appropriate for use in wearable sensors for monitoring acutely-ill
patients. Quality was measured using the correlation between an extracted respiratory signal
and a reference respiratory signal (see Figure 5.1).
The chapter is structured as follows. Firstly, a review is presented of previous investigations
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Figure 5.2: Processes for extraction of respiratory signals. On the left from top are shown sim-
ulated ECG signals with no modulation, baseline wander (BW), amplitude modulation (AM),
and frequency modulation (FM). In the central column the Q- and R-waves have been iden-
tified (shown as dots), allowing feature-based modulation measurement of BW, AM and FM
(shown in red). On the right are the corresponding frequency spectra of idealised signals at
the cardiac frequency (ωc) under the influence of each modulation. Filter-based modulation
measurement consists of extracting signals dominated by the respiratory frequency. Note that
only BW is manifested in the respiratory frequency (ωr) band. Source: [7] (CC BY 3.0, DOI:
10.1088/1361-6579/aa670e)
into the influence of technical and physiological factors on respiratory signals of the ECG and
PPG, and the subsequent performance of RR algorithms. In Section 5.3, the methods are
described for data collection, assessment of the quality of respiratory signals, and statistical
analysis. The results are then presented for each technical and physiological factor in turn. In
Section 5.5, the impacts of these factors on device designs and on the use of RR algorithms
in particular clinical scenarios are discussed. The RRest-healthy Dataset, respiratory signal
extraction algorithms, and analysis code used in this study are being made publicly available
at: http://peterhcharlton.github.io/RRest.
Postscript: A modified version of the study presented in this chapter has been published in
[7]. The methodologies differ slightly because: (i) the analyses of physiological factors were
also conducted using ECG signals from the Fantasia dataset in this version; and, (ii) a few
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additional techniques were used to extract respiratory signals in [7]. Much of the content of this
chapter has been adapted or reproduced accordingly from [7] (CC BY 3.0, DOI: 10.1088/1361-
6579/aa670e).
5.2 Review of Previous Work
The previous work relating to each of the factors assessed in this study is now reviewed.
5.2.1 Technical factors
PPG probes can be positioned at a range of anatomical sites, including the finger, ear, fore-
arm, shoulder and forehead [319]. Of these, only finger and ear measurements are widely used
in clinical practice. The quality of respiratory signals extracted from the PPG may differ at
different sites because of the augmentation of the systolic portion due to arterial pressure wave
reflections [320], and the visco-elasticity of the arterial system [321]. Indeed, previous investi-
gations have shown that the amplitude of BW is greater when the probe is positioned at the
ear than the finger [319], [322]. However, further investigation is required to verify this finding
and determine the effect of measurement site on AM and FM signals. This may impact device
designers’ considerations of the site of PPG measurement for RR estimation.
The equipment used to acquire ECG and PPG signals may influence the quality of respiratory
signals. This is of particular concern with the PPG, since clinical monitors commonly output
a filtered version which has been optimised for display, which may differ from the measured
signal [323]. The processing procedures include auto-gain, auto-centre, and amplitude gain
functions [324]. These adaptive filters may function over a short time scale, comparable to that
of breathing, therefore potentially affecting extracted respiratory signals. Indeed, a recent study
reported that the AM signals extracted from PPG signals acquired from two clinical monitors
were not interchangeable [325]. Since monitors’ filtering characteristics are not usually published
[323], it is not clear how extracted respiratory signals are affected by this process. If high-fidelity
laboratory equipment results in higher quality respiratory signals than a clinical monitor, then
device designers may need to consider modifying the hardware in devices in order to extract
high quality respiratory signals prior to filtering.
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The type of input signal, ECG or PPG, may impact the quality of respiratory signals since
different physiological mechanisms cause the respiratory modulations in the ECG and PPG.
Therefore, the strengths of individual modulations may differ between the two signals, impacting
extracted respiratory signals. The physiological mechanisms have been reported previously in
[79] and [140], and were summarised in Table 4.1 (Section 4.2), although they are not fully
understood. FM-based RR algorithms have previously been found to perform better when
using the PPG rather than the ECG [326], [172], [191]. Further research is required to determine
whether one signal is superior to the other for measurement of respiratory signals.
The sampling frequency of the input signal may affect the quality of respiratory signals. This
is most important for the ECG signal since many of the feature-based respiratory signals are
calculated from measurements of the QRS-spike, which contains high frequency content. It
is intuitively appealing to use high sampling rates to ensure that respiratory modulations are
captured as precisely as possible. Indeed, several studies have used high-fidelity equipment
sampling the ECG and PPG at up to 1 kHz [327], [328]. However, it is desirable to be able to
use low fidelity equipment since it will make ECG- and PPG-based RR estimation more widely
accessible, particularly in resource-constrained settings. For instance, smart phones with PPG
sampling rates as low as 30 Hz [329] are widely accessible. However, any reduction in signal
quality due to lower sampling frequencies must be appreciated to allow appropriate equipment
to be selected for each clinical setting.
5.2.2 Physiological factors
Age may affect the quality of respiratory signals since some of the physiological mechanisms
which cause respiratory modulations of the ECG and PPG diminish with age. In particular,
respiratory sinus arrhythmia (RSA, which causes FM) and chest wall expansion (which is linked
to BW and AM) both diminish with age [141], [142], [143], [10]. Indeed, FM-based ECG
algorithms of RR have been found to perform worse in older subjects [168], [109], [256], [237].
However, a previous investigation into the effect of age on BW-based PPG algorithms of RR did
not find a difference in performance with age [235]. Further investigation is required to determine
the extent to which each respiratory modulation is affected by age. This is particularly important
given that many acutely-ill hospital patients are elderly, as shown by a median age of patients
in the LISTEN Dataset of 67.5 years (Chapter 3).
Chapter 5. Extracting Respiratory Signals 96
It has also been suggested that gender may influence the quality of respiratory signals. The
amplitude of FM in the PPG has been observed to be greater in women than men [330]. In
contrast, the amplitude of BW in the PPG does not appear to be influenced by gender [235].
If the qualities of respiratory signals differ between women and men then potentially different
respiratory signals could be extracted for each gender.
It has also been reported that the amplitudes of respiratory modulations are affected by a
subject’s RR. This would be particularly significant if it results in a reduction in the performance
of RR algorithms at abnormally low or high RRs, since it is important to be able to detect these
extreme values to ensure patient safety [331]. RSA, the mechanism which causes FM, is reduced
above a certain corner respiratory frequency [332]. Furthermore, it has been observed that AM of
the PPG is reduced at increasing RRs [333]. It has been suggested that the reduced amplitude of
respiratory modulations at elevated RRs causes a reduction in the performance of RR algorithms
[188], [189], [334], [329], [327]. Another study found that FM-based ECG algorithms performed
worse at higher RRs, whereas AM-based algorithms performed better at higher RRs [111]. It
has also been proposed that there is a range of RRs within which RR algorithms perform best,
and that performance is reduced for RRs outside of this range. However, the exact range is
unclear, having being reported as 8-11 breaths per minute (bpm) [189], and 16-20 bpm [237].
5.3 Methods
The methods used for both data collection and signal processing have, in part, already been
described in [10]. Those relevant to this study are presented here.
5.3.1 Technical and physiological factors
The technical and physiological factors investigated in this study are listed in Table 5.1. The
investigations were carried out as follows. Firstly, the respective qualities of respiratory signals
extracted from finger and ear PPG signals were compared. The measurement site associated
with lower quality respiratory signals was eliminated from further analyses. Secondly, respira-
tory signals extracted from laboratory and clinical signal acquisition equipment were compared.
Similarly, the signal acquisition equipment associated with lower quality respiratory signals was
eliminated from further analyses. Finally, the influences of the remaining technical factors, and
the physiological factors, on respiratory signal quality were assessed.
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Table 5.1: Technical and physiological factors investigated in this study which may influence
the quality of respiratory signals extracted from the electrocardiogram (ECG) and photoplethys-
mogram (PPG).
Technical Physiological
PPG measurement site: finger or ear Age
Signal acquisition equipment: laboratory or clinical Gender
Input signal: ECG or PPG Respiratory rate (RR)
Sampling frequency Heart rate (HR)
5.3.2 Datasets
The primary dataset used in this investigation was the RRest-healthy Dataset [7]. This dataset
is described in detail in Section 4.6.1. Briefly, it contains data acquired from 41 young healthy
subjects (aged between 18 and 39 years old), and 16 elderly subjects (at least 70 years old), for
approximately 10 mins at rest. ECG, PPG and reference oral-nasal pressure respiratory signals
were acquired simultaneously. This dataset is suitable for the assessment of technical factors
since it contains signals acquired using both laboratory and clinical equipment simultaneously,
and using different PPG measurement sites. This dataset is also suitable for the assessment
of physiological factors since it contains data from young and elderly, and male and female
subjects.
The RRest-healthy Dataset was extended in two ways to allow the impact of sampling frequency
to be assessed. Firstly, ECG and PPG signals were downsampled incrementally from the original
sampling frequencies to 50 Hz for the ECG and 8 Hz for the PPG. The downsampled signals
were then interpolated at the original sampling frequency using cubic-spline interpolation.
A secondary dataset, the publicly available Fantasia dataset [302, 303], was used to assess the
generalisability of the results pertaining to a subset of technical and physiological factors. This
dataset contains data acquired from 20 young healthy subjects (21 - 34 years old), and 20 elderly
subjects (68 - 85 years old). The recordings contain simultaneous ECG and reference respiratory
signals at 250 Hz. The first 66.7 mins of each subject’s recording were used for analysis.
This dataset is suitable for assessing the physiological factors considered in this investigation.
However, it does not contain the range of signals provided by the RRest-healthy Dataset, so
was not used to investigate technical factors.
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Table 5.2: Demographic characteristics of the two datasets used in this investigation.
Characteristic Young Cohort Elderly Cohort
RRest-healthy Dataset
No. subjects 41 16
Age [years], med (lower - upper quartiles) 29 (26 - 31) 75 (72 - 78)
Female [%] 51 56
Fantasia Dataset
No. subjects 20 20
Age [years], med (lower - upper quartiles) 26 (22 - 30) 73 (71 - 77)
Female [%] 50 50
Table 5.3: Data characteristics
Characteristic No. high quality 32 s windows per subject,
med (lower - upper quartiles)
RRest-healthy Dataset
Reference respiratory signal (ref) 19 (18 - 20)
Laboratory ECG and ref 19 (18 - 20)
Laboratory finger PPG and ref 18 (16 - 20)
Laboratory ear PPG and ref 19 (17 - 20)
Clinical ECG and ref 19 (18 - 20)
Clinical finger PPG and ref 19 (17 - 20)
Fantasia Dataset
Reference respiratory signal (ref) 72 (39 - 96)
ECG and ref 56 (33 - 91)
The demographic characteristics of the subjects in each dataset are provided in Table 5.2. Data
from each subject consisted of a median (lower - upper quartiles) of 20 (19 - 20) 32 s windows
in RRest-healthy, and 124 (124 - 124) 32 s windows in Fantasia. The number of high-quality
windows for each signal are given in Table 5.3. The reference values of RR in the RRest-healthy
Dataset were 16.5 (11.6 - 19.7) bpm, and 17.5 (14.6 - 19.1) bpm in the Fantasia Dataset. The
reference values of HR in the RRest-healthy Dataset were 64.0 (58.1 - 69.1) bpm, and 58.8 (55.0
- 63.4) bpm in the Fantasia Dataset.
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5.3.3 Quality assessment
ECG, PPG and oral-nasal pressure signals were segmented into adjacent windows of 32 s dura-
tion. The quality of each signal during each window was assessed using the methods described
below. Any windows in which any of the required signals were of low quality were excluded
from analyses.
The quality of ECG and PPG signals was assessed using the algorithm reported in [124], and
described in Section 3.3. The quality of the oral-nasal pressure signal in the RRest-healthy
Dataset was assessed by calculating its signal-to-noise ratio using a modified periodogram. Any
windows with a low signal-to-noise ratio were deemed to be of low quality, with the threshold
for exclusion set to eliminate windows in which breaths could not be identified visually. The
quality of the reference respiratory signal in the Fantasia Dataset was assessed using the SQI
designed and validated in Section 4.6.2.
5.3.4 Extraction of respiratory signals
Several techniques have been proposed for extraction of respiratory signals from the ECG and
PPG, as described in Section 4.4.3.1. In this study four filter-based techniques (XA1 to XA4,
described in Table 4.4), and nine feature-based techniques (XB1 to XB9, described in Table
4.5) were used to extract a wide range of respiratory signals. All techniques were used with
the RRest-healthy Dataset. However, techniques XA2 to XA4, and XB9 were not used with
the Fantasia Dataset since they were too computationally expensive to be used with the longer
recordings in this dataset.
Filter-based techniques, XA1 to XA4, were implemented as described in Table 4.4, followed by
elimination of frequency content outside of the range of plausible respiratory frequencies by
band-pass filtering.
Feature-based extraction was conducted as follows. Very high frequencies were eliminated using
low-pass filters with -3 dB cut-offs of 100 and 35 Hz for the ECG and PPG, respectively. An
additional 50 Hz notch filter was used to eliminate mains interference in the ECG. Beat detection
was performed on the ECG using a QRS detector based upon the algorithm of Pan, Hamilton
and Tompkins [72], [73], and on the PPG using the Incremental-Merge Segmentation (IMS)
algorithm [74]. R-waves and pulse peaks were detected as the maxima at or between detected
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beats. QRS troughs were detected as the minima within the 0.10 s prior to R-waves [112],
and pulse troughs as the minima between pulse peaks [186]. One of the beat-by-beat features,
XB1 to XB9, was obtained as described in Table 4.5. Features derived from ectopic beats were
eliminated using the algorithm described in [335]. The beat-by-beat features were generated
at a variable rate (the heart rate). The time-series of these features was re-sampled at 5 Hz
using linear interpolation since subsequent processing required a constant sampling frequency
[80]. Frequency content outside of the range of plausible respiratory frequencies was eliminated
by band-pass filtering.
The range of plausible respiratory frequencies was determined as follows. The lower cut-off
was fixed at 4 breaths per minute (bpm). The upper limit was set to 36 bpm to bisect the
maximum RR and minimum heart rate (HR) in the RRest-healthy Dataset (33 bpm and 40 bpm
respectively). This limit was also suitable for the Fantasia Dataset since the maximum RR and
minimum HR were 27 bpm and 40 bpm respectively) This ensured that the extracted respiratory
signals were not contaminated with cardiac frequency content.
5.3.5 Respiratory signal assessment
The quality of extracted respiratory signals was assessed as follows. Signals were segmented into
the 32 s windows defined during quality assessment. For each window, the extracted respira-
tory signals and simultaneous reference respiratory signal were re-sampled at 5 Hz using linear
interpolation, band-pass filtered between 4 and 60 bpm to remove non-respiratory frequencies,
and temporally aligned to account for any phase difference between the two signals. The quality
of each extracted respiratory signal was calculated as the correlation between that extracted
respiratory signal and the reference oral-nasal pressure signal (see Figure 5.1). The correlation
was calculated using Pearson’s linear correlation coefficient (CC) [330]. The remainder of the
methodology varied according to the particular factor being investigated as follows:
• Comparisons between subjects (e.g. young vs. elderly subjects) were performed using
subject-specific CCs. The subject-specific CC was found for each subject and for each
respiratory signal by calculating the median of the extracted respiratory signal’s CCs
from each of a particular subject’s windows.
• Comparisons between input signals (e.g. ear vs. finger PPG) were performed using
subject-specific differences in CCs. The subject-specific difference in CCs was found for
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each subject and for each respiratory signal by calculating the median difference between
the CCs for the extracted respiratory signal when extracted from a first input signal, and
the CCs for the extracted respiratory signal when extracted from a second input signal.
5.3.6 Statistical analysis
Statistical tests were performed using a significance level of α = 0.05. The Wilcoxon signed rank
test was used to compare simultaneously recorded signals, such as ear and finger PPGs. The
Wilcoxon rank sum test was used for results from independent groups, such as those acquired
from young and elderly subjects. When testing for trends, such as across a range of reference
RRs, the Mann-Kendall monotonic trend test was used, as described in [336]. Kendall’s rank
CC was reported for statistically significant trends as an indicator of the strength of the trend,
as described in [337]. This statistic indicates both the magnitude and direction of trends.
A value of zero indicates no trend. Positive values indicates positive trends, and vice-versa,
with values further from zero indicating stronger trends. The directionality of statistically
significant differences was determined by using a normal approximation to compute a z-statistic
corresponding to an approximate p-value, the polarity of which indicated directionality.
During the analysis of each factor, a statistical test was performed to identify any changes in the
quality of each respiratory signal. Since 12 signals were tested for the ECG, and 10 for the PPG,
this would usually increase the probability of a type I error (false rejection of a null hypothesis)
considerably. Therefore, a Holm-Sidak correction was made to ensure that the probability of a
type I error was fixed at 5% [338], [339].
Respiratory signals extracted from the ECG and PPG were ranked by identifying the signal
with the greatest median CC (control), and assessing the probability that each other signal’s
CCs originated from the same distribution as the control signal.
5.4 Results
5.4.1 PPG measurement site
A total of six out of eleven respiratory signals had significantly greater CCs, indicating higher
quality, when extracted from finger PPG signals than ear PPG signals. The remaining signals
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showed no significant differences. The results of the comparisons between finger and ear PPG
signals are provided in full in Table A.1 in the appendix.
5.4.2 Signal acquisition equipment
The respiratory signals extracted from laboratory and clinical signals were mostly comparable,
with the quality of a minority of signals differing significantly in favour of one set of recording
equipment. A total of three (out of 13) signals extracted from the ECG were of higher quality
when using clinical equipment. When using the PPG, five signals were of higher quality when
using clinical equipment, and two when using laboratory equipment (out of 11). Since neither set
of recording equipment provided consistently higher CCs, only clinical signals were considered in
the remaining comparisons to increase the clinical applicability of the conclusions. The results of
the comparisons between signals acquired from laboratory and clinical equipment are provided
in Table A.2 in the appendix.
5.4.3 Input signal: ECG or PPG
The subject-specific CCs of each respiratory signal extracted from the ECG and PPG are shown
in Figure 5.3. All respiratory signals were ranked more highly when extracted from the ECG
than the PPG. Indeed, all of the PPG-extracted respiratory signals had significantly lower CCs
than ECG(XB2), the ECG-extracted respiratory signal with the greatest median CC. Despite
this, ECG and PPG signals were retained in the remainder of the analysis. This ensured the
results were applicable to situations where device design considerations or clinical conditions
enforce the use of one particular signal for practical, rather than performance-based, reasons.
These results also show that some techniques for extraction of respiratory signals performed
particularly poorly, namely: XA4, XB7 and XB9. Furthermore, they indicate that feature-based
techniques mostly performed better than filter-based techniques for extraction of respiratory
signals (e.g. XB2 was ranked higher than XA2). The results of specific comparisons between
feature- and filter-based techniques for extraction of the three fundamental respiratory modula-
tions are shown in Table A.3 in the appendix. Five out of six respiratory signals had significantly
greater CCs when extracted using feature-based techniques than filter-based techniques.
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Figure 5.3: Comparison of the qualities of respiratory signals extracted from the ECG and
PPG: Correlation coefficients (CCs) for each respiratory signal extracted from the ECG and
PPG. The respiratory signal with the greatest median CC, ECG(XB2), was used as a control
against which each respiratory signal was compared in turn. Those with significantly lower
CCs than this control are indicated. Note that all of the signals extracted from the PPG had
significantly lower CCs than the best ECG-extracted signal. Outliers are shown by +.
5.4.4 Sampling frequency
Figure 5.4 shows the CCs of respiratory signals extracted from ECG and PPG signals at different
sampling frequencies. Filter-based respiratory signals (XA1 to XA4) were largely unaffected by
sampling frequency. The CCs of all feature-based respiratory signals (XB1 to XB9) extracted
from the ECG except one were significantly lower at reduced sampling frequencies, beginning
below 250 Hz. In contrast, CCs of feature-based respiratory signals extracted from the PPG
were not reduced until the sampling frequency was below 16 Hz.
5.4.5 Age
In the results from the RRest-healthy Dataset, the CCs of PPG(XB3), a respiratory signal based
on FM, were significantly lower in elderly subjects than young subjects in the RRest-healthy
Dataset. The CCs of other respiratory signals based on FM, namely PPG(XA3), ECG(XA3)
and ECG(XB3) were also substantially lower in elderly subjects, although these differences (p
= 0.04, p = 0.09 and p = 0.01 respectively) did not reach statistical significance, partly due
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(a) ECG
(b) PPG
Figure 5.4: Comparison of sampling frequencies: Subject-specific correlation coefficients
(CCs) are shown for each respiratory signal extracted from the ECG and PPG at different
sampling frequencies. Significant reductions in CCs at lower sampling frequencies are high-
lighted in yellow. Filter-based respiratory signals (XA1 to XA4) were largely unaffected by
sampling frequency, whereas the CCs of many feature-based respiratory signals (XB1 to XB9)
were significantly reduced at lower sampling frequencies. Significant reductions in CCs of ECG-
extracted respiratory signals occurred at sampling frequencies below 250 Hz, whereas reductions
in CCs of PPG-extracted respiratory signals occurred below 16 Hz.
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to the correction for multiple comparisons. For comparison, when the equivalent analysis was
performed on laboratory signals, similarly only the CCs of PPG(XB3) were significantly different
(lower in elderly subjects).
In the results from the Fantasia Dataset, none of the CCs differed significantly between young
and elderly cohorts. However, the CCs of the respiratory signal based on FM, ECG(XB3), were
similarly substantially lower in elderly subjects, although this difference (p = 0.02) also did not
reach statistical significance due to the correction for multiple comparisons.
The results of comparisons between young and elderly subjects performed on the RRest-healthy
and Fantasia Datasets are shown in Tables A.4 and A.5 respectively, in the appendix.
5.4.6 Gender
Similar sub-group analysis of male and female subjects were performed on the two datasets. No
significant differences in quality were found for any respiratory signals between male and female
subjects in either dataset.
5.4.7 Respiratory rate
The results of comparisons of respiratory signals at different reference RRs are shown in Figures
5.5 and 5.6 for the two datasets. The CCs of most respiratory signals extracted from the ECG,
and all extracted from the PPG decreased significantly with increasing RR.
5.4.8 Heart rate
Only small, inconsistent changes in the qualities of respiratory signals were observed at different
HRs. Since these were much smaller than the corresponding changes observed at different RRs,
these were considered to be negligible within the range of HRs encountered in these datasets.
5.5 Discussion
A plethora of algorithms have been proposed for estimation of RR from the ECG and PPG by
extracting a respiratory signal. In this study two datasets were used to investigate the effects
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(a) ECG
(b) PPG
Figure 5.5: Trends in correlation coefficients (CCs) with respiratory rate (RR) in the RRest-
healthy Dataset: The subject-specific CCs of respiratory signals obtained at different RRs are
shown for (a) ECG, and (b) PPG. Significant trends indicating reduced CCs at increased RRs
are highlighted in yellow, with blue indicating trends where CCs increased at increased RRs.
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ECG
Figure 5.6: Trends in correlation coefficients (CCs) with respiratory rate (RR) in the Fantasia
Dataset: The subject-specific CCs of respiratory signals obtained at different RRs are shown for
the ECG. Significant trends indicating reduced CCs at increased RRs are highlighted in yellow.
of a range of technical and physiological factors on the quality of respiratory signals. The main
conclusions are listed in Table 5.4, and are now considered in turn.
5.5.1 PPG measurement site
In current clinical practice the PPG is routinely measured at either the finger or ear for deter-
mining pulse rate and arterial blood oxygen saturation. Whilst cardiac modulation of the PPG
remains strong across a range of anatomical sites, the respiratory modulation is affected by
probe position [319]. The finding that many of the respiratory signals extracted from the finger
PPG were of higher quality than those from the ear PPG, informs the recommendation that
the finger PPG should be used in preference to the ear PPG for RR estimation. This was the
case for many of the respiratory signals based on solely BW or FM: PPG(XA1), PPG(XB1), and
PPG(XB3). However, no significant differences were found in the qualities of respiratory signals
based on AM: PPG(XA2) and PPG(XB2). This is in direct contrast to previous work, where
BW was found to be stronger at the ear than the finger [319], [322]. Despite using the same
transducers as in [322], the finger PPG tended to have a greater signal-to-noise ratio than the
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Table 5.4: Main conclusions on the technical and physiological factors affecting the quality of
respiratory signals extracted from the ECG and PPG.
Factor Conclusion
Technical factors
PPG measurement site It is recommended that the PPG is measured at the
finger rather than the ear for measuring respiratory sig-
nals.
Signal acquisition equipment No evidence was found to suggest that high fidelity
laboratory equipment provided superior measurement
of ECG- and PPG-extracted respiratory signals when
compared to a clinical monitor.
Input signal: ECG or PPG The ECG should be used rather than the PPG for mea-
suring respiratory signals where possible. Furthermore,
the results suggested that feature-based techniques pro-
vide higher quality respiratory signals.
Sampling frequency It is recommended that the ECG and PPG be measured
at ≥ 250 Hz, and ≥ 16 Hz, respectively for measuring
respiratory signals.
Physiological factors
Age It may be helpful to avoid the use of FM-based respi-
ratory signals when estimating RR in elderly subjects.
Gender There were no differences in the qualities of respiratory
signals between women and men.
RR Caution is recommended when using RR algorithms in
settings where the detection of elevated RRs is required
since the qualities of most respiratory signals were re-
duced at higher RRs.
ear PPG in our recordings (although it was not clear whether the cause of the lower signal-to-
noise ratio at the ear was physiological or technical). This may explain why respiratory signals
were of higher quality when extracted from the finger PPG in this study, whereas the ear PPG
provided higher quality signals in previous studies.
5.5.2 Signal acquisition equipment
In this study the qualities of respiratory signals measured using laboratory and clinical equip-
ment were compared to determine whether there were differences which prevented the use of
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clinical monitoring signals for RR estimation. Counter-intuitively, more respiratory signals were
of higher quality when measured using clinical equipment than when using laboratory equip-
ment. This suggests that RR algorithms could be applied to this particular clinical monitor
without a loss in performance, although this conclusion cannot be extrapolated to other clinical
monitors which may contain different filtering procedures. This is in keeping with previously
reported results [8].
5.5.3 Input signal: ECG or PPG
The vast majority of respiratory signals were ranked more highly when extracted from the ECG
compared to the PPG. Therefore, it is recommended that where there is a choice of signals,
the ECG should be preferred to the PPG. However, when taking individual measurements the
PPG is often more convenient to acquire since a PPG finger probe can be more quickly attached
than ECG electrodes. In contrast, previous results suggest that no trade-off is required between
convenience and performance when performing continuous monitoring using wearable sensors,
since in this setting ECG electrodes have been found to be better tolerated than a PPG probe
[3].
A wide variation was observed in the qualities of respiratory signals extracted using different
techniques. Consequently, six respiratory signal extraction techniques will be excluded from
further analyses in this thesis. The following techniques were excluded due to poor performance:
XA4, XB7 and XB9. In addition, the filter-based techniques XA1 to XA3 were excluded as they
tended to be of lower quality than their feature-based equivalents.
5.5.4 Sampling frequency
It was hypothesised that the use of higher sampling frequencies would result in higher quality
respiratory signals. In the ECG, this effect continued up to 250 Hz, above which there was no
significant benefit to using higher sampling frequencies. This finding supports the use of RR
algorithms with current clinical monitors since wearable sensors and static monitors typically
sample the ECG at up to 256 Hz [75] and 500 Hz (this study). In the PPG, significant reductions
in quality were only apparent below 16 Hz. This is promising since it suggests that non-specialist
equipment, such as smart phones [200], tablets [329], and non-contact video cameras [139] should
not be hindered by their relatively low sampling frequencies when measuring respiratory signals.
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5.5.5 Age
Only one respiratory signal was of significantly lower quality in elderly subjects compared to
young subjects in the RRest-healthy Dataset, whereas other signals showed no differences. This
signal, PPG(XB3), is FM-based. Other FM-based signals were consistently of lower quality in
elderly subjects, although these reductions in quality were not statistically significant. This
is in keeping with previous work, and informs the recommendation that FM-based respiratory
signals should be avoided when using RR algorithms with elderly subjects. Previously, RR
algorithms which fuse estimates from different respiratory signals have commonly included FM-
based signals to increase precision [80] [237]. Further research is required to determine whether
the performance of these fusion algorithms could be improved in elderly subjects by exchanging
the FM-based input for an alternative respiratory signal.
5.5.6 Gender
The lack of differences between male and female subjects in this study indicates that gender is
not an important factor in determining the quality of respiratory signals. This is supported by
the relatively high number of subjects in each subgroup (30 female and 27 male in the RRest-
healthy Dataset, and 20 female and 20 male in the Fantasia Dataset), suggesting that the lack
of differences was not simply due to a lack of statistical power. Indeed, the present sample sizes
are greater than in a previous analysis of differences due to gender (14 female and 14 male)
[330].
5.5.7 Respiratory rate
In this study most respiratory signals were of lower quality at higher RRs, in keeping with
previous work. This suggests that the performance of RR algorithms may be gradually reduced
as the true RR increases. This would be clinically significant since an elevated RR is a key
marker of clinical deterioration [331]. If this translates into an unacceptable performance of RR
algorithms at elevated RRs then this would severely limit their clinical utility.
A potential concern with this analysis of the effect of RR on respiratory signal quality is that
the observed reduction in quality is due to inter-subject differences in quality. For instance,
a latent subgroup of subjects with lower respiratory signal quality may also breathe at higher
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RRs by coincidence, rather than there being a causal link between elevated RR and reduced
quality.
5.5.8 Limitations
The key limitations to this study are as follows. Firstly, this study was conducted in a laboratory
setting with healthy subjects. This allowed investigation of the influences of technical factors,
age and gender, without common confounders such as the reduction in autonomic nervous
system functionality associated with diabetes [340]. Further investigation is required prior to
applying the findings to clinical settings. Secondly, a particular set of laboratory equipment,
and a particular clinical monitor were used. Therefore, the findings regarding signal acquisition
equipment may not be universally applicable to all manufacturers’ equipment. Thirdly, a known
statistical property of correcting for multiple comparisons is that the probability of a type II
error (a false negative) is increased. Consequently, some smaller differences in signal qualities
may not have been identified. Finally, the precise nature of the reference respiratory signal
in the Fantasia Dataset is not known. In this study the SQI developed for an impedance
pneumography (ImP) signal was used to assess its quality.
5.6 Final Remarks
This study assessed the impact of technical and physiological factors on the extraction of res-
piratory signals from the ECG and PPG. This was achieved through analysis of ECG, PPG
and reference respiratory signals from young and elderly healthy subjects. The main technical
recommendations for extraction of high quality respiratory signals were: (i) to measure the PPG
at the finger rather than the ear; (ii) where possible, to use the ECG rather than the PPG;
and, (iii) to use sampling frequencies of ≥ 250 Hz for the ECG, and ≥ 16 Hz for the PPG. The
main clinical recommendations were: (i) to consider avoiding the use of FM-based respiratory
signals in elderly subjects; and, (ii) to expect the qualities of respiratory signals to be reduced
at higher RRs. These recommendations will be helpful to equipment manufacturers to inform
the design of wearable sensors, and to clinicians for determining whether RR algorithms should
be used in their particular setting.
The study demonstrated that the quality of respiratory signals is also dependent on the tech-
nique used for respiratory signal extraction. Three techniques, XA4, XB7 and XB9, performed
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particularly poorly, so will not be considered further in this thesis. In addition, the remain-
ing filter-based techniques, XA1 to XA3, will be excluded from further analyses, since their
feature-based equivalents, XB1 to XB3, tended to be of higher quality.
Further work is required to determine whether additional factors encountered in clinical practice,
such as pathological cardiovascular and respiratory changes, affect the qualities of extracted
respiratory signals.
The RRest-healthy Dataset, code to download and format the Fantasia Dataset appropriately,
respiratory signal extraction algorithms, and analysis code used in this study are being made
publicly available at http://peterhcharlton.github.io/RRest. These resources allow future
researchers to reproduce the analyses presented here, and to use the dataset for additional
studies.
Chapter 6
Respiratory Rate Algorithms for the
Electrocardiogram and
Photoplethysmogram: Performance
in Healthy and Hospitalised Subjects
This chapter presents a study of the performances of algorithms to estimate respiratory rate
(RR) from the electrocardiogram (ECG) and photoplethysmogram (PPG) in healthy and hos-
pitalised subjects. The performances of 95 RR algorithms were assessed using four datasets:
two acquired from healthy subjects, and two from hospitalised patients. The aims of this study
were to determine: how well RR algorithms perform in each setting; which algorithms provide
the best performance; and, which input signal (ECG or PPG) provides the best performance.
6.1 Introduction
Over 100 algorithms have been proposed to estimate RR from the ECG or PPG [10]. However,
the systematic review presented in Chapter 4 demonstrated that their performances have not
yet been compared systematically. Previous comparisons of algorithms have been limited by
comparing only a small number of algorithms. Approximately half (53.6 %) of the publica-
tions which have assessed the performance of an RR algorithm compared multiple algorithms
(Section 4.4.4). However, the most algorithms compared in a single publication (outside of the
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The three fundamental stages of a RR algorithm: 













Figure 6.1: Construction of RR algorithms using different combinations of algorithmic tech-
niques: RR algorithms can be constructed using any of the interchangeable techniques for each
of the three fundamental stages. Two exemplary algorithms are shown. Adapted from [9] (CC
BY 4.0, DOI: 10.5281/zenodo.439966).
current work) is 30, assessed using a single dataset [278]. This is not sufficient to determine
which algorithm is the best, given that at least 49 different algorithmic techniques have been
proposed for use in RR algorithms (Tables 4.4 to 4.8). Furthermore, several hundred algorithms
can be constructed by trialling all possible combinations of the interchangeable techniques at
each stage of RR algorithms, as demonstrated in Figure 6.1. Each algorithm may potentially
have different performance characteristics. A convenient way to perform such a comparison
could be to perform a meta-analysis of the existing literature. However, this is not practical for
several reasons: (i) a wide range of incompatible statistics have previously been used to assess
the performance of algorithms (Table 4.12); (ii) previous assessments of algorithms have used a
wide range of datasets acquired from different patient populations, impeding comparisons; (iii)
the complexity of RR algorithms means that algorithm implementations may differ consider-
ably between publications, affecting the reported performances. Consequently, a novel study
is required to perform a comprehensive assessment of RR algorithms, and to determine which
(if any) algorithms perform sufficiently well for monitoring acutely-ill patients using wearable
sensors.
Previous assessments of RR algorithms have suggested that improved performance can be
achieved by using longer durations of input signals, and by fusing respiratory information from
Chapter 6. Performance of Respiratory Rate Algorithms 115
different respiratory signals. Assessments of the effect of input signal duration have used du-
rations of between 16 and 300 s [80, 108, 110, 341]. These assessments found trends towards
improved performance when using longer durations, although there is no consensus on the opti-
mal duration. Fusion of respiratory information from different respiratory signals has also been
shown to improve performance [4, 80, 113, 237, 238, 341]. Usually information from two or
three of the three fundamental respiratory signals (exhibiting BW, AM or FM) is fused, with
a quality assessment procedure used to reject unreliable respiratory signals or RR estimates.
However, there is similarly no consensus on the respiratory signals to be fused, nor the quality
assessment procedure.
The aim of the study presented in this chapter is to perform a comprehensive assessment of
the performances of RR algorithms in healthy and hospitalised subjects. Preliminary investiga-
tions were conducted to: (i) eliminate any algorithmic techniques which performed particularly
poorly; (ii) to select an appropriate duration of input signal; and, (iii) to select the optimal
configuration of fusion techniques. Following this, the performances of 95 RR algorithms were
assessed on four datasets, consisting of two acquired from healthy subjects, and two from hos-
pitalised patients. This assessment was used to: (i) quantify the algorithms’ performances in
these settings; (ii) identify the best-performing algorithms; and (iii) investigate how the input
signal (ECG or PPG) affects performance. The toolbox of RR algorithms and the RRest-healthy
dataset presented in Section 4.6 were used in this study. Both these resources and the analysis
code are being made publicly available at: http://peterhcharlton.github.io/RRest.
6.2 Methods
6.2.1 Datasets
The four publicly available datasets summarised in Table 6.1 were used for this assessment. The
first two datasets, the RRest-healthy [7] (described in Section 4.6.1) and Fantasia datasets [302,
303], contain data from both young and elderly healthy subjects (demographic characteristics
provided in Table 5.2, Section 5.3.2). It is expected that RR algorithms will perform well on
these datasets since they were acquired in laboratory conditions. The signals used from the
RRest-healthy Dataset were the ECG (500 Hz) and PPG (125 Hz) signals acquired using a
clinical monitor, and reference oral-nasal pressure respiratory signals (500 Hz). The signals
used from the Fantasia dataset were the ECG and reference respiratory signals (both at 250
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Table 6.1: The four datasets used for assessment of RR algorithms.
Dataset Population No. subjs Age ECG PPG Reference RRs
















Hz). Only the first 66.7 mins of each recording in the Fantasia dataset were used for this
assessment, since data downloads from PhysioNet in Matlab R© format are limited to 1,000,000
samples. The remaining two datasets, MIMIC-II [299, 303] and CapnoBase [80], contain data
from hospitalised patients. MIMIC-II contains data from adult patients in critical care. The
signals used from the MIMIC-II dataset were the ECG, PPG, and impedance pneumography
(ImP) respiratory signals (all at 125 Hz). A subset of MIMIC-II recordings from 127 ICU stays
was used, each truncated at 30 mins to avoid excess data processing. CapnoBase contains data
from both adult and paediatric patients undergoing elective surgery and routine anaesthesia
[80]. Data from two subjects in the CapnoBase dataset were omitted as the recordings could
not be analysed using the RRest Toolbox of algorithms, leaving data from 40 out of the original
42 subjects for analysis. The ECG and PPG signals in the CapnoBase dataset were sampled at
300 Hz, and the manual breath annotations were used to calculate reference RRs.
6.2.2 Quality assessment
Each subject’s signals were segmented into adjacent windows for analysis. The quality of each
signal during each window was assessed using the following methods. The quality of ECG and
PPG signals was assessed using the template-matching signal quality index (SQI) algorithm
reported in [124], and described in Section 3.3. The quality of the reference oral-nasal pressure
respiratory signal in the RRest-healthy Dataset was assessed by comparing its signal-to-noise
ratio to a threshold value, as described in Section 5.3.3. The quality of the reference respiratory
signals in the Fantasia and MIMIC-II datasets were assessed using the novel SQI designed and
verified in Section 4.6.2. Quality assessment was not required for a reference respiratory signal
in the CapnoBase dataset since it was not used in the analysis. Any windows in which any
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Table 6.2: Data characteristics: the number of 32 s windows per subject before and after




No. high quality windows per subject
resp resp & ECG resp & PPG
RRest-healthy 20 (20 - 20) 20 (18 - 20) 20 (18 - 20) 19 (17 - 20)
Fantasia 124 (124 - 124) 71 (41 - 96) 56 (33 - 90) n/a
CapnoBase 14 (14 - 14) 14 (14 - 14) 14 (14 - 14) 14 (14 - 14)
MIMIC-II 54 (45 - 56) 11 (3 - 24) 6 (0 - 21) 7 (2 - 17)
of the required signals were of low quality were excluded from the analysis. The numbers of
windows included in the analysis are given in Table 6.2.
6.2.3 Respiratory rate estimation from the ECG and PPG
Algorithms to estimate RR from the ECG and PPG were constructed by selecting an inter-
changeable technique for each algorithm stage, as demonstrated in Figure 6.1. The following
techniques were used at each stage:
• Extraction of respiratory signals: XB1 to XB6, and XB8 (defined in Table 4.5);
• Estimation of RRs: EF1 to EF4, EF6, EF7, and ET1 to ET5 (Table 4.7);
• Fusion of RRs (optional): FM1 to FM4 (Table 4.8), and FM5 (introduced in Section 6.3.3).
These techniques were chosen after elimination of techniques which performed particularly
poorly in previous chapters (see Sections 4.6.3 and 5.6 for further details). Algorithms were
constructed using all possible combinations of these techniques. Each algorithm was used with
each window of input signal, outputting either a value for RR, or no output if the algorithm
could not estimate RR from that window. The methods used at each stage of the RR algorithms
are now described.
Respiratory signals were extracted from the ECG and PPG using the approach for feature-
based techniques as described in Section 5.3.4. Previously, the range of plausible respiratory
frequencies was previously set to 4 - 36 bpm to ensure that cardiac frequency content was
excluded. However, in this assessment a wider range of 4 - 60 bpm was used to ensure that the
RR algorithms were able to detect all RRs which may be encountered in clinical practice.
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RRs were estimated from respiratory signals using time and frequency domain techniques. When
using time-domain breath detection techniques (ET1 to ET5) the estimated RR was calculated
as the mean breath duration. When using frequency-domain spectral analysis techniques (EF1
to EF4, and EF7) the RR was identified as the frequency of the spectral peak with greatest
magnitude within the range of plausible respiratory frequencies.
Finally, the optional fusion of RRs derived from BW, AM and FM respiratory signals (XB1
to XB3) was performed using four modulation fusion techniques (FM1 to FM4). FM1 can be
used after any RR estimation technique, whereas the other modulation fusion techniques are
restricted to use with particular RR estimation techniques. FM2 can only be used with frequency-
domain RR estimation techniques since it requires a power spectrum, and FM3 and FM4 can
only be used with EF4 since they utilise autoregressive modelling.
6.2.4 Optimisation of RR algorithms
Preliminary investigations were conducted using the RRest-healthy dataset to optimise the
RR algorithms prior to assessment on the remaining datasets. Firstly, the performances of
the algorithms were inspected to identify any techniques which performed particularly poorly.
These techniques were excluded from further analyses. Secondly, three input signal durations
were compared: 25, 32 and 50 s. To do so the irregularly sampled signals of beat-by-beat features
were re-sampled at 5, 4 and 5 Hz respectively. This avoided excessive zero-padding of the signal
when estimating RR from the signals using the fast Fourier transform. An input signal duration
was selected for use in further analyses, based on RR algorithm performances and the need to
obtain RR estimates frequently enough to detect deteriorations. Thirdly, the best-performing
modulation fusion technique was optimised by trialling the use of either all three respiratory
signals (XB1 to XB3, corresponding to BW, AM and FM), or any two of these three signals. In
addition, the quality assessment threshold was optimised. This novel configuration (FM5) was
then used as an additional technique in the analyses.
6.2.5 Reference respiratory rate estimation
When using the CapnoBase dataset, reference RRs were estimated from the manual breath
annotations. When using the other datasets, reference RRs were estimated from the reference
respiratory signals. For the Fantasia and MIMIC-II datasets, reference RR estimation was
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performed as part of the reference respiratory signal quality assessment. This reference RR
calculator has previously been found to have a bias of 0.0 bpm, and 2SD (standard deviation) of
1.9 bpm (Section 4.6.2; statistics explained below). For the RRest-healthy Dataset, a separate
bespoke breath-detection algorithm was used to estimate reference RRs from the oral-nasal
pressure signal. This algorithm consisted of the following steps:
• Band-pass filter the signal to eliminate non-respiratory frequencies (with 3 dB cut-off
frequencies of 4 and 60 bpm).
• Normalise the signal within each window to have a mean of 0 and SD of 1.
• Detect inhalations as positive-gradient crossings of a specified threshold, k.
A threshold of k = 0.42 was determined by minimising the difference between the value of 2SD
derived from the comparison of the reference RRs to expert breath annotations on 10 subjects.
The performance of the reference RR calculator was then assessed against a second experts
breath annotations on data from a different set of 10 subjects. It had a bias of 0.0 bpm and
2SD of 1.3 bpm.
6.2.6 Statistical analysis
Two approaches were used to assess the performance of RR algorithms. Firstly, several statistics
were calculated to provide a thorough description of each algorithm’s performance. Secondly,
a cost function was designed in order to rank the algorithms according to their suitability for
clinical use in wearable sensors.
The performance of RR algorithms was reported primarily using the limits of agreement (LoAs)
technique [309] since it is widely used in comparisons of algorithms for estimation of biomarkers
[342]. It consists of the following statistics:
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calculated as the mean difference between the estimated RR, RRest, and the reference
RR, RRref , across the i = 1, . . . , n subjects, each of which had mi pairs of estimated and
reference RRs.
• 2SD: The precision of RR algorithms was assessed by calculating the expected range of
95% of errors around the systematic bias, ±1.96s, denoted 2SD in this work [309]. The
method described in [343] was used to account for repeated measurements per subject
in the calculations. 2SD was calculated from the standard deviation of the errors, s =
√
total variance, where the total variance is the sum of the within-subjects and between-
subjects variance. These two variance components were estimated using one-way analysis
of variance:













where MSresidual is the mean square error, and MSsubject is the difference between the
mean squares for subjects, and the sums are for i = 1, . . . , n.
• LoAs: The limits within which 95% of errors are expected to lie, were estimated as [309]
95% LoAs = bias± 1.96s . (6.4)
The following statistics were also calculated to assess clinical utility:
• CP2: The proportion of high quality windows for which highly useful RRest values are
returned, defined as being within ±2 bpm of RRref . This statistic is known as the
coverage probability, CP [344].
• iCP5: The proportion of high quality windows for which potentially misleading RRest
values are returned, defined as being outside of ±5 bpm of RRref . This statistic is
referred to as the inverse coverage probability, iCP .
• TDI95: The 95th percentile of errors, indicating the error below which 95 % of errors fall.
This statistic is referred to as the total deviation index, TDI [344].
• prop: the proportion of windows for which an algorithm provides a valid RRest value, as
opposed to a null output.
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which varies between 0 and ∞, with higher values indicating improved performance. It is the
ratio of CP2 to iCP5, and as such is the ratio of the probability that an RRest value is within
±2 bpm of RRref , to the probability that it is outside of ±5 bpm of RRref . For example,
C = 10 indicates that an RRest value is ten times more likely to be within ± 2 bpm than to
be outside ± 5 bpm. This cost function was used to rank algorithms to identify an algorithm
for use with wearable sensors.
The Wilcoxon signed rank test was used to test for significant differences between the perfor-
mances of algorithms when assessing paired data, and the Wilcoxon rank sum test was used
when assessing non-paired groups.
6.3 Results
6.3.1 Elimination of techniques due to poor performance
Inspection of the performances of algorithms on the RRest-healthy Dataset revealed that those
algorithms containing the EF4 technique performed poorly compared to the other algorithms,
as illustrated in Figure 6.2. The technique, which uses auto-regressive all-pole modelling to
estimate RR, was therefore excluded from further analyses. Consequently, no RR estimation
techniques remained which use auto-regressive all-pole modelling, since the one other technique
which uses this approach, EF5, had been excluded previously due to poor performance on sim-
ulated data (Section 4.6.3). This resulted in the exclusion of two modulation fusion techniques,
FM3 and FM4, since they can only be used following RR estimation using an auto-regressive
all-pole modelling technique.
6.3.2 Duration of input signal
The performances of the remaining algorithms for the three trialled input signal durations are
shown in Figure 6.3. The performances of algorithms improved significantly when using longer
durations of input signals, with a duration of 32 s providing improved performance over 25 s, and
a duration of 50 s providing improved performance over both 25 and 32 s. Although performance











Figure 6.2: Poor performance of algorithms containing EF4: This plot shows the performance
of the algorithms on the RRest-healthy Dataset. The algorithms, each shown by a dot, have
been categorised according to whether or not they used the EF4 technique. The EF4 technique
was associated with poor performance as shown by the much lower C values for most of the
algorithms containing it. These results were obtained using a 32 s duration of input signal,
although similar results were obtained for other durations.
Figure 6.3: The performances of algorithms assessed on the RRest-healthy Dataset for input
signal durations of 25, 32 and 50 s.
did improve when using longer durations, the size of the improvement was minimal, as shown
by the median C values of: 1.55, 1.61 and 1.71 bpm for 25, 32 and 50 s respectively. Therefore,
a duration of 32 s was chosen for the remainder of this work as a compromise between improved
RR algorithm performance, and the need to maintain high data coverage rates (Figure 3.6,
Section 3.4).











Figure 6.4: This plot shows the performances of algorithms which contained a modulation
fusion technique on the RRest-healthy Dataset. The algorithms, each shown by a dot, have been
categorised according to whether they used the FM1 or FM2 technique. The highest-performing
algorithms used the FM1 technique.
6.3.3 Optimisation of fusion techniques
The performances of the algorithms which included a modulation fusion technique are shown
in Figure 6.4. The highest-performing algorithms used FM1. This suggested that this technique
might provide the best overall performance across the multiple datasets under consideration.
Therefore, an additional investigation was undertaken to optimise the performance of FM1 on
the RRest-healthy Dataset.
Figure 6.5 shows how the performance of algorithms using FM1 varied as the input signals
and value of the quality threshold were varied. The results corresponding to the ECG (first
plot) suggest that performance could be improved by only using RR estimates derived from the
BW and AM respiratory signals, since the BW,AM configuration appeared to give superior
performance. In addition, the results demonstrate a compromise between the precision of RR
estimates, and the proportion of windows for which RR estimates are provided. This compromise
is determined by the quality threshold. A lower quality threshold tends to provide improved
performance, albeit for a smaller proportion of windows. Based on these observations, a new
configuration of the technique was proposed, consisting of using the BW,AM configuration
and a quality threshold of 3.0. The performance of this new configuration is indicated by
the hollow black dot. In contrast, the results corresponding to the PPG (second plot) do not
provide rationale for modifying FM1, since reducing the set of input signals did not provide a







































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 6. Performance of Respiratory Rate Algorithms 125
large increase in C, when compared to the original BW,AM,FM configuration. The third and
fourth plots show a sub-group analysis of the results for the ECG for young (third plot) and
elderly (fourth plot) subjects. These show that the new configuration of FM1 (indicated by a
hollow black dot) provided higher performance than the original implementation (solid black
dot) in both groups. However, the advantage was greatest in elderly subjects. Therefore, the
new configuration of FM1 was used as an additional technique termed FM5 in the remaining
analyses, with the expectation that it may provide superior performance when used with the
ECG, particularly in elderly subjects.
6.3.4 Algorithm performances in health
The performances of 95 algorithms were assessed, ten of which contained XB8. Those containing
XB8 could only be used with the ECG signal since this technique calculates the area under the
QRS complex.
The algorithms exhibited a wide range of performances in health, as demonstrated in Figure
6.6. The values of 2SD ranged from 3.6 bpm at best to 12.5 bpm at worst. Similarly, there
were large variations in the other performance characteristics, with CP2 ranging from 25.1 % to
82.7 %, iCP5 from 2.2 % to 61.9 %, C from 0.4 to 36.6, and TDI95 from 3.7 bpm to 14.2 bpm.
Table 6.3 shows how the performance of algorithms varied according to whether a time- or
frequency-domain RR estimation technique was used. Most performance statistics showed that
algorithms which used time-domain RR estimation techniques performed significantly better
than those which used frequency-domain techniques. Indeed, the use of time-domain techniques
resulted in substantially higher C values than frequency-domain techniques when estimating
RRs from ECG signals in the Fantasia dataset, and PPG signals in the RRest-healthy Dataset.
Despite this apparent improvement in performance when using time-domain techniques, CP2
and prop were not significantly improved by the use of time-domain techniques: CP2 was either
similar between the groups of algorithms, or improved in the frequency-domain group; and there
were no significant differences in prop between the two groups. The reason for the difference
in performance becomes apparent upon inspection of the differences in the distributions of RR
algorithms errors, as shown in Figure 6.7. This figure shows that frequency-domain techniques
were more vulnerable to underestimating RR. This is shown by the increased proportion of
estimates resulting in errors of between -5 and -20 bpm. This tendency of frequency-domain
techniques to underestimate RR explains why algorithms using time-domain estimates produced
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ECG FantasiaPerformances in health
Figure 6.6: Performances of RR algorithms in health: Cumulative distribution functions of
the performance characteristics of the algorithms assessed on the ECG and PPG signals in the
RRest-healthy and Fantasia datasets (see legend).
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Table 6.3: Performances of algorithms using time- and frequency-domain RR estimation tech-
niques in health. Significant differences are annotated by *, with the domain providing improved
performance labelled.
Algorithm performance, med (quartiles)
Signal Statistic Time domain Freq domain
ECG
RRest-healthy
C 4.3 (1.9 - 7.4) 4.0 (1.7 - 5.9)
2SD 6.8 (5.7 - 8.4) 8.3 (7.0 - 9.8) *Time
bias -0.3 (-0.8 - 0.8) -1.7 (-2.5 - -1.4) *Time
CP2 57.0 (45.5 - 65.0) 64.4 (49.3 - 69.4) *Freq
iCP5 13.3 (8.7 - 24.2) 16.5 (12.1 - 29.4)
TDI95 8.4 (6.3 - 9.9) 11.2 (9.1 - 12.2) *Time
prop 100.0 (98.0 - 100.0) 100.0 (96.8 - 100.0)
ECG
Fantasia
C 3.7 (2.3 - 6.0) 1.6 (1.1 - 3.7) *Time
2SD 6.6 (5.8 - 7.2) 9.5 (7.8 - 10.2) *Time
bias -1.1 (-2.1 - 0.2) -2.9 (-4.0 - -2.0) *Time
CP2 53.4 (46.9 - 62.1) 52.9 (43.9 - 69.2)
iCP5 14.7 (10.1 - 20.3) 32.7 (18.7 - 40.5) *Time
TDI95 7.7 (6.9 - 8.6) 12.5 (10.7 - 13.2) *Time
prop 100.0 (98.2 - 100.0) 100.0 (97.0 - 100.0)
PPG
RRest-healthy
C 1.3 (1.0 - 1.6) 0.7 (0.6 - 1.0) *Time
2SD 9.4 (8.2 - 9.8) 11.9 (11.2 - 12.2) *Time
bias -2.3 (-2.7 - -0.3) -5.5 (-5.7 - -5.0) *Time
CP2 37.2 (33.9 - 42.2) 35.7 (32.6 - 41.2)
iCP5 29.8 (26.2 - 33.3) 48.0 (41.4 - 50.8) *Time
TDI95 11.4 (10.3 - 12.0) 16.4 (16.2 - 16.6) *Time
prop 100.0 (93.2 - 100.0) 100.0 (97.0 - 100.0)
significantly improved 2SD values, whilst producing either similar or worse CP2 values. The
underestimates have a large effect on 2SD as it is highly sensitive to outliers, but little effect
on CP2. Figure 6.7 also demonstrates that frequency-domain techniques very rarely result in
overestimates of RR by more than 5 bpm.
Table 6.4 shows how the performance of algorithms varied in health according to whether or
not a modulation fusion technique was used. Most performance statistics showed that the use
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Figure 6.7: Comparison of RR algorithm errors when using time- or frequency-domain RR
estimation techniques in health: The distributions of RR algorithm errors are shown when
using algorithms containing time- and frequency-domain RR estimation techniques, applied to
the ECG (left plot) and PPG (right).
Error [bpm]





































































Figure 6.8: Comparison of RR algorithm errors when using or not using a modulation fusion
technique in health: The distributions of RR algorithm errors are shown when using algorithms
applied to the ECG (left and middle plots) and PPG (right).
of a modulation fusion technique significantly improved performance. The single exception was
prop, which was significantly reduced when using a modulation fusion technique. This is to be
expected, since modulation fusion techniques contain a quality assessment procedure resulting in
RR not being estimated on some windows. Again, it is helpful to inspect how the distributions
of RR algorithm errors are influenced by modulation fusion techniques, as shown in Figure
6.8. This figure demonstrates that algorithms using modulation fusion techniques were less
vulnerable to underestimating RR when applied to the ECG (left and middle plots). In both
these plots the proportion of estimates resulting in errors of between -5 and -20 bpm was much
less when using modulation fusion techniques. However, modulation fusion techniques did not
substantially reduce the vulnerability of algorithms to underestimating RR when applied to the
PPG (right hand plot). This is shown by the similar proportions of underestimates regardless
of whether or not a modulation fusion technique was used.
The performances of the highest ranked algorithms are provided in Table 6.5. Most of the
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Table 6.4: Performances of algorithms with and without a modulation fusion technique in
health. Significant differences are annotated by *, with the approach providing improved per-
formance labelled.
Algorithm performance, med (quartiles)
Signal Statistic Fusion Non-fusion
ECG
RRest-healthy
C 9.5 (4.5 - 11.8) 3.1 (1.7 - 4.9) *Fusion
2SD 5.2 (4.9 - 6.6) 8.2 (7.0 - 8.9) *Fusion
bias -1.1 (-1.5 - -0.6) -1.3 (-2.4 - -0.4)
CP2 70.6 (65.6 - 72.6) 55.3 (46.4 - 64.8) *Fusion
iCP5 7.5 (6.4 - 13.7) 18.2 (13.1 - 28.6) *Fusion
TDI95 6.6 (5.7 - 9.2) 10.6 (8.5 - 12.0) *Fusion
prop 82.0 (74.9 - 86.0) 100.0 (100.0 - 100.0) *Non-fusion
ECG
Fantasia
C 4.76 (3.73 - 8.33) 1.88 (1.23 - 3.57) *Fusion
2SD 6.1 (4.8 - 7.1) 7.9 (6.7 - 9.9) *Fusion
bias -1.9 (-2.1 - -1.2) -2.6 (-3.9 - -1.1) *Fusion
CP2 68.7 (61.8 - 71.6) 50.6 (39.3 - 56.5) *Fusion
iCP5 14.2 (8.0 - 19.3) 27.3 (17.5 - 38.8) *Fusion
TDI95 10.0 (6.0 - 10.6) 10.7 (8.4 - 12.7) *Fusion
prop 76.4 (63.0 - 86.7) 100.0 (100.0 - 100.0) *Non-fusion
PPG
RRest-healthy
C 1.1 (0.8 - 1.5) 0.9 (0.7 - 1.2)
2SD 10.3 (8.1 - 11.0) 11.0 (9.6 - 12.1) *Fusion
bias -5.0 (-5.5 - -2.5) -3.9 (-5.5 - -2.3)
CP2 40.4 (38.0 - 43.9) 34.9 (32.1 - 40.7) *Fusion
iCP5 38.7 (28.3 - 45.3) 38.8 (31.1 - 49.3)
TDI95 16.2 (11.0 - 16.5) 14.3 (11.7 - 16.4)
prop 77.6 (72.4 - 88.4) 100.0 (100.0 - 100.0) *Non-fusion
top-ranking algorithms used a time-domain RR estimation technique and a modulation fusion
technique, as expected based on the earlier results. Algorithm XB1,2,3ET4FM1 gave the best
performance on both the ECG and PPG. It was consistently ranked most highly (according to
the proposed cost function, C). Its LoAs were 0.2±4.6 bpm and −0.1±3.6 bpm when used with
the ECG, and −0.3± 6.2 bpm when used with the PPG. This demonstrates good performance
on the ECG, with 95% of errors expected to lie within approximately ±5 bpm of the bias, and
reasonable performance on the PPG, with a corresponding range of ±7 bpm. These results are
supported by the similar TDI95 values. Furthermore, when applied to the ECG the C values
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XB1,2,3ET4FM1 15.7 4.6 0.2 72.2 4.6 4.8 82.0
XB1,2EF3FM5 12.8 4.8 -0.7 77.5 6.1 5.5 80.5
XB1,2ET3FM5 12.8 4.7 -0.3 72.0 5.6 5.1 86.5
XB1,2ET2FM5 12.5 4.7 -0.3 71.9 5.7 5.2 88.3
XB1,2EF7FM5 12.2 5.0 -1.0 77.7 6.3 6.1 78.4
XB1,2EF6FM5 12.0 4.8 -0.8 76.4 6.4 5.9 79.6
XB1,2,3ET2FM1 12.0 4.9 -0.7 67.5 5.7 5.4 85.1
XB1,2,3ET3FM1 10.4 5.0 -0.8 66.0 6.4 5.5 84.4
XB1,2,3EF3FM1 10.3 5.2 -1.1 74.4 7.2 6.3 62.1
XB1,2EF1FM5 9.9 5.5 -1.1 72.8 7.4 6.7 81.1
Fantasia
ECG
XB1,2,3ET4FM1 36.6 3.6 -0.1 81.2 2.2 3.7 85.0
XB1,2ET4FM5 15.0 4.5 0.2 77.4 5.2 5.1 79.0
XB1,2,3ET2FM1 10.5 4.3 -1.3 62.9 6.0 5.3 86.9
XB1,2,3ET3FM1 9.5 4.2 -1.3 61.4 6.4 5.4 86.6
XB1,2,3ET1FM1 9.0 4.7 1.5 65.9 7.3 5.9 90.0
XB1,2ET2FM5 8.5 4.9 -0.9 68.1 8.0 5.9 75.6
XB1,2ET3FM5 8.3 4.9 -0.9 66.1 8.0 6.0 76.3
XB3ET4 8.2 6.2 -0.2 71.4 8.8 6.8 98.0
XB5ET4 7.0 6.3 0.2 68.2 9.7 7.0 99.1
XB3ET1 6.8 6.7 1.4 65.1 9.6 7.5 100.0
RRest-healthy
PPG
XB1,2,3ET4FM1 4.3 6.2 -0.3 54.1 12.5 7.1 72.5
XB3ET4 2.8 8.1 0.3 52.3 18.5 8.9 96.7
XB1,2ET4FM5 2.8 7.1 -0.7 50.5 18.2 9.1 66.6
XB6ET4 2.3 8.8 -0.4 48.4 21.3 9.9 97.5
XB1,2,3ET2FM1 1.8 7.7 -2.1 40.4 22.8 10.2 89.0
XB1,2,3ET1FM1 1.8 7.8 2.4 45.2 25.5 10.2 88.4
XB3ET2 1.8 8.6 -2.0 44.5 25.2 10.4 100.0
XB3ET3 1.7 8.6 -2.0 43.1 25.2 10.7 100.0
XB2ET4 1.7 9.7 -0.3 43.4 25.3 10.9 97.3
XB1,2,3ET3FM1 1.7 7.8 -2.2 39.7 23.9 10.2 88.6
were 15.7 and 36.6, indicating a low proportion of erroneous RRs. However, when applied to
the PPG the C value was 4.3, indicating that approximately one in four outputted RRs were
erroneous. It should be noted that half of the top ten algorithms contained frequency-domain
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RR estimation techniques when used with ECG signals in RRest-healthy, and these had higher
CP2 values than the remaining top-ten algorithms.
The algorithms performed significantly better when using the ECG, compared to the PPG. This
was the case for all performance statistics except prop, which was significantly higher when using
the PPG. The results of the comparison between using the ECG or PPG as the input signal are
provided in Table A.6 in the appendix.
Algorithms tended to perform better on young subjects in the RRest-healthy Dataset, and on
elderly subjects in the Fantasia dataset. The sizes of the differences between the groups were
minimal, suggesting that the effect of age on performance is not clinically relevant. The results
of the comparisons between age groups are provided in Table A.8 in the appendix.
6.3.5 Algorithm performances in hospitalised patients
The algorithms exhibited a wide range of performances in hospitalised patients, as demonstrated
in Figure 6.9. The values of 2SD ranged from 2.5 bpm at best to 22.0 bpm at worst. Similarly,
there were large variations in the other performance characteristics, with CP2 ranging from 8.2
to 98.0 %, iCP5 from 0.6 to 80.4 %, C from 0.1 to 159.5, and TDI95 from 0.74 to 28.6 bpm. The
figure also shows variation between the datasets, with an apparent improvement in performance
when algorithms were applied to the CapnoBase dataset compared to the MIMIC-II dataset.
Table 6.6 shows how the performance of algorithms varied according to whether a time- or
frequency-domain RR estimation technique was used. Whereas in health time-domain RR
estimation techniques consistently provided improved performance, there was not the case in
hospitalised patients. Instead, frequency-domain techniques provided improved performance
when algorithms were applied to ECG and PPG signals in the CapnoBase dataset; there was a
moderate advantage to using frequency-domain techniques with ECG signals in the MIMIC-II
dataset; and time-domain techniques provided improved performance on PPG signals in the
MIMIC-II dataset. An explanation for the differences in performance was found by inspecting
the differences in the distributions of RR algorithms errors, shown in Figure 6.10. This figure
shows that time-domain techniques were vulnerable to overestimating RR on both datasets, and
frequency-domain techniques were vulnerable to underestimating RR when used with MIMIC-II
signals.
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Performances in critical illness
Figure 6.9: Performances of RR algorithms in hospitalised patients: Cumulative distribution
functions of the performance characteristics of the algorithms assessed on the ECG and PPG
signals in the CapnoBase and MIMIC-II datasets (see legend).
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Table 6.6: Performances of algorithms using time- and frequency-domain RR estimation tech-
niques in hospitalised patients. Significant differences are annotated by *, with the domain
providing improved performance labelled.
Algorithm performance, med (quartiles)
Signal Statistic Time domain Freq domain
ECG
CapnoBase
C 2.2 (1.1 - 4.1) 8.8 (4.5 - 21.0) *Freq
2SD 9.4 (7.5 - 11.0) 10.2 (8.2 - 11.7)
bias 1.3 (1.0 - 3.6) -1.0 (-1.4 - -0.4) *Freq
CP2 49.7 (41.6 - 61.1) 82.0 (70.6 - 90.4) *Freq
iCP5 23.5 (14.9 - 36.3) 9.4 (4.4 - 15.6) *Freq
TDI95 10.2 (8.6 - 14.2) 10.3 (4.6 - 12.4)
prop 98.7 (94.1 - 98.7) 98.7 (97.2 - 98.7)
ECG
MIMIC-II
C 1.4 (0.6 - 2.1) 2.0 (1.3 - 3.1) *Freq
2SD 10.2 (8.7 - 12.4) 12.3 (10.5 - 13.9)
bias 0.9 (0.4 - 4.1) -2.4 (-2.8 - -1.6)
CP2 42.3 (27.7 - 46.8) 54.6 (46.2 - 66.1) *Freq
iCP5 29.3 (22.7 - 46.4) 29.0 (21.1 - 34.8)
TDI95 11.9 (9.8 - 16.4) 15.7 (13.8 - 17.3) *Time
prop 100.0 (99.0 - 100.0) 100.0 (94.3 - 100.0)
PPG
CapnoBase
C 1.6 (0.8 - 2.5) 5.3 (4.6 - 14.5) *Freq
2SD 9.2 (7.5 - 11.5) 10.2 (6.9 - 11.6)
bias 3.2 (2.0 - 5.1) 0.3 (0.1 - 0.5) *Freq
CP2 46.4 (33.8 - 52.5) 80.4 (78.5 - 90.3) *Freq
iCP5 30.4 (21.6 - 43.9) 14.9 (6.3 - 16.4) *Freq
TDI95 12.0 (9.9 - 16.8) 12.7 (9.6 - 15.4)
prop 98.7 (85.5 - 98.7) 98.7 (88.1 - 98.7)
PPG
MIMIC-II
C 2.0 (1.0 - 2.6) 1.2 (0.6 - 1.3) *Time
2SD 9.9 (9.1 - 11.6) 13.6 (12.6 - 14.6) *Time
bias -1.6 (-1.9 - 1.6) -4.4 (-5.2 - -4.1) *Time
CP2 46.7 (35.2 - 53.6) 47.8 (32.6 - 50.4)
iCP5 24.1 (20.7 - 35.0) 39.9 (38.4 - 52.9) *Time
TDI95 11.0 (10.4 - 14.6) 18.0 (16.9 - 20.0) *Time
prop 98.3 (83.7 - 100.0) 100.0 (71.8 - 100.0)
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Figure 6.10: Comparison of RR algorithm errors when using time- or frequency-domain RR
estimation techniques in hospitalised patients: The distributions of RR algorithm errors are
shown when using algorithms containing time- and frequency-domain RR estimation techniques,
applied to the ECG (upper plots) and PPG (lower plots).
Table 6.7 shows how the performance of algorithms varied in hospitalised patients according
to whether or not a modulation fusion technique was used. Algorithms containing modulation
fusion techniques showed improved performance when used on ECG signals from both datasets,
and on PPG signals in CapnoBase. However, they showed no overall improvement when used
with PPG signals on the MIMIC-II dataset. Again, it is helpful to inspect how the distributions
of RR algorithm errors are influenced by using or not using a modulation fusion technique, as
shown in Figure 6.11. This shows that modulation fusion techniques reduced the proportion of
both under- and overestimates when using ECG and PPG signals in the CapnoBase dataset, and
ECG signals in the MIMIC-II dataset. However, even when using modulation fusion techniques
over 25 % of RR estimates derived from PPG signals in the MIMIC-II dataset remained at least
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Table 6.7: Performances of algorithms with and without a modulation fusion technique in
hospitalised patients. Significant differences are annotated by *, with the approach providing
improved performance labelled.
Algorithm performance, med (quartiles)
Signal Statistic Fusion Non-fusion
ECG
CapnoBase
C 21.0 (9.4 - 36.3) 3.8 (1.8 - 5.7) *Fuse
2SD 6.4 (4.8 - 8.0) 10.5 (9.4 - 11.7) *Fuse
bias -0.3 (-0.6 - 1.1) -0.0 (-1.2 - 1.4) *Fuse
CP2 89.0 (71.1 - 93.6) 61.2 (46.9 - 76.5) *Fuse
iCP5 4.4 (2.5 - 7.4) 17.0 (12.8 - 24.5) *Fuse
TDI95 4.6 (2.5 - 6.1) 11.4 (9.7 - 14.3) *Fuse
prop 76.6 (72.0 - 80.2) 98.7 (98.7 - 98.7) *None
ECG
MIMIC-II
C 3.3 (2.5 - 5.5) 1.6 (0.8 - 2.0) *Fuse
2SD 7.3 (6.7 - 9.3) 12.3 (10.5 - 13.9) *Fuse
bias -1.4 (-1.6 - 0.7) -0.8 (-2.5 - 1.0)
CP2 56.5 (48.2 - 70.1) 44.4 (36.1 - 52.9) *Fuse
iCP5 16.2 (13.0 - 21.7) 31.9 (26.0 - 42.5) *Fuse
TDI95 11.4 (10.0 - 13.3) 15.7 (13.1 - 17.7) *Fuse
prop 68.4 (50.7 - 74.5) 100.0 (100.0 - 100.0) *None
PPG
CapnoBase
C 12.0 (2.8 - 26.5) 4.1 (1.5 - 5.1) *Fuse
2SD 5.1 (4.4 - 7.3) 10.7 (9.7 - 12.5) *Fuse
bias 0.2 (0.1 - 2.2) 1.1 (0.4 - 3.3) *Fuse
CP2 88.6 (52.8 - 92.4) 69.1 (46.4 - 79.4) *Fuse
iCP5 6.4 (3.5 - 16.4) 18.5 (15.7 - 31.8) *Fuse
TDI95 8.1 (2.9 - 9.7) 14.3 (11.7 - 16.4) *Fuse
prop 69.4 (66.5 - 77.3) 98.7 (98.7 - 98.7) *None
PPG
MIMIC-II
C 1.3 (1.0 - 2.4) 1.2 (0.6 - 1.8)
2SD 10.9 (8.8 - 11.9) 13.3 (10.0 - 14.9) *Fuse
bias -3.5 (-5.2 - -1.8) -2.7 (-4.3 - -1.1)
CP2 49.3 (39.9 - 54.7) 47.0 (31.5 - 50.0)
iCP5 37.9 (20.6 - 41.4) 38.5 (26.1 - 52.4)
TDI95 16.4 (10.3 - 19.2) 16.8 (11.3 - 18.5)
prop 59.8 (46.9 - 70.2) 100.0 (98.6 - 100.0) *None
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Figure 6.11: Comparison of RR algorithm errors when using or not using a modulation fusion
technique in hospitalised patients: The distributions of RR algorithm errors are shown when
using algorithms applied to the ECG (upper plots) and PPG (lower plots).
5 bpm below the reference RR.
There were some improvements in performance when using the ECG signal as the input, rather
than the PPG, although these were not consistent across the datasets. There were no differences
in 2SD or CP2 values. These results are provided in full in Table A.7 in the appendix.
The performances of the highest ranked algorithms are provided in Table 6.8. All of the top-
ranked algorithms applied to the ECG used frequency-domain RR estimation techniques. When
using the PPG, all of the top-ranked algorithms on the CapnoBase dataset used frequency-
domain RR estimation techniques, whereas all except one of those on the MIMIC-II dataset
used time-domain techniques. Most of the top-ranked algorithms used a modulation fusion
technique. XB1,2,3EF7FM2 provided high performance throughout. It achieved CP2 values of
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Table 6.8: Performances of the ten highest ranked algorithms for the ECG and PPG in
















XB1,2,3EF3FM1 74.0 4.8 -0.3 91.8 1.2 2.5 75.9
XB1,2,3EF1FM1 62.2 6.4 -0.6 93.5 1.5 2.6 75.1
XB1,2,3EF7FM2 61.9 3.6 -0.1 98.0 1.6 0.7 83.2
XB1,2,3EF6FM1 55.7 6.3 -0.6 94.7 1.7 2.1 77.6
XB1,2,3EF7FM1 54.4 6.5 -0.6 94.1 1.7 2.2 76.3
XB1,2EF6FM5 37.0 8.1 -0.6 95.8 2.6 1.9 80.0
XB1,2EF1FM5 36.1 7.4 -0.6 91.7 2.5 2.6 81.5
XB1,2,3EF2FM1 35.4 5.8 -0.8 84.7 2.4 3.4 78.7
XB1,2,3EF3FM2 33.9 6.3 -0.3 95.4 2.8 1.8 93.6
XB1,2EF3FM5 30.4 7.8 -0.6 93.6 3.1 2.5 79.5
ECG
MIMIC-II
XB1,2,3EF7FM2 7.3 8.6 -1.2 84 11.6 12.1 49.4
XB1,2EF6FM5 6.2 7.3 -1.4 76.6 12.3 10.9 69.2
XB1,2EF3FM5 5.9 7.5 -1.3 75.2 12.7 10.7 71.3
XB1,2EF7FM5 5.8 7.6 -1.5 75.7 13.1 11.5 71.0
XB1,2,3EF6FM1 5.7 6.5 -1.5 68.3 12.1 10.5 50.8
XB1,2EF1FM5 5.7 7.8 -1.4 74.2 13.1 11.2 70.8
XB1,2,3EF3FM1 5.5 6.7 -1.4 68.0 12.4 11.0 49.8
XB1,2,3EF7FM1 5.4 6.8 -1.6 68.8 12.8 11.9 50.4
XB1,2,3EF1FM1 4.9 7.0 -1.5 66.4 13.6 11.4 49.4
XB1,2,3EF3FM2 4.7 9.3 -1.4 75.9 16.2 13.7 71.9
PPG
CapnoBase
XB1,2,3EF1FM1 159.5 3.1 -0.2 94.1 0.6 2.4 63.2
XB1,2,3EF2FM1 116.7 2.5 -0.2 92.8 0.8 2.4 70.3
XB1,2,3EF6FM1 69.8 3.3 0.0 93.6 1.3 2.2 69.6
XB1,2,3EF7FM1 68.4 3.5 -0.1 92.4 1.4 2.5 69.0
XB1,2,3EF3FM1 46.4 3.7 0.1 92.3 2.0 2.7 65.7
XB1,2EF2FM5 29.2 5.1 0.2 90 3.1 3.4 78.7
XB1,2EF7FM5 25.5 4.4 0.1 93.2 3.6 2.9 76.7
XB1,2,3EF7FM2 23.2 4.9 0.2 94.8 4.1 2.6 82.1
XB1,2EF6FM5 22.8 4.9 0.1 92.4 4.1 3.2 78.2
XB1,2EF1FM5 20.3 5.1 0.1 92.2 4.5 4.2 73.9
PPG
MIMIC-II
XB1,2ET4FM5 5.7 7.5 0.2 66.9 11.7 7.8 59.7
XB1,2,3EF7FM2 4.6 10 -1.8 78.8 17.3 14.0 39.6
XB1ET4 4.6 8.9 0.1 64.3 14.1 9.1 97.3
XB1,2,3ET4FM1 3.4 7.1 0.7 52.1 15.5 7.5 39.8
XB6ET4 3.3 9.9 0.7 59.1 18.2 10.1 97.1
XB5ET4 3.1 10.0 0.3 59.3 19.3 10.4 97.8
XB4ET4 3.0 9.9 0.2 58.2 19.1 10.6 96.9
XB1,2ET5FM5 2.9 7.8 -2.1 56.5 19.8 9.7 70.5
XB1,2ET3FM5 2.8 8.1 -1.8 57.6 20.3 9.7 70.0
XB1,2ET2FM5 2.6 9.1 -2.0 55.9 21.3 10.8 72.7
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98.0 and 94.8 % when applied to CapnoBase ECG and PPG signals respectively, and 84.0 and
78.8 % when applied to MIMIC-II ECG and PPG signals. However, differences in performances
between the two datasets make it difficult to predict how this and other algorithms would
perform on other clinical datasets. Its LoAs when used with the ECG were -0.1 ± 3.6 bpm and
-1.2 ± 8.6 bpm on the CapnoBase and MIMIC-II datasets respectively. Similarly, when used
with PPG signals the LoAs were 0.2 ± 4.9 bpm and -1.8 ± 10.0 bpm respectively. Furthermore,
both this algorithm and the other high-performing algorithms exhibited iCP5 values of greater
than 10 % when applied to MIMIC-II data, reflected in low C values of less than 10.
6.4 Discussion
This chapter presented a comprehensive assessment of the performances of RR algorithms in
healthy and hospitalised patients. A total of 95 RR algorithms were assessed using the ECG
as an input signal, and 85 using the PPG. The assessment was conducted on four publicly
available datasets: two acquired from healthy subjects, and two from hospitalised patients. In
contrast, previous studies of RR algorithms in the literature have assessed a maximum of 30
RR algorithms [278] using a maximum of two datasets (Section 4.4.4), with the exception of
publications arising from this work [10]. This study provides a thorough assessment of existing
RR algorithms in comparison. Furthermore, the assessment was conducted using the publicly
available RRest Toolbox of algorithms [6, 10]. Consequently, it provides a foundation with
which researchers can refine existing RR algorithms, and develop novel RR algorithms.
The performances of the RR algorithms varied greatly. Firstly, the set of 95 algorithms provided
vastly different performances when assessed using any particular dataset and input signal. For
instance, the smallest range of 2SD values exhibited by the algorithms when using any particular
dataset and input signal was 6.17 - 12.45 bpm, when assessing the algorithms on the RRest-
healthy Dataset using PPG signals. This indicates that the expected range of errors provided
by the worst-performing algorithm can be twice that of the best-performing algorithm, demon-
strating the importance of selecting the best-performing algorithm for clinical use. Secondly,
the performances of algorithms varied across different datasets. For example, XB1,2,3EF7FM2
was considered one of the best algorithms in hospitalised patients. The reported 2SD values
of this algorithm in hospitalised patients were 3.6 and 4.9 bpm when using ECG and PPG sig-
nals respectively from the CapnoBase dataset, compared to 8.6 and 10.0 bpm on the MIMIC-II
dataset. This demonstrates the importance of dataset selection for algorithm assessment. In
Chapter 6. Performance of Respiratory Rate Algorithms 139
this instance, it is notable that most of the subjects in the CapnoBase dataset were younger
than acutely-ill patients who might be monitored using a wearable sensor with an inbuilt RR
algorithm. The CapnoBase dataset contains data from 29 paediatrics and 13 adults. Further-
more, the adults were relatively young, aged a median (lower - upper quartiles) of 47.0 (39.0 -
54.5) years. They were much younger than the LISTEN Trial subjects (Chapter 3) who were
aged 67.5 (60.0 - 76.0) years. Therefore, results from the CapnoBase dataset, whilst useful, may
not be representative of those that could be expected in acutely-ill adult patients. In contrast,
the MIMIC-II dataset contains only data from adults staying in critical care, who may be more
representative of acutely-ill adult patients than those in CapnoBase.
Key features of RR algorithms were identified which provide improved performance. In health,
improved performance was achieved by using a time-domain RR estimation technique, and by
using a modulation fusion technique. Time-domain RR estimation techniques provided im-
proved performance since they did not under-estimate RRs as frequently as frequency-domain
techniques. This effect was greatest with the PPG signal, where 45.1 % of RR estimates derived
using frequency-domain techniques underestimated the reference RR by between 5 and 20 bpm.
Modulation fusion techniques provided improved performance when using ECG signals as they
reduced the proportion of underestimated RRs. However, modulation fusion techniques did
not substantially reduce the proportion of underestimated RRs when using PPG signals. In
contrast, frequency-domain techniques provided improved performance in hospitalised patients,
apart from when using PPG signals from the MIMIC-II dataset, where algorithms containing
time-domain techniques were superior. Similarly, modulation fusion techniques remained bene-
ficial, providing improved performance apart from when using PPG signals from the MIMIC-II
dataset. Once again, modulation fusion techniques were not able to reduce the large proportion
of underestimated RRs when using the PPG signals in the MIMIC-II dataset. The choice of
input signal also impacted performance, with ECG signals providing improved performance in
health, and on the MIMIC-II dataset.
The best-performing algorithms were XB1,2,3ET4FM1 in health, and XB1,2,3EF7FM2 in hospi-
talised patients. The performances of these algorithms are summarised in Table 6.9. For
comparison, the LoAs of the routinely used ImP RR monitoring technique have been previously
reported as -0.2 ± 5.4 bpm [10], or worse [32]. Therefore, one could assume that an algorithm
with similar or better performance would be suitable for use in wearable sensors. Based on
this, XB1,2,3ET4FM1 appears to perform sufficiently well when used with the ECG and healthy
subjects. However, it showed poorer performance in hospitalised patients, suggesting that it
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Table 6.9: A summary of the performances of the best RR algorithms.
Dataset
XB1,2,3ET4FM1 XB1,2,3EF7FM2
ECG PPG ECG PPG
LoAs, bias± 2SD [bpm]
Healthy subjects
RRest-healthy 0.2 ± 4.6 -0.3 ± 6.2 -1.8 ± 7.9 -5.0 ± 10.2
Fantasia -0.1 ± 3.6 n/a -1.8 ± 7.8 n/a
Hospitalised patients
CapnoBase 2.2 ± 5.3 3.2 ± 5.6 -0.1 ± 3.6 0.2 ± 4.9
MIMIC-II 2.5 ± 7.1 0.7 ± 7.1 -1.2 ± 8.6 -1.8 ± 10.0
Cost function, C
Healthy subjects
RRest-healthy 15.7 4.3 6.1 1.4
Fantasia 36.6 n/a 5.3 n/a
Hospitalised patients
CapnoBase 3.6 2.0 61.9 23.2
MIMIC-II 2.0 3.4 7.3 4.6
may not be suitable for use with acutely-ill subjects. XB1,2,3EF7FM2 showed poorer performance
when assessed using the LoAs technique, with the exception of the CapnoBase dataset results,
which cannot be considered representative of acutely-ill patients for the reasons detailed earlier.
Therefore, it appears that none of the algorithms assessed are suitable for use with acutely-ill
patients. The C statistic is also informative, indicating how many more times likely it is that
an RR estimate will have an error of < 2 bpm, than an error of > 5 bpm. The C values were
relatively low (C < 10, indicating that more than one in ten RR estimates had absolute errors
of > 5 bpm) with the exceptions of: (i) XB1,2,3ET4FM1 applied to the ECG in health; and
(ii) XB1,2,3EF7FM2 applied to the CapnoBase data. None of the algorithms reached C > 10
when assessed on the MIMIC-II dataset. This confirms that although XB1,2,3ET4FM1 may per-
form sufficiently well with the ECG in health, none of the algorithms appear to be suitable for
continuous monitoring of acutely-ill patients.
The issues with the best-performing algorithms are further illustrated in Figure 6.12. The
issues identified with time- and frequency-domain RR estimation techniques remain in the best-
performing algorithms, despite them both containing a modulation fusion technique. The figure
shows that the frequency-domain algorithm (XB1,2,3EF7FM2) frequently underestimated RR by
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Figure 6.12: The distributions of RR algorithm errors for the best algorithms used with hospi-
talised patients: The distributions of RR algorithm errors are shown when using XB1,2,3ET4FM1,
which contains a time-domain RR estimation technique, and XB1,2,3EF7FM2, which contains a
frequency-domain RR estimation technique.
more than 5 bpm. The time-domain algorithm (XB1,2,3ET4FM1) showed a wider spread of
errors, indicating a lower level of precision. In addition, on the MIMIC-II dataset it frequently
overestimated RR.
Therefore, this assessment suggests that a novel algorithm is required to estimate RR from
the ECG or PPG for use in wearable sensors. One approach to improve algorithms which
has recently been proposed is to incorporate an algorithm stage in which the quality of the
extracted respiratory signals is assessed [154, 155]. The techniques which could be used at this
stage, known as respiratory quality indices (RQIs), are similar to SQIs in that they assess the
quality of a continuous signal, and are used to eliminate low quality signals. However, RQIs
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Figure 6.13: The rationale for a respiratory quality index (RQI): This shows the power
spectra of the three input signals fused by XB1,2,3EF7FM2 for a particular window. The RR
was substantially underestimated due to the algorithm detecting non-respiratory, low frequency
content, despite the true RR being manifested in all three power spectra. It may be possible to
develop an RQI to mitigate against such errors.
assess whether or not sufficient respiratory modulation is present in a signal, in contrast to SQIs
which assess whether a signal contains high-fidelity cardiac modulation. Inspection of windows
on which RR algorithms failed suggests that RQIs may improve RR algorithm performance. For
instance, Figure 6.13 shows the power spectra of the three input signals fused by XB1,2,3EF7FM2
for a particular window. In this example all three power spectra showed peaks at the reference
RR. However, the RR was underestimated because two of the power spectra showed larger
peaks at a much lower RR. A RQI could potentially be used to eliminate any input signals
which exhibit multiple peaks in their power spectra, thereby avoiding this issue.
In this study a novel cost function was proposed to rank RR algorithms. The cost function was
calculated primarily using CP2 and iCP5, and indicates the relative likelihood of an RR estimate
being within ± 2 bpm of the reference RR, compared to being outside ± 5 bpm of the reference.
This approach was chosen to reflect the potential utility of RR algorithms for use with wearable
sensors. The rationale for its design is based on the potential use of an RR algorithm with
the national early warning score (NEWS, Section 2.2). The NEWS assigns a score to RR (and
other physiological parameters) based on its deviation from normal values. When calculating
the NEWS (Table 2.2) an error in RR of 2 bpm can only change a patient’s calculated risk of
deterioration by one level out of four. In contrast, an error of 5 bpm can change the calculated
risk of deterioration from no risk up to the highest level (and vice versa). Therefore, the CP2 and
iCP5 statistics were chosen to reflect the potential for either false detection of deteriorations,
or missing deteriorations, based on erroneous RR values. Other statistics were also reported as
together they provide a more comprehensive description of algorithm performance.
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6.5 Final Remarks
This study assessed the performance of algorithms to estimate RR from the ECG and PPG in
healthy and hospitalised patients. A total of 95 algorithms were assessed using four datasets.
The main finding was that XB1,2,3ET4FM1 performed sufficiently well for use with the ECG in
healthy subjects. However, no algorithms were found to perform sufficiently well with hospi-
talised patients. The best-performing algorithm in hospitalised patients was XB1,2,3EF7FM2,
although this did not perform sufficiently well with data from critical care. Therefore, further
refinement of algorithms is required before their use in wearable sensors to monitor acutely-ill
patients.
Key features of algorithms were identified which provide improved performance. Firstly, the
use of a modulation fusion technique to fuse RRs derived from multiple respiratory signals im-
proved performance when using ECG signals. Secondly, time-domain RR estimation techniques
provided improved performance in healthy subjects, and frequency-domain RR estimation tech-
niques provided superior performance when used with ECG signals in hospitalised patients.
Thirdly, algorithms performed better in health when using ECG signals rather than PPG sig-
nals.
The RRest-healthy dataset, code to download and appropriately format the Fantasia, Cap-
noBase and MIMIC-II datasets, RRest Toolbox of algorithms, and analysis code used in this
study are being made publicly available at http://peterhcharlton.github.io/RRest. These
resources allow future researchers to reproduce the analyses presented here, and to develop and
evaluate novel RR algorithms.
Chapter 7
An Algorithm for Continuous
Respiratory Rate Monitoring using
the Electrocardiogram and
Photoplethysmogram
This chapter presents a novel algorithm for continuous monitoring of respiratory rate (RR)
in hospitalised patients using the electrocardiogram (ECG) and photoplethysmogram (PPG).
The algorithm was designed to harness the strengths of both time- and frequency-domain RR
estimation techniques. The algorithm was optimised using data from healthy subjects, and
assessed using data from hospitalised patients. Its performance was compared to that of a
control algorithm, the best performing algorithm in Chapter 6. In addition, analyses were
conducted to determine whether performance varied between subjects and at different RRs.
The results were used to evaluate the potential utility of the algorithm for use with the ECG
and PPG, and to identify particular areas for further clinical testing.
7.1 Introduction
Existing RR algorithms have been designed for use in clinical settings where it is important that
a RR measurement is provided for most, or all, windows of input signal. This design approach
is appropriate in settings such as exercise stress tests [345], where RR changes rapidly, or for
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making diagnoses in an outpatient clinic [80], where a single measurement is required in a short
space of time. In these settings there is a high penalty for not outputting a measurement at
any particular time, since this will interrupt real-time monitoring, or prolong the time taken
to make a diagnosis in busy clinics. However, the downside to this design approach is that
less importance is placed on ensuring that the estimated RRs are as precise as possible, which
results in frequent erroneous RRs (see Section 6.4).
In contrast, when monitoring acutely-ill patients for detection of deteriorations there is no need
to output a RR for most windows of input signal. This is because the physiological changes
which accompany acute deteriorations occur over the course of hours [18–22], so one can afford
to analyse several minutes of input signal before outputting a RR. However, in this setting there
is a high penalty for outputting an erroneous RR since it could be mistaken for an early sign of
deterioration requiring a clinical response. False alerts of deteriorations waste clinical resources,
since a clinician typically has to visit a patient showing signs of deterioration. In addition, they
may desensitise clinicians to true alerts, a phenomenon known as alarm fatigue [117], reducing
the effectiveness of clinical responses when they are truly needed.
More recently some RR algorithms have been developed without the requirement of outputting
a RR for every window of input signal [80, 109, 147, 154]. These algorithms only output a RR
at times when the estimated RR is judged to be of high quality. This is achieved by either
(i) analysing the quality of the extracted respiratory signal from which an RR is estimated
[109, 154], or (ii) assessing the similarity of multiple RRs generated simultaneously [80] or within
a short time period [147]. Indeed, techniques such as Smart Fusion [80], which incorporates a
quality assessment step to determine whether to output the current estimate, have been shown
to improve the precision of RR algorithms at the expense of outputting RRs less frequently [10].
Nonetheless, even algorithms which are not constrained to outputting RRs for every window of
input signal can have a high error rate (see Section 6.4), with over 10 % of RR estimates having
errors of > 5 bpm (breaths per minute). An error of this magnitude is enough to raise a false
alert for a patient showing no signs of deterioration (as explained in Section 6.4). Therefore,
further research is required to design an algorithm specifically for continuous monitoring of
acutely-ill patients.
This chapter presents the design and assessment of a novel RR algorithm specifically designed
for continuous monitoring of hospitalised patients to detect deteriorations. The rationale for
the design is presented in Section 7.2. Section 7.3 describes the methods used to optimise the
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design of the algorithm, and to assess its performance, including a comparison of its performance
with that of the best-performing algorithm identified in Chapter 6 (the control algorithm). The
results are described in Section 7.4. The implications of the results, and the potential utility of
the novel algorithm for use in wearable sensors are discussed in Section 7.5.
7.2 Algorithm Design
RR algorithms for use with the ECG and PPG broadly consist of three fundamental stages [4]
(see Figure 6.1): extraction of a respiratory signal, estimation of RR, and fusion of multiple
RR estimates. Several studies have compared techniques for extracting respiratory signals
[157, 159, 179, 186, 268, 330], and techniques for fusion of RR estimates have recently been
the subject of much research [4, 80, 113, 237, 238, 341]. However, there has been relatively little
research into the relative performances of algorithms using different RR estimation techniques
[109]. The novel algorithm presented here exploits the differing performance characteristics of
different RR estimation techniques to improve the precision of RR estimation.
RR estimation techniques act in either the time- or the frequency-domain (detailed in Section
4.4.3.3). Time-domain techniques identify individual breaths within a signal, and then estimate
RR from the time intervals between each breath. In contrast, frequency-domain techniques
transform the signal into a power spectrum, and the RR is estimated as the frequency corre-
sponding to the maximum power spectral density. Techniques from both domains have been
widely used in the literature (see Table 4.7).
Time- and frequency-domain RR estimation techniques have differing performance character-
istics. This is demonstrated in Figure 7.1, which shows plots illustrating the performances of
time- and frequency-domain techniques from both the literature and novel analyses. The plots
corresponding to time-domain techniques (upper panel of four plots) exhibit a wide spread of
estimates around the line of identity, indicating moderate precision. In contrast, frequency-
domain techniques exhibit a smaller spread of estimates around the line of identity indicating
high precision, but also have frequent erroneous estimates resulting in estimated RRs of (ap-
proximately) < 12 bpm. Consequently, neither approach is ideal for use with wearable sensors:
time-domain techniques are not highly precise; and frequency-domain techniques, whilst highly
precise for much of the time, are also vulnerable to large errors.





































































































































Figure 7.1: Scatter plots of RR estimates produced by RR algorithms containing time- and
frequency-domain RR estimation techniques: The upper panel of three plots shows estimates
produced by algorithms containing time-domain techniques, and the lower panel of five plots
shows estimates produced by frequency-domain techniques. The upper panel and the upper
row of the lower panel show plots produced from analyses of publicly available datasets (using
the best-performing algorithms from Chapter 6: XB1,2,3ET4FM1 and XB1,2,3EF7FM2). The
lower row of the lower panel shows plots adapted from the literature: PPG, CapnoBase [80] c©
2013 IEEE, and PPG, MIMIC-II [341] c© 2016 IEEE. The frequency-domain plots show several
underestimates lying below the line of identity, occurring at estimated RRs of (approximately)
< 12 bpm. This characteristic is used in the novel RR algorithm to identify and mitigate against
underestimates produced by frequency-domain techniques.
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Estimate RRf using frequency-
domain technique and 
modulation fusion 
Is RRf  >  
threshf ? 
Output RRf 
Estimate RRt using time-domain 
technique and modulation fusion 








Estimate RRcomb as the mean of 
RRt and RRf 
Figure 7.2: The novel RR algorithm: The algorithm primarily uses a frequency-domain tech-
nique to estimate RR (RRf), although if the estimated RR is < threshf then a time-domain
technique is also used. If the difference between the time-domain estimate (RRt) and RRf is
less than threshcomb then a combined estimate (RRcomb) is outputted. Otherwise, no RR is
outputted.
The novel RR algorithm presented in this chapter was designed to combine the strengths of
time- and frequency-domain RR estimation techniques. The key feature of the algorithm is its
ability to use the high-precision RR estimates produced by frequency-domain RR estimation
techniques, whilst identifying and mitigating against those with large errors. Underestimates
produced by frequency-domain techniques share a common feature which facilitates their iden-
tification and exclusion: they manifest at estimated RRs of (approximately) < 12 bpm (see
bottom row, Figure 7.1). This was, in part, reported in Chapter 6, where it was observed
that algorithms containing frequency-domain RR estimation techniques frequently underesti-
mate RR, but very rarely overestimate RR (see Figure 6.8). The underestimates produced by
frequency-domain techniques have also been noted in [80, 277, 341]. In contrast, time-domain
techniques do not tend to produce large underestimates (top panel, Figure 7.1). This difference
in performance characteristics is used by the novel algorithm to identify and mitigate against
underestimates produced by frequency domain techniques.
The novel RR algorithm is summarised in Figure 7.2. Firstly, an algorithm containing a
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frequency-domain RR estimation technique was used to produce a candidate RR. This was
performed using either XB1,2,3EF7FM1 or XB1,2EF7FM5 (both algorithms were trialled). The
frequency-domain RR estimation technique, EF7, was chosen based on its high performance in
Chapter 6 (for definitions see Tables 4.5, 4.7, and 4.8). The threshold value used for quality
assessment during RR estimation was either thresh2 or thresh3 depending on whether two
or three inputs were used (FM1 uses three, whereas FM5 uses only two). If the RR estimate
produced was above a threshold RR, threshf , then it was accepted as the final RR estimate
since it was likely to be highly precise. If the RR estimate was below this threshold, then a
second RR estimate was obtained using an algorithm containing a time-domain technique. This
was performed using either XB1,2,3ET4FM1 or XB1,2ET4FM5. The time- and frequency-domain
RR estimates were then fused using FM5. In this work FM5 was performed by calculating the
difference between the two estimates, and outputting the mean of the two estimates if the dif-
ference was below thresh2. If the difference was greater than thresh2 then no RR estimate was
outputted.
The following stages of the algorithm were optimised during the design process:
• The threshold RR, threshf , above which frequency-domain estimates were accepted re-
quired optimisation. The bottom row of plots in Figure 7.1 suggested that a value of
approximately 12 bpm may be appropriate.
• The quality assessment threshold used for the fusion of three RR estimates in FM1, thresh3,
was optimised. It was expected that a value of approximately 3 - 5 bpm would be appro-
priate, in line with the value of 4 bpm proposed in [80].
• The quality assessment threshold used for the fusion of two RR estimates in FM5, thresh2,
was optimised. It was expected that a value of approximately 3 bpm would be appropriate,
based on previous work (Section 6.3.3).
Each of these stages was optimised in the study now presented to produce an algorithm suitable
for continuously monitoring of acutely-ill patients.
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7.3 Methods
7.3.1 Datasets
Four publicly available datasets were used in this study: RRest-healthy [7], Fantasia [302, 303],
CapnoBase [80] and MIMIC-II [299, 303]. Since these datasets were also used for the study
presented in Chapter 6, they are only briefly summarised here (for further details see Section
6.2.1). The datasets contain simultaneous ECG, PPG, and respiratory signals (except Fantasia,
which does not contain PPG signals). CapnoBase also contains manual breath annotations. The
RRest-healthy and Fantasia datasets were acquired from young and elderly healthy subjects,
whereas CapnoBase and MIMIC-II were acquired from hospitalised patients. The datasets
acquired from healthy subjects were used for algorithm optimisation, and those acquired from
hospitalised subjects were used for assessing the algorithm’s performance.
7.3.2 RR estimation
RR estimation was performed using the RRest Toolbox of algorithms, which is a publicly-
available framework with which to assess the performance of both existing and novel RR algo-
rithms [6, 10] (described in Section 4.6.3). Since the processing steps performed by the toolbox
were described in detail in Section 6.2, they are only briefly recapped here. Firstly, the quality
of each 32 s window of ECG, PPG and reference respiratory signals was assessed. The signal
quality index (SQI) algorithms described in Section 3.3 were used for the ECG and PPG. The
quality of each of the reference respiratory signals was assessed using the algorithms described
in Section 6.2.2, including the novel SQI described in Section 4.6.2. Any windows in which any
of the required signals were of low quality were excluded from the analysis. Secondly, RRs were
estimated from the ECG and PPG using two algorithms: the novel RR algorithm, and the al-
gorithm previously identified as the most suitable existing algorithm for continuous monitoring
of hospitalised patients (Section 6.4): XB1,2,3EF7FM2 (definitions provided in Tables 4.5, 4.7
and 4.8). Thirdly, reference RRs were estimated from the manual breath annotations in the
CapnoBase dataset, and from the reference respiratory signals in the other datasets (see Section
6.2.5 for details of the algorithms used).
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7.3.3 Statistical analysis
The performance of each algorithm was assessed in the same manner as for the study in Chapter
6. The performances of algorithms were quantified using the following statistics (as detailed in
Section 6.2.6):
• bias: The systematic bias, indicating an algorithm’s accuracy.
• 2SD: The expected range encompassing 95% of errors around the bias.
• CP2: The proportion of RR estimates which have an absolute error of < 2 bpm.
• iCP5: The proportion of RR estimates which have an absolute error of > 5 bpm.
• TDI95: The 95th percentile of absolute errors, indicating the absolute error below which
95 % of absolute errors fall.
• prop: The proportion of windows for which an algorithm provides a RR estimate, rather
than no output.
• C: A bespoke cost-function indicating the clinical utility of an algorithm: CP2/iCP5 .
Algorithms were ranked according to C, since this statistic was designed to assess the clinical
utility of algorithms for continuous monitoring of acutely-ill patients. Further details of the
rationale for C can be found in Sections 6.2.6 and 6.4.
7.3.4 Algorithm optimisation
The optimal configurations of the novel RR algorithm were identified by assessing the algorithm’s
performance when using a range of configurations. The following options were trialled:
• threshf = {5.0, 5.5, 6.0, ..., 20.0} bpm
• thresh2 = {0.5, 1.0, 1.5, ..., 8.0} bpm
• thresh3 = {0.5, 1.0, 1.5, ..., 8.0} bpm
This resulted in a total of 7936 configurations when using FM1 (which takes three input signals
and therefore uses thresh3), and 496 configurations when using FM5 (which takes two input
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signals and therefore does not use thresh3). The novel algorithm’s performance was optimised
using the two datasets acquired from healthy subjects: RRest-healthy and Fantasia. For this
process the two datasets were each split according to young and elderly subjects, resulting in four
data subsets. Optimal configurations were identified for eight design specifications formed from
combinations of: using the ECG or PPG signal; using either two or three input RR estimates
(using either XB1 and XB2, or XB1, XB2 and XB3); and insisting on a prop of at least either
20 % or 40 %. The C and prop statistics were used for this process, since ideally an algorithm
would have both a high C and a high prop value. The performances of the configurations were
ranked according to their C values on each data subset. Any configurations which had less than
the required prop on any data subset were excluded. The lowest ranking of each configuration
across the data subsets was used as its overall ranking. The optimal configuration for each
design specification was then the one with the highest overall ranking.
The configurations of the novel algorithm were denoted as (for example):
XB1,2,3EF7,T4FM1(E, 20%) ,
indicating the respiratory signals used (XB1, XB2 and XB3), the RR estimation techniques used
(EF7 and ET4), the modulation fusion method (FM1), and the design configuration (E for ECG,
and a minimum prop of 20 %).
The performances of the novel algorithm were assessed when using each of the eight identified
configurations. This was performed on all four datasets, although particular importance was
placed on the performances on the MIMIC-II dataset, since the patients in this dataset were
most similar to those of acutely-ill hospitalised patients, such as those in the LISTEN Trial
(described in Chapter 3). Performance was assessed using the C and prop statistics. The most
suitable configurations for use with the ECG and PPG were selected from the four configurations
for each signal.
7.3.5 Performance assessment
The performance of the novel algorithm was compared to that of a control algorithm:
XB1,2,3EF7FM2, which has previously been identified as the most suitable existing algorithm for
continuous monitoring of hospitalised patients (Section 6.4). This comparison was performed to
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determine whether the novel algorithm would be more suitable for use in this clinical scenario
than the best existing algorithm.
Firstly, the performances were compared using the statistics described in Section 7.3.3. This was
performed using the datasets acquired from hospitalised patients: CapnoBase and MIMIC-II.
In addition, the MIMIC-II dataset was used to analyse the performances of the two algorithms
across individual subjects, and across a range of reference RRs. These latter analyses were
used to determine whether the algorithm performed consistently across different subjects and
RRs. These were important since respiratory signals extracted from the ECG and PPG are of
lower quality at higher RRs (see Section 5.5), and the performance of RR algorithms can vary
greatly between different subjects [278]. Only subjects which contributed at least 5 high quality
windows were included in the analyses across individual subjects to avoid spurious results. The
C and prop statistics were used for the analysis across RRs. The CP2 and prop statistics
were used for the analysis between subjects since often sufficient windows were not available to
calculate C robustly for individual subjects.
7.4 Results
7.4.1 Algorithm optimisation
Figure 7.3 shows an example of the procedure used to optimise the novel algorithm. This
figure demonstrates the selection of optimal configurations for each of the following de-
sign specifications: XB1,2,3EF7,T4FM1(E, 20%) and XB1,2,3EF7,T4FM1(E, 40%), indicated by
diamond and circular red dots respectively on ECG plots; XB1,2,3EF7,T4FM1(P, 20%) and
XB1,2,3EF7,T4FM1(P, 40%), indicated by diamond and circular red dots respectively on PPG
plots. These optimal configurations did not necessarily provide the best performance on any
particular dataset. For instance, XB1,2,3EF7,T4FM1(E, 20%) never provided the best perfor-
mance on any of the individual data subsets. However, it gave the best overall performance
across the four data subsets according to the ranking criteria used. The choice of algorithm
configuration had a large impact on the algorithm’s performance, with a large range of C and
prop values produced by different configurations.
The optimal configurations of the novel algorithm identified for each design specification are
listed in Table 7.1. The values of thresh2 and thresh3 tended to be lower at smaller specified
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Figure 7.3: The performances of the novel RR algorithm across a range of configurations:
Each plot shows the performances of the 7936 assessed configurations of the novel algorithm,
quantified using the cost function, C, and the proportion of windows for which a RR estimate
was provided, prop. Each individual configuration is shown by a blue cross. The performances
of the optimal configurations for the ECG and PPG are shown in red, with a diamond red
dot indicating a prop of ≥ 20 %, and a circular red dot indicating a prop of ≥ 40 %. Some
configurations had infinite C values (when the denominator of C, iCP5, was zero), which have
been re-scaled and are shown in black. Note that y-axis scales vary between plots.
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XB1,2EF7,T4FM5(E, 20%) ECG 2 20 18.5 1.5 n/a
XB1,2EF7,T4FM5(E, 40%) ECG 2 40 18.0 3.0 n/a
XB1,2,3EF7,T4FM1(E, 20%) ECG 3 20 18.0 1.5 2.0
XB1,2,3EF7,T4FM1(E, 40%) ECG 3 40 18.0 3.5 5.0
XB1,2EF7,T4FM5(P, 20%) PPG 2 20 16.0 3.5 n/a
XB1,2EF7,T4FM5(P, 40%) PPG 2 40 15.0 6.0 n/a
XB1,2,3EF7,T4FM1(P, 20%) PPG 3 20 12.0 5.0 2.5
XB1,2,3EF7,T4FM1(P, 40%) PPG 3 40 15.5 5.0 5.0
Table 7.2: The performances of the optimised configurations of the novel RR algorithm
Algorithm
RRest-healthy Fantasia CapnoBase MIMIC-II
C prop C prop C prop C prop
ECG
XB1,2EF7,T4FM5(E, 20%) 31.7 40.1 160.0 28.9 64.5 25.0 28.7 31.7
XB1,2EF7,T4FM5(E, 40%) 28.3 55.8 44.3 41.8 63.0 36.5 26.4 40.3
XB1,2,3EF7,T4FM1(E, 20%) 59.5 25.2 543.0 24.1 ∞ 18.5 18.7 17.3
XB1,2,3EF7,T4FM1(E, 40%) 20.6 50.0 67.2 44.7 59.3 35.6 15.0 29.6
PPG
XB1,2EF7,T4FM5(P, 20%) 6.8 23.0 n/a n/a 17.5 38.8 7.9 28.6
XB1,2EF7,T4FM5(P, 40%) 2.8 45.5 n/a n/a 20.2 53.2 5.1 40.3
XB1,2,3EF7,T4FM1(P, 20%) 11.5 23.7 n/a n/a 203.0 39.0 5.5 19.3
XB1,2,3EF7,T4FM1(P, 40%) 7.8 41.1 n/a n/a 70.3 45.9 4.3 23.6
prop values. This is because lower thresholds result in fewer RR estimates being deemed to
be of high quality. In addition, threshf was lower in configurations optimised for the PPG
(approximately 15 bpm) than for the ECG (approximately 18 bpm).
The performances of the optimal configurations of the novel algorithm on each dataset are
shown in Table 7.2. Performances are reported for all four datasets, although the performances
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Table 7.3: Performances of the novel algorithm, XB1,2EF7,T4FM5(. . .), and the control algo-
rithm, XB1,2,3EF7FM2 (identified in Chapter 6 as being most suitable for continuous monitoring


















XB1,2EF7,T4FM5(E, 40%) 63.0 1.5 0.4 97.4 1.5 1.5 36.5
XB1,2,3EF7FM2 61.9 3.6 -0.1 98.0 1.6 0.7 83.2
ECG
MIMIC-II
XB1,2EF7,T4FM5(E, 40%) 26.4 3.2 0.0 85.8 3.2 4.5 40.3
XB1,2,3EF7FM2 7.3 8.6 -1.2 84 11.6 12.1 49.4
PPG
CapnoBase
XB1,2,3EF7FM2 23.2 4.9 0.2 94.8 4.1 2.6 82.1
XB1,2EF7,T4FM5(P, 20%) 17.5 3.3 0.8 92.8 5.3 6.9 38.8
PPG
MIMIC-II
XB1,2EF7,T4FM5(P, 20%) 7.9 9.0 -0.2 82.0 10.4 9.4 28.6
XB1,2,3EF7FM2 4.6 10.0 -1.8 78.8 17.3 14.0 39.6
on the MIMIC-II dataset (shaded) were used to select the final configurations for use with
the ECG and the PPG. On this dataset, the use of two input signals (FM5) rather than three
(FM1) always resulted in higher C and prop values. Therefore, only configurations containing
FM5 were considered. XB1,2EF7,T4FM5(E, 40%) was chosen for use with the ECG signal over
XB1,2EF7,T4FM5(E, 20%), since it provided RR estimates with a similar C value (26.4 com-
pared to 28.7), for a greater proportion of windows (40.3 compared to 31.7 %). For the PPG,
XB1,2EF7,T4FM5(P, 20%) was chosen since it had the highest C value. This was chosen irrespec-
tive of prop since none of the PPG configurations provided a particularly high C value. Only
the chosen configurations were carried forward to the performance assessment now presented.
7.4.2 Performance assessment
Table 7.3 provides a comparison of the performances of the novel algorithm and the most suitable
existing algorithm for continuous monitoring of hospitalised patients (the control algorithm,
XB1,2,3EF7FM2, identified in Chapter 6). On the CapnoBase dataset there was no advantage
to using the novel algorithm, since it provided similar C values to the control algorithm, but
produced RR estimates for approximately half the proportion of windows compared to the
control algorithm. In contrast, on the MIMIC-II dataset the novel algorithm provided improved
C values for both the ECG and PPG, at the expense of only a small reduction in prop. Indeed,
when using the ECG signal the novel algorithm had a C value of 26.4, returning RR estimates
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Figure 7.4: The error distributions of the novel and control RR algorithms when used with
the ECG (left hand plot) and PPG (right hand plot). Results are from the MIMIC-II dataset.
for 40.3 % of windows, compared to C = 7.3 for the control algorithm across 49.4 % of windows.
Furthermore, the LoAs improved from -1.2 ± 8.6 bpm to 0.0 ± 3.2 bpm when using the novel
algorithm. Only 3.2 % of the RR estimates provided by the novel algorithm had absolute errors
of > 5 bpm. There was some benefit to using the novel algorithm with the PPG, since the C
value improved from 4.6 to 7.9. However, the LoAs remained similarly large between the two
algorithms: -0.2 ± 9.0 bpm for the novel algorithm, compared to -1.8 ± 10.0 bpm for the control
algorithm.
The distributions of the errors produced by the novel algorithm and the control algorithm are
shown in Figure 7.4. The novel algorithm produced fewer underestimates (errors < -5 bpm)
than the control algorithm (a reduction from 9.9 to 1.9 % with the ECG, and 15.0 to 6.2 %
with the PPG). This suggests that the fusion of time- and frequency-domain RR estimates was
effective in mitigating against underestimates. The scatter plots in Figure 7.5 demonstrate the
smaller number of underestimates produced when using the novel algorithm. However, despite
the improvement, some large underestimates remained when using the novel algorithm with the
PPG.
The performances of the novel algorithm and the control algorithm on individual subjects are
summarised in Figure 7.6. This figure shows the distributions of prop and CP2 values calculated
for each individual subject. Both algorithms exhibited wide variations in prop and CP2 values
between subjects, regardless of the input signal. This suggests that the performance of the
algorithms may vary between subjects when used in clinical practice.
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Figure 7.5: Scatter plots of RR estimates produced by the novel and the control RR algo-
rithms: Results are shown for the ECG (upper plots) and PPG (lower plots). Results are from
the MIMIC-II dataset.
The performances of the novel algorithm and the control algorithm at different reference RRs are
shown in Figure 7.7. When using the ECG, both algorithms had lower C values at elevated RRs.
In addition, the novel algorithm produced RR estimates for a smaller proportion of windows at
lower RRs than at higher RRs. When using the novel algorithm with the PPG the variation in
performance at different RRs was smaller, although the algorithm had lower C values at extreme
RR values than at normal RR values. It also produced RR estimates for a higher proportion of
windows at lower RRs than at higher RRs, in contrast with the ECG.

































Figure 7.6: The performances of the novel and the control RR algorithms on individual
subjects: The proportion of windows for which an RR estimate was returned (prop), and the
proportion of RR estimates within 2 bpm of the reference RR (CP2), are shown for the two
algorithms when using the ECG (first and second plots) and PPG (third and fourth plots).
Results are from the MIMIC-II dataset.
7.5 Discussion
In this chapter a novel algorithm was presented to estimate RR from the ECG and PPG, de-
signed specifically for continuous monitoring of acutely-ill hospitalised patients. The algorithm
uses both time- and frequency-domain RR estimation techniques, whereas previously proposed
RR algorithms tend to use a single RR estimation technique. The algorithm was optimised
using data from healthy subjects, and assessed on data from hospitalised patients. It performed
well when used with the ECG, giving LoAs (within which 95 % of errors are expected to lie) of
0.0 ± 3.2 bpm and providing RR estimates for 40.3 % of windows. This level of performance is
suitable for clinical use, particularly as only 3.2 % of estimates had absolute errors of > 5 bpm.
Indeed, it may allow RR to be monitored unobtrusively using wearable sensors equipped with
ECG monitoring. However, both the novel algorithm and the control algorithm did not perform
well enough for continuous monitoring when used with the PPG.
The novel algorithm consists of the fusion of time- and frequency-domain RR estimates derived
from baseline wander (BW) and amplitude modulation (AM) signals extracted from either the
ECG or PPG signal. The addition of RR estimates derived from frequency modulation (FM)
signals was detrimental to performance, so FM-based estimates were not included in the chosen
configurations. This may be because the quality of FM signals diminishes with age (see Section
5.5). It has been observed both previously and in the current work that frequency-domain RR
estimation techniques have a tendency to underestimate RRs, perhaps due to the presence of
low frequency oscillations such as Traube-Hering-Mayer waves [80, 277]. The novel algorithm
Chapter 7. An Algorithm for Continuous Respiratory Rate Monitoring 160
RR [bpm]
































Figure 7.7: The performances of the novel and the control RR algorithms at different reference
RRs: The bespoke cost-function (C, indicating the clinical utility of an algorithm), and the
proportion of windows for which an RR estimate was returned (prop), are shown for the five
quintiles of reference RRs. Performances are shown for the ECG (upper plots) and PPG (lower
plots). Results are from the MIMIC-II dataset.
mitigated against this by only providing low RR estimates if both time- and frequency-domain
RR estimates agreed. Fusion was found to be beneficial below 18 bpm for the ECG, and 16 bpm
for the PPG. In this algorithm agreement was assessed between RR estimates to determine
whether to output a final RR estimate. More advanced techniques consider the quality of
respiratory signals from which RR estimates were derived to determine whether to output a
final RR, and may warrant further investigation [154, 155, 199].
Further testing and refinement of the algorithm is required prior to implementation in clini-
cal practice. Firstly, the algorithm should be assessed using data which is representative of
acutely-ill hospitalised patients. The dataset most representative of acutely-ill patients in this
study was the MIMIC-II dataset. However, even this dataset may not be fully representative
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of acutely-ill patients, since some of the critically-ill patients in this dataset were receiving
mechanical ventilation, which may affect the performance of RR algorithms [341, 346]. They
also received drugs such as inotropes, beta-blockers and vasoactive agents which may impact
the physiological mechanisms which cause respiratory modulation of the ECG and PPG (see
Section 4.2). Secondly, the optimal design specification of an RR algorithm for continuous
monitoring of hospitalised patients is not yet clear. The relative importance of precise RR esti-
mates, avoiding highly erroneous estimates (both captured in C), and providing RR estimates
for a high proportion of windows (prop) is not yet known. Thirdly, there was variation in the
algorithm’s performance between different subjects, and some variation with the reference RR.
Further investigation is required to determine whether these variations in performance affect
the clinical utility of the algorithm.
This investigation was conducted using the RRest Toolbox of algorithms (described in Section
4.6.3). The toolbox is publicly available (see the accompanying tutorial for an introduction [6]),
and has several features which may be of benefit to other researchers. The toolbox can be used
to perform equivalent analyses across multiple datasets (four were used in this investigation). To
do so, scripts are provided to download and appropriately format each dataset for use with the
toolbox. In addition, several methods are provided to precisely derive reference RRs from each
dataset, whether using a reference respiratory signal or breath annotations. Three different
methods were used to derive reference RRs in this investigation. Furthermore, the toolbox
provides a standardised framework for assessing the performance of RR algorithms. This allows
the performances of algorithms reported in this investigation to be directly compared to those
of algorithms used in other investigations conducted with the toolbox, such as the assessment
of previously proposed RR algorithms in Chapter 6.
This study highlighted the importance of selecting an appropriate dataset with which to assess
the performance of RR algorithms. Two datasets containing data from hospitalised patients
were used: CapnoBase and MIMIC-II. However, the conclusions were drawn primarily from
analyses conducted on the MIMIC-II dataset. This dataset was prioritised since it is more
representative of acutely-ill adult patients. In addition, the algorithms did not perform as
well on this dataset, making it a worst-case scenario. It is important that datasets used for
assessment of RR algorithms are as representative as possible of the clinical setting in which
the algorithms will be used. Further work is now ongoing to assess the performance of the novel
algorithm on the RRest-acute dataset, which is designed to be as representative as possible of
acutely-ill hospitalised patients (see Section 4.6.1).
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7.6 Final Remarks
In this chapter a novel RR algorithm for continuous monitoring of acutely-ill hospitalised pa-
tients was designed and optimised. The algorithm uses a frequency-domain technique to es-
timate higher RRs, and both time- and frequency-domain techniques to estimate lower RRs.
In doing so it utilises the high precision of many estimates produced using frequency-domain
techniques, whilst mitigating against the underestimates often produced by these techniques.
The algorithm’s performance was compared to that of the best-performing algorithm from the
literature, identified in Chapter 6. The algorithm was found to provide greater precision than
the control algorithm, at the expense of providing RR estimates for a smaller proportion of
windows of input signal. It was found to perform sufficiently well for continuous monitoring
when used with the ECG, although not when used with the PPG.
The results from this study suggested that the novel algorithm’s performance may vary between
patients, and across different RRs. Therefore, further work is required to determine whether the




This chapter presents a study investigating the potential utility of wearable sensors for detecting
deteriorations using the LISTEN Processed Dataset (Chapter 3). The respiratory rate (RR)
algorithm presented in Chapter 7 was used to estimate RR continuously from the electrocar-
diogram (ECG) signals monitored by the wearable sensors. This provided three continuously
monitored parameters: heart rate (HR), arterial blood oxygen saturation (SpO2), and RR. The
parameters were median-filtered to eliminate short-term variability. Three algorithms were then
used to assess the likelihood of deterioration at each time point, and a windowing scheme was
used to activate and deactivate alerts. The results were used to assess the performance of al-
gorithms to detect deteriorations when applied to wearable sensor data compared to routine,
intermittent physiological measurements.
8.1 Introduction
It has been widely suggested that wearable sensors could be used to provide early warning
of clinical deteriorations [61, 66, 69, 91, 347, 348]. Recent developments in wearable sensor
technology have made them particularly suited to this application (as detailed in Section 2.3).
Developments have included: broadening the range of physiological parameters which wearable
sensors can monitor [29]; reducing their size and weight [66, 67]; increasing their battery life
[68]; and automating rejection of low quality measurements [67, 124]. However, relatively little
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attention has been paid to the design of algorithms to detect deteriorations from wearable sensor
data, prompting a clinical response [348]. This is a key step, since no monitoring device can
improve patient outcomes unless coupled with an effective clinical intervention [349]. There
is no commonly accepted approach for the design of algorithms to detect deteriorations from
wearable sensor data, and there is little evidence for the clinical utility of such algorithms.
Therefore, further research is required to optimise algorithm designs, and to determine whether
they provide earlier warning of deteriorations than current practice [348].
A significant barrier to research in this area is the difficulty of acquiring wearable sensor data
from sufficiently large numbers of patients. Clinical trials to acquire datasets using wearable
sensors have suffered from poor data coverage rates [75] and short monitoring durations (see
Section 2.4). In contrast, the LISTEN Processed Dataset, described in Chapter 3, is a uniquely
comprehensive wearable sensor dataset. It consists of wearable sensor data, routine physiological
measurements, and labels of adverse events acquired from 226 acutely-ill patients (see Section
3.4). The wearable sensors monitored HR and SpO2, as well as acquiring ECG and PPG
signals continuously (as described in Table 3.1). Consequently, when an algorithm is used
to retrospectively estimate RR from the ECG or PPG signals, three physiological parameters
can be continuously derived from the wearable sensor data: HR, SpO2 and RR. This provides a
comparable set of parameters to those acquired by existing wearable sensors for use with acutely-
ill patients. For instance, the SensiumVitals R© patch acquires HR, RR and temperature [68];
and the Philips Biosensor acquires HR, RR, temperature, and activity measures [350]. Although
the LISTEN Processed Dataset is subject to some limitations, as described in Section 3.5, it
is a valuable resource for developing and evaluating algorithms to detect deteriorations from
wearable sensor data.
This chapter presents a study in which the LISTEN Processed Dataset was used to assess
the potential utility of wearable sensors for early detection of deteriorations. The aim of this
pilot study was to assess the performance of algorithms to detect deteriorations when applied
to wearable sensor data compared to routine, intermittent physiological measurements. The
algorithms used to detect deteriorations are presented in Section 8.2. Section 8.3 describes the
methods used to evaluate the algorithms using the LISTEN Processed Dataset. The results
are described in Section 8.4. The implications of the results, and the potential utility of the
algorithms for use in wearable sensors are discussed in Section 8.5.








Figure 8.1: The stages of an algorithm to detect deteriorations from wearable sensor data.
8.2 Algorithms to Detect Deteriorations
Algorithms to detect deteriorations from wearable sensor data generally consist of three stages,
as illustrated in Figure 8.1. The first stage, pre-processing of wearable sensor data, involves
cleaning the data corresponding to each physiological parameter. This is important since the
data are particularly susceptible to noise. Reasons for this include [4]: (i) movement artefact
is common since wearable sensors are used with ambulatory patients; (ii) wearable sensor data
are acquired continuously, regardless of whether a patient is active, causing physiological pa-
rameters to vary from their baseline values at rest; (iii) sensors can become partially detached
resulting in poor contact. Therefore, data pre-processing is important to ensure that the data
are representative of a patient’s underlying physiological state. The second stage, assessing the
likelihood of deterioration, usually involves using a novelty detection technique to compare a set
of wearable sensor data to a model of normal physiology (physiology in the absence of adverse
clinical events). The third stage, generating alerts of deteriorations, consists of comparing time
series of likelihoods of deterioration to a set of criteria to determine whether a new alert should
be raised, or in the case of an ongoing alert, whether it should be stopped. Each stage of the
algorithm is important in ensuring that alerts of deteriorations are as useful as possible.
The algorithms used to detect deteriorations in this study are now described.
8.2.1 Data Pre-Processing
The first pre-processing step was to filter the HR, SpO2 and RR parameters to eliminate short-
term variability, and produce more stable values from which the likelihood of deterioration could
be assessed. Some short-term variability was evident in the LISTEN Processed Dataset, despite
the prior use of signal quality indices to eliminate any parameters derived from low quality
signals (see Section 3.3). An example of this is shown in Figure 8.2 (where crosses indicate the
raw 1 Hz measurements). Median filtering appears to be a reasonable technique for eliminating
short-term variability from wearable sensor data since it has been widely used to attenuate
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Figure 8.2: Pre-processing of wearable sensor data using a median filter: the raw HR, RR and
SpO2 measurements at 1 Hz were median-filtered to produce filtered values once per minute.
Raw values at 1 Hz are shown by crosses, and median-filtered values are shown by large dots. In
this example HR values were available during each minute of monitoring, and therefore a median-
filtered value was calculated for each minute. Median-filtered RR values were calculated for all
minutes except those finishing at 300 and 480 s, in which there were no raw values available.
Raw SpO2 values were only available for two windows, resulting in only two median-filtered
values.
high frequency noise from physiological time series [351–353], including as a pre-processing step
prior to detection of deteriorations [354]. Median filters have the advantage of retaining edges
in a signal which are indicative of a sustained change in physiological state [351]. Therefore,
the parameters (originally sampled at 1 Hz) were median-filtered to provide filtered values once
per minute (using a filter window duration of one minute), as shown in Figure 8.2 (large dots
indicate filtered values). The benefit of median-filtering is demonstrated by the raw SpO2 values
between 180 and 240 s in this figure, which ranged from 94 - 97 % over the course of only one
minute. The use of median-filtering across this window eliminated the short-term variability.
Without this step the high level of variability in the raw values could result in variability in the
assessed risk of deterioration over a short period of time, potentially causing false alerts.
The second pre-processing step was to generate a complete set of data at each time point with
which to assess the likelihood of deterioration. The five routinely measured vital signs (HR,
SpO2, RR, systolic blood pressure - SBP, and temperature - temp) were used, as well as a
binary variable indicating whether or not supplemental oxygen was being administered (O2).
There were gaps in the HR, SpO2 and RR data at times when these parameters were either not
acquired, or were of low quality. Furthermore, SBP, temp and O2 were only acquired during
intermittent, manual measurements as they were not monitored by the wearable sensors. A
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sample-and-hold algorithm was used to impute the most recent measurement at time points
when a parameter was not measured. This provided a complete set of parameters, from which
the likelihood of deterioration could be assessed at all time points.
8.2.2 Assessing the Likelihood of Deterioration
Novelty detection algorithms have previously been used to assess the likelihood of deterioration
from wearable sensor data [348]. They are particularly suitable for detection of deteriorations
since they can be trained using normal physiological data, which is easier to acquire since most
patients do not suffer from major adverse events. In contrast, it is relatively difficult to ac-
quire the abnormal physiological data which would be required for two-class classification [355].
Novelty detection algorithms used with wearable sensors take one of three broad approaches:
(i) comparison of a single-parameter to a threshold indicating abnormality [85]; (ii) continu-
ously updating a traditional EWS using wearable sensor data [114]; and, (iii) a more complex
novelty detection algorithm requiring electronic calculation, such as kernel density estimation
(KDE), support vector machines, Gaussian processes and Gaussian mixture models [348]. The
first approach, that of using a single parameter in isolation, is not considered in this work since
deteriorations are expected to be manifested across multiple parameters [44]. Commercially
available implementations of the latter two approaches have been described in Section 2.5.2.
The implementations of these approaches used in this study are now described.
8.2.2.1 Abbreviated Early Warning Scoring
The first algorithm used to assess the likelihood of deterioration was a continuous implemen-
tation of the National Early Warning Score (NEWS, described in Section 2.2). The NEWS is
used in the UK to detect deteriorations from intermittent physiological measurements [28]. It
is calculated from seven intermittently measured vital signs (see Table 2.1 for further details):
HR, RR, SpO2, systolic blood pressure (SBP), temperature (temp), oxygen therapy (O2) and
level of consciousness (LOC). In this study NEWSa, an abbreviated version of the NEWS, was
used to assess the likelihood of deterioration. The NEWS was abbreviated by removing the need
for LOC, since this parameter was not acquired in the Listen Trial. This means that NEWSa is
an underestimate since any potential contribution to the likelihood of deterioration from LOC
is omitted.
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Figure 8.3: The benefit of NEWSai, an interpolated National Early Warning Score (NEWS):
Wearable sensor data is subject to variability due to its high sampling frequency. The NEWS
is a step function of the input parameters, as shown in the background of (a). Therefore, a
small fluctuation in RR, perhaps of only 1 bpm as shown in (a), causes an unreasonably large
fluctuation in the NEWS as shown in (b). This may cause false alerts. In contrast, when a
continuous function such as NEWSai is used as shown in (c), small changes in RR only result
in small changes in the contribution to NEWSai. This may reduce the frequency of false alerts
compared to a step function.
8.2.2.2 Interpolated Early Warning Scoring
The second algorithm, NEWSai, was a further modification of the NEWS, designed specifically
for use with wearable sensor data. The NEWSa algorithm was interpolated to provide a con-
tinuous output rather than a quantised output. The NEWS algorithm assigns an integer score
to each vital sign, and the overall score is obtained by summing the integer scores for each vital
sign. For instance, a score of 0 is assigned to the RR if 12 ≤ RR ≤ 20 bpm, and a score of 2 if
21 ≤ RR ≤ 24 bpm. However, if the vital sign value happens to lie close to a scoring threshold
then natural variability in physiology will cause unreasonably large fluctuations in the NEWS.
For instance, if a patient’s RR is approximately 20 bpm, then every time the RR rises to 21 bpm
the NEWS will increase by 2, as demonstrated in Figure 8.3 (a) and (b). This gives the mis-
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leading impression of a marked increase in the likelihood of deterioration for a relatively small
physiological change. Each vital sign’s contribution to NEWSai was calculated using a linear
interpolation of the algorithm’s current integer contributions to avoid these large fluctuations.
The application of this approach to calculating the contribution of RR to the overall score can
be seen in the background of Figure 8.3 (c) and (d).
8.2.2.3 Kernel Density Estimation
The third algorithm, KDE, calculated the level of abnormality (termed novelty) of a set of
physiological parameters (a pattern) through comparison with a model of normal physiology.
To do so a training dataset of normal physiology was extracted from the LISTEN dataset. The
likelihood of deterioration was assessed in four steps: (i) the training dataset was normalised so
that each parameter had zero mean and unit standard deviation; (ii) the dataset was reduced
to a smaller set of representative features for ease of computation; (iii) a model of normality
was constructed from the smaller set of features using KDE; (iv) the model of normality was
used to evaluate the novelty of a set of physiological parameters. The methodology used for
each step is now explained. Further information on the approach can be found in [354, 356].
The first step was to normalise each parameter in the training dataset to have zero mean and





where xn is the normalised value of measurement x, and µg and σg are the mean and standard
deviation of the parameter in the training data. The parameters were normalised in preparation
for the use of KDE later in the procedure, in which a single variance was assumed to describe
the deviation of all the input parameters from their means. Extremely abnormal patterns were
identified as those which contained a value > 5σg. These patterns were excluded from the
training dataset to avoid including highly imprecise measurements.
The second step was to reduce the normalised training dataset to a smaller set of representative
patterns. This was necessary because the computational cost of comparing an incoming pattern
to all the individual patterns in the training dataset would be overly high. The patterns in the
dataset were grouped into k = 500 clusters as suggested in [354, 356, 357]. This was performed
using the k-means++ algorithm, which identifies k central patterns, attempting to minimise the
squared distance between each original pattern and its closest centre [358]. Outlying clusters




















Figure 8.4: Using kernel density estimation (KDE) to estimate the probability density function
(PDF) of a multivariate dataset: An estimated PDF, p(x), is shown, where the two-dimensional
feature vector x consists of HR and RR. The five-dimensional model of normal physiology
estimated using KDE in this study also contained SpO2, SBP and temp.
were excluded to retain only the most normal clusters as suggested in [354, 356, 357]. The
exclusion of outlying clusters is intended to ensure that transient departures from normality
exhibited by normal patients are not included in the model. A total of 15 % of clusters were
excluded in line with [354], leaving 425 clusters. Two methods have been used in this field for
identifying outlying clusters for exclusion: clusters can be ranked according to their distance
from the mean, and those furthest from the mean excluded [354]; or, clusters can be ranked
according to their weights (numbers of patterns allocated to each cluster), and those with the
lowest weights excluded. The weighted method was used in this study because it was found to
provide superior performance in [359].
The third step was to construct a model of normality using KDE. The Parzen window kernel
density method was used [360] to estimate the probability density function (PDF), p(x), of the
training dataset, where x is a pattern at a single time point. An example is shown in Figure
8.4. The Parzen window method consists of locating a Gaussian kernel at each of the cluster
centres. p(x) is then estimated by evaluating the sum of the contributions of each kernel to the













where N is the number of clusters used to represent the training dataset, D is the number of
Chapter 8. Detecting Deteriorations using Wearable Sensors 171
dimensions in the dataset, wi is the cluster weight (wi = ni/
N∑
i=1
ni, where ni is the number of
patterns associated with a cluster) and σ is the bandwidth (standard deviation) of the isotropic
kernels. It is important to select an appropriate value for σ, which acts as a smoothing function,
since too small a value will result in overfitting the training data, and too large a value will not
capture local variation [357]. Several methods have been proposed to select an appropriate value
of σ [357, 359]. In this work the optimal value of σ was selected by maximising the log-likelihood
of the training patterns (for 0.02 ≤ σ ≤ 1.00). This method for optimising σ was used as it
has previously been shown to perform well in a comparison of different methods across several
datasets [359].
The final step was to use the model of normality to evaluate the novelty (level of abnormality)




= −logep(x) , (8.3)
which increases as p(x) decreases. An increase of 1 in the novelty compared to the previous
value indicates that the current p(x) is e times smaller than the previous value. The novelty
score is offset so that the maximum of p(x) results in a novelty of approximately zero. This was
performed by calculating the novelty at x = [0, 0, 0, 0, 0], as suggested in [354]. This value was
then subtracted from all novelty calculations.
8.2.3 Generating Alerts
Techniques for generating alerts from estimated likelihoods of deterioration have received rela-
tively little attention in the literature. The simplest method is to generate an alert every time
the likelihood breaches a pre-defined threshold. However, this method can result in excessive
activation and deactivation of alerts due to natural variation in physiology. A more advanced
method was proposed in [354] for use with static patient monitors to activate and deactivate
alerts in an attempt to reduce the frequency of false alerts. This consisted of activating an
alert only if the likelihood was above a threshold value for at least 80 % of the previous five
minutes’ data [115]. Similarly, an alert was only deactivated if the likelihood was below the
threshold for at least 80 % of the previous five minutes’ data. This method has since been
used in a clinical study [361]. The benefits of this more advanced method are illustrated in
Figure 8.5. This shows the use of each of the methods to generate alerts for a patient’s entire
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Figure 8.5: A comparison of methods for generating alerts of deteriorations from wearable
sensor data: The results of two different methods for generating alerts are shown, where red dots
indicate an alert. In the upper plot an alert was activated when the likelihood of deterioration,
NEWSai, was greater than a threshold value (5 in this case). In the lower plot an alert was
activated if at least 80 % of the NEWSai values in the last 30 minutes were greater than 5, and
only deactivated when at least 80 % of the NEWSai values in the last 30 minutes were less than
5.
duration of wearable sensor monitoring (3.1 days). The simple method raised alerts throughout
the duration of monitoring, until discharge from hospital, despite the patient not suffering from
any adverse events. In contrast, the more advanced method only generated alerts in the first
half day of monitoring, when physiology is more likely to be unstable [51]. Thereafter the false
alerts caused by transient changes in physiology were suppressed by the advanced method.
8.3 Methods
8.3.1 Respiratory Rate Estimation
RRs were estimated retrospectively from the ECG signals in the LISTEN Processed Dataset
using the algorithm proposed and assessed in Chapter 7 (at 1 Hz using 32 s windows). Figure
8.6 shows an example of RRs estimated from the ECG, alongside those acquired simultaneously
as part of routine monitoring using impedance pneumography (ImP) in critical care. The
performance of the RR algorithm on this particular dataset is currently being assessed by clinical
collaborators using the RRest-acute, RRest-afib and RRest-vent datasets described in Section
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Figure 8.6: RRs estimated retrospectively from the ECG signals in the LISTEN Processed
Dataset (shown in black), alongside those acquired during routine critical care monitoring using
impedance pneumography (ImP, shown in red). The RRs shown have been median-filtered to
produce (at most) one estimate per minute.
Time [s]






Figure 8.7: An ECG signal on which the RR algorithm did not perform well. In this case, the
suboptimal performance may have been caused by abnormal ECG morphology, resulting in a re-
duction of the quality of respiratory signals extracted from the ECG using feature measurement
techniques.
4.6.1. Preliminary results showed high performance. However, the algorithm was not flawless,
with poorer performance seen in unusual situations such as with the ECG signal shown in
Figure 8.7, which exhibits abnormal morphology. The abnormal morphology may have resulted
in reduced quality of respiratory signals extracted from the ECG using feature measurement
techniques, leading to imprecise RR estimates.
8.3.2 Patient Classification
The LISTEN Processed Dataset contains data from 226 acutely-ill hospitalised patients recov-
ering from cardiac surgery (see Section 3.4 for further details). Only the 184 patients who had
wearable sensor data available after median-filtering were included in this study. Patients were
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readmission to critical care, death, cardiac arrest, unplanned return to
surgery, ‘do not resuscitate’ order
Adverse Event
(AE)
stroke or transient ischaemic attack, seizure, reintubation, pneumoth-
orax, ischaemic ECG changes, insertion of pleural drain or aspiration,
insertion of other drain, commencement of inotropes or intra-aortic bal-
loon pump, deep wound infection, cardiac failure, bowel obstruction,
bleeding, sepsis, acute myocardial infarction, altered mental state, acute
kidney injury, atrial fibrillation requiring treatment, non-invasive ven-
tilation or continuous positive airways pressure ventilation, unplanned
cardiac pacing or DC cardioversion, ventricular tachycardia, torsade de
pointes, transient loss of consciousness
226 patients in LISTEN 
Processed Dataset 
184 patients included 
42 patients excluded 
no wearable sensor data 
11 abnormal patients 
SAE on ambulatory ward 
125 normal patients 
included in training 
dataset 
no SAEs prior to 
ambulatory ward 
37 moderate patients 
AE on ambulatory ward 
136 normal patients 
no AEs or SAEs on 
ambulatory ward 
11 normal patients 
excluded from training 
dataset 
SAE prior to ambulatory 
ward 
Figure 8.8: Flow of patients through the study
divided into three categories: (i) normal (did not experience an adverse event - AE - on the am-
bulatory ward); (ii) moderate (experienced an AE on the ambulatory ward); and, (iii) abnormal
(experienced a severe adverse event - SAE - on the ambulatory ward). Table 8.1 lists the events
which were considered to be AEs and SAEs. Figure 8.8 shows the numbers of patients assigned
to each category.
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Figure 8.9: The number of patterns contributed by each patient to the training dataset: the
number of patterns per patient was limited to 725, the median number available per patient.
Therefore, 62 patients contributed < 725 patterns, whilst the remainder each contributed 725
patterns.
8.3.3 Extracting a Training Dataset
A training dataset of normal physiology was extracted from the LISTEN Processed Dataset.
Only normal patients were considered for inclusion in the training dataset. Those which expe-
rienced a SAE prior to admission to the ambulatory ward were excluded since any physiological
derangement caused by the SAE could have remained during wearable sensor monitoring. Con-
sequently, 125 normal patients were included in the training dataset (see Figure 8.8).
Many patterns were available from each patient since wearable sensor data were typically ac-
quired for several days, sampled once per minute after median-filtering. Patterns were only
included in the analysis if measurements of HR, SpO2 and RR had been acquired by a wearable
sensor during the minute from which a pattern was generated. Furthermore, the number of
patterns contributed by any individual patient was limited to the median number of patterns
available from each patient. This resulted in a median and maximum of 725 patterns per pa-
tient (see Figure 8.9). A subset of patterns were identified for each patient for whom more than
this number of patterns were available. This subset consisted of 725 patterns equally spaced
from the first to the last pattern of each patient’s recording. The resulting training dataset,
containing 6.1× 104 patterns, was balanced by ensuring that no individual patient contributed
an excessive number of patterns, and by ensuring that patterns were taken from throughout the
time for which wearable sensor data were acquired.
The distributions of individual parameters in the training dataset are shown in Figure 8.10. The
histograms of temp and RR show approximately normal distributions. SBP and HR exhibit
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Figure 8.10: Histograms of individual parameters in the training dataset. Ranges shaded grey
show values deemed to be normal according to the NEWS.
positive skews, and SpO2 exhibits a large negative skew (as expected since SpO2 cannot exceed
100 %). Normal ranges of values at rest, shaded in grey, are those which score 0 in the NEWS,
indicating minimal likelihood of deterioration (see Table 2.1 for details). The histogram for temp
coincides well with the normal range. In contrast, a substantial proportion of the measurements
of the remaining parameters lie outside of their normal ranges. SBP and SpO2 tended to be
lower than normal, and RR and HR were slightly higher than normal. This may have been due
to: (i) the post-operative population, whose physiology may have been deranged by the major
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Table 8.2: Normalisation of physiological parameters.
Parameter mean, µg standard deviation, σg
HR [bpm] 79.1 13.4
RR [bpm] 20.0 5.7
SpO2 [%] 95.2 3.2
SBP [mmHg] 122.1 16.2
temp [◦C] 36.9 0.5
surgery only days before these measurements; and, (ii) HR, RR and SpO2 measurements being
acquired by wearable sensors in all conditions, rather than only at rest.
8.3.4 Algorithms to Detect Deteriorations
Three algorithms were implemented to detect deteriorations as described in Section 8.2. The
data steps for pre-processing and generating alerts were common to all three algorithms. The
algorithms differed in their methodology for assessing the likelihood of deterioration, using the
NEWSa, NEWSai and KDE approaches respectively. Details of the methods which are specific
to this study are now described.
The training dataset was normalised to create a model of normal physiology for the KDE
approach. The mean and standard deviation values calculated for each parameter are provided
in Table 8.2. Extremely abnormal patterns, accounting for 0.54 % of the training patterns, were
excluded to avoid including highly imprecise measurements. The majority of these patterns
(72.0 %) were abnormal because of extremely high RR measurements (> 48.5 bpm), which
are likely to be imprecise. The remaining patterns were excluded due to extremely low SpO2
measurements (18.9 %), extremely high SBP measurements (6.7 %), and extremely high HR
measurements (2.4 %). Following clustering of the data, the optimal bandwidth of the kernels
for use in the KDE was found to be σ = 0.34. The KDE novelty value at x = [0, 0, 0, 0, 0] was
4.77, which was subtracted from the novelty calculations when using the KDE approach.
The generalised methodology for generating alerts described in Section 8.2.3 was adapted for
use with wearable sensors in this study. An alert was activated (or deactivated) if a novelty
score had been calculated for at least 50 % of the previous 30 minutes’ data, and at least
80 % of the scores were greater than (or less than) the relevant threshold (e.g. kw,NEWSai for
the NEWSai algorithm, where subscript w indicates a threshold optimised for wearable sensor
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data). Optimal thresholds were identified as those which limited the frequency of false alerts to
a maximum of one per day, as suggested in [11].
8.3.5 Comparison to Routine Practice
Patients in the LISTEN dataset had routine, manual physiological assessments approximately
4 times per day (as reported in Table 3.6). Three early warning scores were calculated from
these intermittent data as benchmarks against which to compare the algorithms applied to
wearable sensor data. All three approaches used to assess the likelihood of deterioration with
wearable sensor data were also used with the intermittent data. When using intermittent data
an alert was raised immediately if the score breached an alerting threshold (e.g. ki,NEWSai for
the NEWSai algorithm, where subscript i indicates a threshold optimised for intermittent data).
Optimal thresholds were set in the manner as for the wearable sensor data.
8.3.6 Performance evaluation
To evaluate the performances of the six methods (three algorithms applied to wearable sensor
data, and three applied to intermittent data), data from each subject were segmented into
windows of one hour duration. Reference classifications for each window were assigned as follows.
Windows were classified as negative if they were not proceeded by an AE or a SAE. Windows
were classified as positive-AE, or positive-SAE, if the first AE, or the first SAE, following
admission to the ambulatory ward occurred within 48 hours of the start of the window. The
novelty scores in each window were classified as positive if the window contained an alert.
Performances were initially assessed using the area under the receiver-operator curve (AUROC)
statistic, since this has been widely used to assess the performance of algorithms to detect
deteriorations [11, 23, 45, 53, 130, 362]. The algorithm with the highest AUROC was selected
for further analysis. The performance of the selected algorithm was then assessed when using
the optimal threshold to generate alerts. The widely used sensitivity and specificity metrics were
reported to allow comparison with other algorithms from the literature. However, it has recently
been noted that the specificity is not highly informative in this setting, since physiological
deterioration has an extremely low prevalence [363]. Therefore, the positive predictive value
(PPV), and proportion of scores which alerted were also reported.
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Table 8.3: Data characteristics: The number of 1-hour windows classified as negative (those
which were not proceeded by an adverse event - AE or severe adverse event - SAE) and positive
(those which were proceeded by an AE or SAE within 48 hours).
Window classification, n (%)
Events Negative Positive
SAEs 17,872 (98.5) 263 (1.5)
AEs 17,872 (95.0) 935 (5.0)
Table 8.4: Performances of algorithms to detect deteriorations when applied to wearable
sensor data and to intermittent data, evaluated using the area under the receiver-operator
curve (AUROC).
AUROC











Table 8.3 shows the numbers of windows classified as negative and positive when evaluating the
performance of algorithms for detection of SAEs and AEs. There were low incidences of positive
windows, indicating windows within the 48 hours prior to an adverse event, when detecting both
SAEs (1.5 %) and AEs (5.0 %).
8.4.2 Algorithm Selection
Table 8.4 shows the performances of the three algorithms to detect deteriorations when applied
to wearable sensor and to intermittent data in turn. Performances are shown separately for
the detection of SAEs and AEs. Higher AUROC values, indicating improved performance,
were observed when detecting SAEs compared to AEs. This is to be expected since SAEs
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Figure 8.11: Receiver-operator curves for the NEWSai algorithm when detecting severe ad-
verse events (SAEs, left hand plot) or adverse events (AEs, right hand plot), using wearable
sensor data (shown in red) or intermittent data (blue). Performances at the optimal thresholds
are shown by dots (optimal thresholds were found as described in Section 8.4.3).
are likely to result in a greater level of physiological abnormality. When detecting SAEs, the
AUROCs of the NEWSa and NEWSai algorithms were similar regardless of whether wearable
sensor data or intermittent data were used. This suggests that the wearable sensor parameters,
including the continuous RR estimates, were sufficiently precisely measured to maintain the
performances of the algorithms between intermittent measurements. When detecting AEs, the
AUROCs of the NEWSa and NEWSai algorithms were higher when using wearable sensor data
than when using intermittent data. This suggests that wearable sensors may have utility for
improving the detection of less severe deteriorations in ambulatory patients. The AUROCs of
the KDE algorithm were higher when applied to wearable sensor data than when applied to
intermittent data, which is to be expected since the KDE algorithm was trained using a model
of normality extracted from the wearable sensor data. The NEWSai consistently provided the
best performance when detecting both SAEs and AEs. Therefore, it was chosen as the most
suitable algorithm for use in the remainder of the study. The receiver-operator curves for this
algorithm when applied to wearable sensor and to intermittent data are shown in Figure 8.11.
The ROCs were similar when using intermittent data or wearable sensor data.
8.4.3 Performance Assessment
Figures 8.12 and 8.13 show how the PPV and the alert rate of the algorithm varied at different
candidate alert thresholds. Both the PPVs and the alert rates were similar between applying
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Figure 8.12: The PPV of the NEWSai algorithm across the range of candidate thresholds.
Performances are shown for detection of SAEs (left hand plot) and AEs (right). Performances
at the optimal thresholds are shown by dots.
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Figure 8.13: The proportion of windows which contained NEWSai alerts across the range of
candidate thresholds.
the algorithm to intermittent or wearable sensor data. This supports the observation that the
continuous input data to the algorithm provided by wearable sensors were sufficiently precise to
maintain algorithmic performance between intermittent observations. There is a clear compro-
mise between different aspects of algorithmic performance when selecting an alerting threshold.
Increasing the sensitivity of the algorithm (which increases the proportion of deteriorations de-
tected) reduces the algorithm’s specificity (Figure 8.11), decreases its PPV, and increases the
alert rate.
Optimal alerting thresholds were selected for the algorithm when using wearable sensor data
(kw,NEWSai) and intermittent data (ki,NEWSai) by limiting the frequency of false alerts to one
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Figure 8.14: The frequency of false alerts when using the NEWSai algorithm across the range
of candidate thresholds.
Table 8.5: The performance of the NEWSai algorithm when applied to wearable sensor data
and to intermittent data
Wearable sensor data Intermittent data
Performance metric SAEs AEs SAEs AEs
Sensitivity [%] 41.9 29.1 75.0 57.5
Specificity [%] 93.0 93.0 73.4 72.4
PPV [%] 8.0 21.5 4.7 9.9
Proportion of windows containing alerts [%] 7.4 8.3 27.4 29.1
Frequency of false alerts [per day] 1.0 1.0 1.0 1.0
per day. Figure 8.14 shows how the frequency of false alerts varied at different thresholds. The
optimal threshold for use with wearable sensor data was found to be kw,NEWSai = 6.3 when
detecting both SAEs and AEs, and the optimal threshold for use with intermittent data was
ki,NEWSai = 3.0. The performances of the algorithm when using these thresholds are indicated
by the dots on each figure, and are summarised in Table 8.5. The threshold selected for use with
wearable sensor data was more stringent (requiring a greater level of physiological abnormality)
than that for use with intermittent data. This was because intermittent data were acquired less
frequently, and so a less stringent threshold could be used and still result in the same frequency
of false alerts per day. Consequently, the algorithm had a lower sensitivity when using wearable
sensor data compared to intermittent data (e.g. 41.9 % compared to 75.0 % when detecting
SAEs), indicating that a lower proportion of deteriorations were detected. However, the PPV of
the algorithm when using wearable sensor data was approximately twice as high as when using
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intermittent data.
8.4.4 Case Studies
Four case studies are now presented demonstrating the utility of the NEWSai algorithm. Each
case study is accompanied by a plot of the NEWSai score and the physiological parameters
continuously monitored by wearable sensors. In these figures wearable sensor measurements
are shown by small dots, and intermittent measurements by large dots. AEs and SAEs are
annotated. Alerting NEWSai scores are shown in red, and non-alerting scores in green.
The first case study is of a normal patient’s recovery on the ambulatory ward, shown in Figure
8.15. The patient arrived on the ambulatory ward two days into their recovery from surgery. The
NEWSai algorithm did not alert at all throughout their stay when calculated using intermittent
data. When calculated using wearable sensor data, it alerted briefly at the time of 3 hours.
This was classified as a false alert in the above analysis, since it was not followed by an AE
or SAE. It was caused by a rapid desaturation, accompanied by an increase in HR. The low
SpO2 measurement was quickly assessed by ward staff (as shown by the large dot indicating
a manual measurement), and supplementary oxygen administered. The SpO2 and HR values
quickly returned to normal, and the NEWSai score dropped to zero. Despite being classified
as a false alert, this alert would have been clinically useful (prompting the administration of
supplementary oxygen). For the next three days the algorithm did not alert, and the patient
was discharged from hospital after a relatively short length of stay of 5.1 days, indicating a
quick recovery. Throughout the monitoring period the continuous RR estimates agreed closely
with the intermittent manual observations.
The second case study is of a 24 hour period of wearable sensor monitoring taken from an
abnormal patient’s recovery. The 24 hour period, shown in Figure 8.16, culminated in three
SAEs in quick succession: a cardiac arrest, an unplanned return to surgery, and readmission to
critical care. The NEWSai algorithm alerted consistently throughout the first 12 hours, even
though both the HR and SpO2 measurements were within normal ranges. The alerts were in
part caused by the continuous RR estimates being elevated at approximately 30 bpm. Whilst
the intermittent HR and SpO2 values during this period agreed closely with the corresponding
wearable sensor measurements, the intermittent RR values were markedly different. Whereas
the continuous RR estimates were elevated, resulting in continuous NEWSai scores of approxi-
mately 7, the intermittent RR measurements were within the normal range, resulting in lower
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Figure 8.15: Case study of a normal patient’s recovery on the ambulatory ward: This figure
shows the continuous NEWSai, RR, HR and SpO2 measurements derived from wearable sensor
data (small dots), and the corresponding measurements derived from intermittent data (large
dots). The NEWSai algorithm alerted only once (as indicated by red, rather than green dots),
at a time of 3 hours, indicating the need for supplementary oxygen. The patient made a quick
recovery and was discharged from hospital after 72 hours on the ambulatory ward.
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Figure 8.16: Case study of a 24 hour period culminating in a cardiac arrest, return to surgery
and readmission to critical care. The NEWSai algorithm alerted consistently throughout the
first 12 hours, caused in part by elevated RR estimates of 30 bpm, indicating a high level of
physiological abnormality. Approximately 8 hours later the patient suffered a cardiac arrest.
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intermittent NEWSai scores of approximately 4. Therefore, the level of physiological abnormal-
ity exhibited by the patient may not have been fully recognised by ward staff. In the second
half of the recording the RRs returned to normal (approximately 20 bpm). The parameters no
longer indicated a high likelihood of deterioration, and the algorithm stopped alerting. Despite
this, the patient suffered a cardiac arrest only hours after the NEWSai alerts. This was followed
by a prolonged hospital stay, including over two weeks in critical care and a further month on
the ambulatory ward.
The first two case studies were both of male patients between 60 and 70 years of age, undergoing
combined coronary artery bypass graft (CABG) and heart valve operations. In contrast, the
third case study, shown in Figure 8.17, concerns the ambulatory ward stay of a male patient
between 40 and 50 years of age, a relatively young patient. The NEWSai algorithm alerted con-
sistently throughout this patient’s stay, both when calculated using intermittent and wearable
sensor data. The patient experienced an AE after 13 hours in the ambulatory ward: paroxysmal
atrial fibrillation (AFib). Although this is common amongst patients recovering from cardiac
surgery, in this instance it was accompanied by a drop in SBP from 123 to 99 mmHg. The
patient’s cardiovascular state was poor, with a variable cardiac output caused by the AFib, and
a low blood pressure. In addition, the continuous RR estimates were frequently elevated to
highly abnormal levels. This was reflected in extremely high NEWSai scores of over 10. The
NEWSai scores dropped to approximately 8 upon the cessation of AFib at 22 hours. However,
in the following hours the SBP remained as low as 78 mmHg, and the SpO2 was as low as
90 % despite receiving supplementary oxygen. After two days of consistent NEWSai alerts, the
patient was returned to surgery and readmitted to critical care. The patient died only three
days later.
The fourth case study provides an example of when the NEWSai performed poorly, providing
many false alerts despite the patient recovering well and being discharged after an uneventful
hospital stay. Figure 8.18 shows the patient’s data from throughout their post-operative stay,
both in critical care (initial three days) and on the ambulatory ward (subsequent four days).
The NEWSai algorithm generated many false alerts between 3 and 6 days, despite the patient
not suffering from adverse events, and having a typical length of stay of 6.9 days (the median
length of stay was 7.0 days, as noted in Table 3.1). The algorithm generated false alerts when
calculated using either intermittent data, or the combination of intermittent and wearable sensor
data, indicating that these false alerts were due to poor algorithmic performance rather than
unreliable wearable sensor data. The patient exhibited slightly deranged physiology during the
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Figure 8.17: Case study of an abnormal patient’s recovery on the ambulatory ward: The
NEWSai algorithm alerted consistently for over two days, culminating in the patient returning
for surgery, and being readmitted to critical care. The patient died only 72 hours later.
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Figure 8.18: Case study of a normal patient’s recovery with many false alerts: in which the
NEWSai algorithm provided many false alerts: This plot shows data from a patient’s entire
post-operative stay, in critical care wards for the first three days, followed by monitoring using
a wearable sensor on the ambulatory ward for the latter four days. The NEWSai algorithm
alerted for much of the first three days on the ambulatory ward, despite the patient recovering
well and being discharged from hospital approximately one week after their operation.
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period of false alerts of : HR ≈ 100 bpm, SpO2 ≈ 94 %, SBP ≈ 107 mmHg, intermittent RR
≈ 18 bpm, and continuous RR ≈ 23 bpm. In this case study of a patient classified as normal,
slightly deranged physiology across multiple parameters resulted in elevated NEWSai scores and
alerts.
8.5 Discussion
This study demonstrated the feasibility of detecting deteriorations using multi-parametric wear-
able sensors, coupled with an algorithm to estimate RR continuously from the ECG. The algo-
rithm used to detect deteriorations was a modified version of the NEWS in which the scoring
system was interpolated to avoid the quantised outputs provided by the standard NEWS. This
algorithm acted on three median-filtered parameters (HR, SpO2 and RR), sampled once per
minute, and three intermittent parameters acquired intermittently by hand (SBP, temp and
O2). Alerts were generated if the algorithm’s output consistently breached a threshold indi-
cating increased likelihood of deterioration. The algorithm exhibited similar performance when
applied to both wearable sensor and intermittent data, demonstrating the feasibility of using
unverified wearable sensor data to detect deteriorations. However, as the algorithm provided
more frequent assessments of the likelihood of deterioration when applied to wearable sensor
data, the frequency of false alerts at any particular alerting threshold was increased. Conse-
quently, the threshold had to be set at a much higher value when using wearable sensor data
compared to intermittent data to maintain a clinically manageable false alert rate. As a result
the sensitivities of the algorithm when applied to wearable sensor data were 41.9 and 29.1 %
for detection of SAEs and AEs respectively, indicating that a large proportion of deteriorations
were not identified. This suggests that further work is required to improve the performance of
algorithms to detect deteriorations from wearable sensor data before they can be expected to
be clinically beneficial.
Several studies have previously evaluated multi-parametric wearable sensors for continuous mon-
itoring of hospital patients [33, 66, 75, 77, 84–91, 91, 92] (see Table 2.4 for details). However,
few studies have investigated the utility of multi-parametric wearable sensor data for detection
of deteriorations. The evidence provided by this study suggests that early warning scores can
be continuously updated using the unverified data provided by wearable sensors, with no loss in
performance. This is notable since wearable sensor data are vulnerable to imprecise measure-
ments, and measurements which are not representative of the patient’s physiological status at
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rest (as described in Section 8.2). The use of signal quality assessment algorithms and median-
filtering to clean data ensured that the algorithm’s performance was maintained between the
intermittent manual measurements. In the future this may confer two potential clinical benefits
(as described in Section 2.3). Firstly, it may be possible to provide early warning of SAEs
and AEs using wearable sensors, since they may detect changes in physiology in-between rou-
tine manual assessments. Secondly, it may be possible to reduce the workload associated with
manual assessments by reducing their frequency at times when the continuously updated early
warning score remains low.
In this study the NEWSai algorithm did not perform sufficiently well to expect that the poten-
tial benefits of wearable sensors for detection of deteriorations could be realised without further
algorithmic development. Its AUROC for detection of AEs (0.780 for wearable sensor data,
and 0.794 for intermittent data) was lower than the value of 0.873 reported previously [45].
There are several possible reasons for this impaired performance. Firstly, the normal patients
in this dataset exhibited abnormal physiology (see Figure 8.10), which may have impaired the
algorithm’s ability to distinguish between normal and abnormal patients. Secondly, the dataset
used in this study did not contain LOC, which has previously been shown to be a valuable pre-
dictor of in-hospital mortality [331]. Thirdly, this study used data from the narrow population
of patients recovering from cardiac surgery, and this population may not be representative of all
acutely-ill patients. For instance, it suffers from a high incidence of paroxysmal AFib [364]. It
may be necessary to refine algorithms to detect deteriorations prior to using them continuously
with wearable sensor data. Potential refinements include: (i) the use of additional variables
commonly recorded in electronic health records (EHRs), such as demographics, laboratory test
results, and co-morbidities [11, 23, 121, 130]; (ii) the use of alternative machine learning tech-
niques such as tree-based models, support vector machines, logistic regression and Gaussian
processes [348, 365]; and, (iii) the use of vital sign trends to identify trajectories of deterioration
[366, 367].
In this study three algorithms were used to assess the likelihood of deterioration, with the
NEWSai providing superior performance over the NEWSa and KDE algorithms. This may
have been because the interpolated score calculation reduced the frequency of false alerts, or
because the calculation more precisely evaluates the abnormality of each vital sign, increasing the
precision of the assessed likelihood of deterioration. Surprisingly, the KDE algorithm performed
less well than the others, despite its model of normality being constructed using training data
from the dataset. This may be because the training dataset was relatively small (6.1 × 104
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patterns), compared to the training dataset in the original development of the KDE algorithm
(2.3× 106 patterns) [354]. In addition, when using the KDE technique a single parameter (such
as an extremely abnormal HR of 140 bpm due to AFib) can contribute very strongly towards
the final score, whereas in the NEWSai model the contribution of any single parameter is always
limited to a score of three.
In this study RRs were estimated from the ECG signal using the novel algorithm presented in
Chapter 7. The performance of this algorithm has been assessed extensively using a range of
datasets acquired from both healthy and sick subjects (see Chapter 7). However, its performance
in the ambulatory setting has not yet been assessed. The second case study (Figure ??) demon-
strated the potential benefits of continuous RR monitoring, since the alerts preceding a cardiac
arrest in this example were greatly contributed to by the high RR estimates. However, some
examples of poor performance were observed as described in Section 8.3.1. It has traditionally
been difficult to assess the performance of RR algorithms in the ambulatory setting, since it
is difficult to obtain a precise reference RR. However, recently developed wearable sensors can
acquire both ECG and impedance pneumography (ImP) signals. Such equipment could be used
to acquire a dataset with which to assess the algorithm in the ambulatory setting when used
with the novel ImP signal quality index presented in Section 4.6.2.
8.6 Final Remarks
This chapter has presented a study investigating the feasibility of using wearable sensor data
to continuously assess the likelihood of deterioration of acutely-ill, ambulatory patients. The
novel algorithm presented in Chapter 7 was used to continuously estimate RR from the ECG.
A modified version of the NEWS designed specifically for wearable sensor data was selected
to assess likelihood of deterioration. The algorithm was found to provide similar performance
when applied to wearable sensor data as when applied to intermittent data, suggesting that it is
feasible to use wearable sensors to continuously assess the likelihood of deterioration. However,
the use of wearable sensor data produced more frequent outputs, causing the rate of false alerts
per day to be increased in comparison to the use of intermittent data. This suggests that further
work is required to improve the performances of algorithms to detect deteriorations before they
can be expected to confer widespread clinical benefit when used with wearable sensors.
Chapter 9
Conclusion
This chapter concludes the thesis by presenting an overview of its achievements (Section 9.1),
and recommended directions for future research (Section 9.2).
9.1 Summary of Thesis Achievements
The aim of this thesis was to develop and assess the performance of techniques for continu-
ous respiratory rate (RR) monitoring using electrocardiogram (ECG) and photoplethysmogram
(PPG) signals for use in wearable sensors to detect deteriorations. Chapters 3 to 8 presented
investigations to address this aim. The achievements of the thesis are summarised as follows:
Chapter 3: Assembling a comprehensive physiological dataset using wearable
sensors
Chapter 3 presented the data processing conducted to assemble a comprehensive physiological
dataset suitable for the development of algorithms to detect deteriorations from wearable sensor
data. In the LISTEN Trial, data were collected from 226 patients during their recovery from
major cardiac surgery. Of these, 200 patients were provided with a wearable sensor, which was
worn for a median (lower - upper quartiles) of 3.7 (2.6 - 5.2) days. The data acquired in this
trial were processed to provide two datasets suitable for use in this thesis and in future research:
The LISTEN Prepared Dataset, and the LISTEN Processed Dataset. The LISTEN Prepared
Dataset is designed for a minority of investigations which require raw monitoring data, such
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as investigations into the efficacy of using wearable sensors to acquire data continuously from
ambulatory patients. The LISTEN Processed Dataset is more suitable for the development of
algorithms to detect deteriorations, since the continuous data have been quality assessed to
eliminate low quality measurements. The wearable sensor data consist of continuous electrocar-
diogram (ECG) and photoplethysmogram (PPG) signals, routinely acquired heart rate (HR)
and arterial blood oxygen saturation (SpO2) parameters, and additionally RR estimates derived
from the ECG using the algorithm presented in Chapter 7. In addition to wearable sensor data,
the datasets contain: (i) continuous monitoring data acquired using static bedside monitors in
critical care; (ii) intermittently measured physiological data (such as vital signs measurements
taken manually by ward staff), from which benchmark early warning scores (EWSs) can be
calculated; (iii) laboratory test results; (iv) end-points for training machine learning algorithms
(such as adverse events - AEs, and severe adverse events - SAEs); (v) fixed variables (such
as demographic data); and (vi) times of transfers between wards and levels of care. This is a
valuable resource since it contains wearable sensor data acquired for several days from a large
set of acutely-ill patients.
After describing the processes undertaken to assemble the datasets, the LISTEN Processed
Dataset was evaluated for the purposes of this thesis. It was observed that the data coverage
rate was higher for the ECG signal than for the PPG signal, which informed the decision to
estimate RRs continuously from the ECG signal.
Chapter 4: Identifying algorithms to estimate RR from the ECG and PPG
from the literature, and methods used to assess their performance, to create
a toolbox of resources for algorithm assessments
Chapter 4 presented a systematic review of algorithms to estimate RR from the ECG and
PPG, and the methods previously used to assess their performances. The findings of the review
informed the design of a toolbox of resources for assessments of RR algorithm performances.
The systematic review identified 140 publications describing RR algorithms for use with the
ECG or PPG, using both manual and electronic searches. A generalised structure of RR algo-
rithms was proposed, consisting of five algorithmic stages, and the use of any one of a number
of interchangeable techniques at each stage. A total of 49 previously proposed interchangeable
techniques were identified. Several aspects of algorithm assessment methodologies were com-
mon in the literature: (i) most assessments used window durations of between 30 and 90 s; (ii)
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only two publications compared the performances of > 15 algorithms (one of which arose from
this work [10]); (iii) the datasets used tended to include data from young and healthy adults,
with fewer assessments using data from elderly adults or patients, and only 5.7 % using data
from acutely-ill patients; (iv) eleven publicly available datasets have been used to assess RR
algorithms, although only one publication was identified which used more than two datasets;
(v) impedance pneumography (ImP) and air flow/pressure signals have been used most often
to obtain reference RRs, although the performance of algorithms to estimate reference RRs was
usually unknown; and, (vi) a range of statistics have been used to assess performance, with no
clear consensus as to the most appropriate approach.
The findings of the review were used to identify key areas for future research, which were then
addressed by designing a toolbox of resources to facilitate research into these areas. The three
directions identified for future research were: (i) to perform a comprehensive comparison of al-
gorithms; (ii) to assess their performance in acutely-ill patients; and (iii) to develop techniques
to ensure that reference RRs are reliable. Consequently, the toolbox contains three features
to address these research areas. Firstly, novel datasets were collated from clinical trial data,
which are being made publicly available. The datasets consist of: (i) synthetic data to ensure
algorithm implementations are reasonable; (ii) data from young healthy subjects to assess al-
gorithms in ideal conditions [10]; (iii) data from young and elderly healthy subjects to assess
the impact of age on algorithms; (iv) data from 108 acutely-ill hospitalised patients to assess
performance in this population; (v) a dataset to assess the impact of atrial fibrillation (AFib)
on algorithms; and (vi) a dataset to assess the impact of mechanical ventilation on algorithms.
Secondly, a novel signal quality index (SQI) for the ImP signal, which is commonly used to
estimate reference RRs. It was designed and validated using manual annotations of 1801 signal
segments from 34 patients across three clinical settings, and was shown to have high accuracy
and precision when used to estimate reference RRs. Thirdly, a toolbox of algorithms was created
using Matlab R©, containing 370 algorithms formed through combinations of 31 interchangeable
algorithmic techniques [10, 11].
Chapter 5: Assessing the influence of technical and physiological factors on
respiratory signals extracted from the ECG and PPG
Chapter 5 presented a study to assess the influence of technical and physiological factors on
the quality of respiratory signals extracted from the ECG and PPG, using the RRest-healthy
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dataset collated in Chapter 4. Quality was assessed using the correlation between an extracted
respiratory signal and a reference respiratory signal. A total of thirteen respiratory signals were
extracted from the ECG and PPG signals. The study primarily used data from 57 healthy
subjects, acquired in ideal conditions using multiple measurement devices. In addition, the
publicly available Fantasia dataset [302, 303] was used for external verification of a subset of
the results. The results informed recommendations regarding wearable sensor designs when
incorporating an algorithm to estimate RR from the ECG or PPG, and regarding potential
clinical applications.
The recommendations for wearable sensor design were: (i) the PPG should be measured at the
finger rather than the ear, in contrast to the findings of previous work which have suggested
using the ear [319], [322]; (ii) current clinical monitoring equipment can be used to acquire ECG
and PPG signals suitable for extraction of high quality respiratory signals; (iii) the ECG should
be used rather than the PPG for measuring respiratory signals when available; and, (iv) the
minimum recommended sampling frequencies for the ECG and PPG for extraction of respiratory
signals were 250 Hz and 16 Hz respectively. The recommendations regarding potential clinical
applications were as follows: (i) it may be helpful to avoid the use of respiratory signals which are
based on frequency modulation (FM) in elderly subjects (such as when using wearable sensors
to monitor acutely-ill patients); (ii) no evidence was found to suggest that gender influences the
quality of respiratory signals; (iii) the qualities of most respiratory signals were lower at higher
RRs, suggesting that RR algorithms may not be as precise at higher RRs. These findings will be
useful to equipment designers, and clinicians, for optimising the performance of RR algorithms
in wearable sensors.
Chapter 6: Assessing the performance of RR algorithms for the ECG and
PPG in healthy subjects and hospitalised patients
Chapter 6 presented a comprehensive assessment of the performances of RR algorithms in
healthy subjects and hospitalised patients, using the ImP SQI, and the toolbox of algorithms
designed in Chapter 4. Data from four datasets were used to ensure the generalisability of the
results, and a total of 95 RR algorithms were used to identify the most suitable algorithm for
use with wearable sensors. Algorithm performances were found to vary greatly between different
RR algorithms, and between datasets, both in healthy subjects and hospitalised patients. Key
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features of RR algorithms were identified which provide improved performance. In health, im-
proved performance was achieved using a time-domain RR estimation technique, and by using
a modulation fusion technique. The best-performing algorithms only performed sufficiently well
(in comparison to routine RR monitoring) when used with ECG signals in healthy subjects, sug-
gesting that none of the algorithms assessed performed well enough for use in wearable sensors
with acutely-ill patients. Key reasons for this were: frequency-domain RR estimation tech-
niques frequently underestimate RR substantially, and time-domain RR estimation techniques
generally have a lower level of precision when an algorithm performs well. This suggested that a
novel algorithm was required to estimate RR from the ECG or PPG for use in wearable sensors.
Chapter 7: Developing a novel algorithm for continuous RR monitoring
Chapter 7 presented a novel RR algorithm designed specifically to provide precise RR estimates
when using wearable sensors. It was designed to harness the strengths of both time- and
frequency-domain RR estimation techniques. A frequency-domain technique was initially used
to estimate RR, and if the RR estimate was greater than an empirical threshold then it was
accepted. However, if the RR estimate was less than the threshold then a time-domain technique
was also used, and a final estimate was only provided if the two estimates were in close agreement.
This was designed to exploit the high precision of frequency-domain RR estimation techniques,
whilst eliminating the underestimates provided by these techniques. In addition, the novel RR
algorithm was designed to only output RR estimates which were likely to be precise, in contrast
to many existing algorithms. The empirical thresholds used in the algorithm were optimised
using two datasets acquired from healthy subjects.
The performance of the novel RR algorithm was assessed using the same procedure as used in
Chapter 6, ensuring that the results were directly comparable to existing algorithms. It was
primarily assessed using data from 127 subjects in the MIMIC-II dataset [299, 303]. It was
found to perform well when using the ECG, providing RR estimates for 40 % of windows, with
95 % of absolute errors ≤ 3.2 breaths per minute (bpm). For comparison, the errors of the
best-performing algorithm assessed in Chapter 6 were ≤ 8.6 bpm. Furthermore, only 3.2 %
of the absolute errors were > 5.0 bpm, indicating a high level of clinical utility. However, the
algorithm did not perform well enough for use in wearable sensors when applied to the PPG
signal.
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Chapter 8: Assessing the potential utility of wearable sensors for detecting
deteriorations
Chapter 8 presented a study investigating the potential utility of wearable sensors for detect-
ing deteriorations. The study used the LISTEN Processed Dataset, presented in Chapter 3,
and the novel RR algorithm presented in Chapter 7. RRs were continuously estimated from
the ECG signals acquired from 184 patients using wearable sensors. Deteriorations were de-
tected using three algorithms: (i) an abbreviated National Early Warning Score (NEWSa), in
which level of consciousness was omitted from the routine scoring system; (ii) an interpolated
NEWS (NEWSai); (iii) and a kernel density estimation (KDE) algorithm trained using data
from normal LISTEN patients. Wearable sensor data were pre-processed using median-filtering
to eliminate short-term variability, and alerts of deteriorations were activated and deactivated
using empirically determined thresholds.
The NEWSai algorithm was found to provide the best performance, and provided similar perfor-
mance regardless of whether it was calculated using wearable sensor data, or routine intermittent
data. This demonstrated that it is feasible to continuously update EWSs using data from wear-
able sensors, including continuous RRs estimated from the ECG. However, the frequency of
false alerts per day was higher when using wearable sensor data since it is acquired continu-
ously. Therefore, a higher alerting threshold was required to maintain a clinically manageable
false alert rate when using wearable sensor data. Consequently, alerts of deteriorations were
raised in less than half of the windows which were followed by SAEs or AEs within 48 hours
(sensitivities of 41.9 % and 29.1 % respectively). Therefore, further work is required to improve
the performance of algorithms to detect deteriorations from wearable sensor data before they
can be expected to confer clinical benefit.
9.2 Future Work
Future research into the use of continuous RR monitoring in wearable sensors to detect clinical
deteriorations will encounter several technical challenges which must be overcome to ensure that
the full potential of wearable sensors is realised. These challenges are now discussed.
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9.2.1 Further assessment and development of RR algorithms
This thesis has presented one of the most comprehensive assessments of RR algorithms to date.
In Chapter 6 the performances of 95 algorithms were assessed using four datasets acquired
from both healthy and hospitalised patients. Despite this, further assessment and development
of RR algorithms may be required before they can be considered for widespread clinical use.
Further assessment of performance is required since performance may vary between different
patient populations. The datasets presented in Section 4.6.1 are currently being used by clinical
collaborators to assess the performance of RR algorithms in acutely-ill patients (RRest-acute
Dataset), and in patients with atrial fibrillation (AFib, RRest-afib Dataset). This is important
because acutely-ill patients will benefit most from the use of RR algorithms in wearable sensors,
and arrhythmias may adversely affect the performance of RR algorithms. However, relatively
few algorithm assessments have been conducted previously in these populations ([148, 155,
209, 238, 249, 261, 265] describe assessments using acutely-ill patients, and [273] describes an
assessment of the impact of AFib on performance). In particular, AFib may adversely affect
the quality of respiratory signals extracted from the ECG and PPG [253, 273]. In addition,
algorithm performance should be assessed in the intended setting for the algorithms: using
data acquired from ambulatory patients over prolonged time periods. This has previously been
difficult as it is challenging to acquire ECG or PPG signals alongside a reference respiratory
signal for a prolonged time period in this setting. However, it is now possible to acquire these
signals simultaneously from novel wearable sensors (see Section 8.5), providing opportunity to
assess performance in this setting using routinely acquired data.
Further development of RR algorithms may be beneficial to enable them to be applied to other
signals acquired by wearable sensors, such as accelerometer signals. Accelerometers are now
being incorporated into novel wearable sensors. It may be beneficial to estimate RR from
accelerometer signals either to provide a stand-alone estimate, or to fuse with estimates from
other signals such as the ECG [163] to improve performance. Crucially, accelerometers may
provide more precise RR estimates in the presence of cardiac arrhythmias. Previous research
into estimation of RR from accelerometers has suggested that it is feasible [107, 163, 368–370],
although further work is required to refine RR algorithms for use with accelerometers and to
assess their performance with acutely-ill patients.
Chapter 9. Conclusion 199
9.2.2 Improving algorithms to detect deteriorations
The conclusion of Chapter 8 was that further work is required to improve the performance of al-
gorithms to detect deteriorations from wearable sensor data to avoid excessively high alert rates.
There are at least three ways in which continuous, multi-parametric data provided by wearable
sensors could be used to improve the performance of algorithms to detect deteriorations:
1. Earlier identification of changes in physiology: The continuous data provided by
wearable sensors may provide earlier identification of changes in physiological state than
current intermittent measurements [3]. In addition, wearable sensor data may provide
early identification of movement towards a clinical state which is associated with a greater
risk of adverse events. Evidence based on intermittent measurements is emerging sug-
gesting that trends in parameters, rather than simply the absolute values, can be used
to improve models for detection of deteriorations [367, 371]. The power of this approach
may be greatly improved when using trend analysis algorithms with wearable sensor data,
such as those in [372].
2. Personalised alerting: The high sampling rate of wearable sensor data may facilitate
machine learning of personalised alert thresholds based on a quickly amassed historical
dataset for each patient [354]. In contrast, the low sampling rate of intermittent mea-
surements means it is not realistic to personalise alerting thresholds of EWSs. Therefore,
current EWSs do not account for the heterogeneity of individual patients physiologies and
disease progressions, and typically use the same alert thresholds for all patients.
3. Variability analysis: The continuous nature of wearable sensor data permits assess-
ment of physiological variability, which cannot be performed at the same resolution with
intermittent measurements. Variability analysis provides additional insight into the phys-
iological state, beyond that provided by the absolute values of physiological parameters
[373–376]. It can take two forms. Firstly, the variability of quasi-periodic phenomena,
such as beat-to-beat or breath-to-breath intervals can be analysed to obtain information
on autonomic function. For instance, heart rate variability (HRV) provides insight into
the sympathetic-parasympathetic balance [375]. Both decreased and increased variability
can be indicative of perturbations from health to disease states [374], and therefore offer
potential for early detection of deteriorations [377]. Changes in variability have been asso-
ciated with infection [378], sepsis [376], severity of illness and organ failure [379]. Secondly,
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the variability of physiological parameters, such as temperature, can provide insight into
physical activity or the maintenance of homeostasis.
9.2.3 Extraction of additional parameters from wearable sensor signals
The physiological signals monitored by wearable sensors contain a wealth of information on
cardiac, vascular and autonomic function. However, very little of this information is utilised
in wearable sensors at present. There is scope to facilitate more comprehensive physiological
assessments using wearable sensors by increasing the range of parameters extracted from these
signals. For instance, the ECG and PPG signals, considered in this thesis, contain information
on several physiological systems including the cardiac, vascular, autonomic and respiratory
systems. The ECG provides a rich source of information on the heart and autonomic nervous
system. Its morphology is largely determined by the electrical activity of the heart. It is
constructed of several waves and intervals, as illustrated in Figure 9.1. The PPG provides
information on the heart and the vascular and autonomic nervous systems. A typical waveform is
shown in Figure 9.2. When in sinus rhythm, beat-to-beat intervals of ECG and PPG waveforms
are controlled by the autonomic nervous system, and contain information on the balance between
sympathetic and parasympathetic activity [375]. Despite the wealth of physiological information
available in the ECG and PPG waveforms, usually only HR and SpO2 are extracted from them
by wearable sensors. There is scope to extract a range of additional physiological parameters
from the waveforms to facilitate more comprehensive physiological assessment using wearable
sensors.
To this end, waveform analysis has recently been incorporated into wearable sensors. One
wearable sensor now in clinical use provides measurements of ECG morphology which may be
indicative of myocardial ischaemia [83]. Other sensors used in research provide beat-to-beat
timings for HRV analyses [383]. In contrast, the PPG morphology is not currently used to
derive additional parameters.
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Figure 9.1: A typical electrocardiogram (ECG) waveform for one cardiac cycle [380]: The
P-wave indicates atrial depolarization, with atrial contraction beginning at the end of the P-
wave. The QRS complex indicates the onset of ventricular contraction. The T-wave indicates
ventricular repolarisation. The P-R interval is the time from the beginning of the P-wave to the
beginning of the QRS complex, approximately indicative of the time for an electrical impulse
to travel from the sino-atrial node to the atrioventricular node. The S-T segment is the time
from the S-wave to the beginning of the T-wave, indicative of ventricular contraction.
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Figure 9.2: A typical photoplethysmogram (PPG) waveform for one cardiac cycle: The wave-
form can be separated into anacrotic and catacrotic phases, which are dominated by systolic
ejection and wave reflections from the periphery respectively [381]. The systolic rising edge in
the anacrotic phase is caused by the expansion of the arterial system due to inflow of blood.
The rate of expansion is linked to the contractility of the heart, and the amplitude of the sys-
tolic peak is linked to the stroke volume. The dicrotic notch and diastolic peak are caused by
wave reflections, with their location and timing influenced by arterial stiffness [382]. The dias-
tolic decay is determined by the exponential contraction of the arterial system due to outflow
of blood. Its time constant, τ , is determined by the systemic vascular resistance, R, and the
arterial compliance, C.
Appendix: Additional Results
Some of the results in chapters 5 and 6 were summarised for ease of reading, rather than being
given in full. Additional results tables are now provided for completeness.
A.1 Results Relating to Chapter 5
Several comparisons were performed to assess the impact of technical and physiological factors
on the quality of respiratory signals extracted from the ECG and PPG in this chapter. The
following tables provide additional results for some of the comparisons:
• PPG measurement site: Table A.1 provides the results of comparisons between respi-
ratory signals extracted from finger and ear PPG signals (referenced in Section 5.4.1).
• Signal acquisition equipment: Table A.2 provides the results of comparisons between
respiratory signals exttracted from signals acquired using laboratory and clinical equip-
ment (referenced in Section 5.4.2).
• Feature- and filter-based techniques: Table A.3 provides the results of comparisons
between feature- and filter-based techniques for extraction of the three fundamental res-
piratory modulations (referenced in Section 5.4.3).
• Age: Tables A.4 and A.5 provide the results of comparisons between young and elderly
subjects performed on the RRest-healthy and Fantasia Datasets respectively (referenced
in Section 5.4.5).
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Table A.1: Comparison of qualities of respiratory signals acquired at finger and ear PPG
measurement sites: Subject-specific differences in correlation coefficients (CCs) of respiratory
signals extracted from finger (fin) and ear PPG signals are expressed as median (lower - upper
quartiles) Fin - Ear PPG CCs. Respiratory signals with significantly greater CCs are indicated
by a *.
Respiratory signal Subject-specific differences in CCs
XA1 (BW) 0.06 (-0.01 - 0.17) *Fin
XA2 (AM) -0.01 (-0.09 - 0.05)
XA3 (FM) 0.00 (-0.01 - 0.01)
XA4 (BW, AM, FM) 0.01 (-0.02 - 0.04)
XB1 (BW) 0.07 (0.01 - 0.19) *Fin
XB2 (AM) 0.03 (-0.03 - 0.14)
XB3 (FM) 0.11 (0.04 - 0.18) *Fin
XB4 (BW) 0.06 (0.00 - 0.14) *Fin
XB5 (BW, AM) 0.08 (-0.01 - 0.16) *Fin
XB6 (BW, AM) 0.08 (0.00 - 0.18) *Fin
XB9 (FM) 0.02 (-0.03 - 0.09)
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Table A.2: Comparison of qualities of respiratory signals acquired using laboratory and clinical
equipment: Subject-specific differences in correlation coefficients (CCs) of respiratory signals
extracted from clinical (clin) and laboratory (lab) equipment are expressed as median (lower -
upper quartiles). Respiratory signals with significantly greater CCs are indicated by a *.
Respiratory signal Subject-specific differences in CCs
ECG PPG
XA1 (BW) 0.01 (-0.05 - 0.10) 0.05 (-0.02 - 0.15) *Clin
XA2 (AM) 0.01 (-0.01 - 0.05) *Clin -0.02 (-0.07 - 0.03)
XA3 (FM) 0.00 (0.00 - 0.01) -0.01 (-0.04 - 0.00) *Lab
XA4 (BW, AM, FM) 0.02 (-0.05 - 0.04) 0.07 (0.03 - 0.11) *Clin
XB1 (BW) 0.04 (-0.01 - 0.13) *Clin 0.07 (-0.01 - 0.15) *Clin
XB2 (AM) 0.01 (-0.02 - 0.10) -0.09 (-0.16 - 0.01) *Lab
XB3 (FM) 0.00 (0.00 - 0.00) 0.02 (-0.01 - 0.07) *Clin
XB4 (BW) 0.02 (-0.03 - 0.11) 0.02 (-0.05 - 0.10)
XB5 (BW,AM) 0.04 (0.00 - 0.11) *Clin 0.01 (-0.08 - 0.12)
XB6 (BW,AM) 0.03 (-0.04 - 0.10) 0.14 (0.04 - 0.20) *Clin
XB7 (FM) 0.00 (-0.06 - 0.05) NA
XB8 (AM,FM) 0.01 (-0.06 - 0.08) NA
XB9 (FM) 0.01 (-0.03 - 0.09) 0.04 (-0.06 - 0.13)
Table A.3: Comparison of feature- and filter-based techniques for extraction of respiratory
signals: Subject-specific differences in correlation coefficients (CCs) of respiratory signals ex-
tracted using filter-based and feature-based techniques are expressed as median (lower - upper
quartiles) feature - filter-based CCs. Respiratory signals with significantly greater CCs are
indicated by a *.
Respiratory signals Subject-specific differences in CCs
ECG(XB1) - ECG(XA1) (BW) 0.04 (-0.05 - 0.17) *Feature-based
ECG(XB2) - ECG(XA2) (AM) 0.34 (0.15 - 0.50) *Feature-based
ECG(XB3) - ECG(XA3) (FM) 0.16 (0.06 - 0.21) *Feature-based
PPG(XB1) - PPG(XA1) (BW) 0.00 (-0.03 - 0.03)
PPG(XB2) - PPG(XA2) (AM) 0.06 (-0.01 - 0.11) *Feature-based
PPG(XB3) - PPG(XA3) (FM) 0.12 (0.05 - 0.18) *Feature-based
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Table A.4: Comparison of qualities of respiratory signals obtained from young and elderly
subjects in the RRest-healthy dataset: Subject-specific correlation coefficients (CCs) for young
and elderly subjects, expressed as median (lower - upper quartiles). Respiratory signals with





ECG(XA1) 0.52 (0.44 - 0.76) 0.60 (0.42 - 0.80)
ECG(XA2) 0.32 (0.23 - 0.58) 0.37 (0.30 - 0.53)
ECG(XA3) 0.43 (0.34 - 0.60) 0.31 (0.25 - 0.47)
ECG(XA4) 0.39 (0.31 - 0.45) 0.37 (0.32 - 0.41)
ECG(XB1) 0.66 (0.57 - 0.77) 0.72 (0.64 - 0.79)
ECG(XB2) 0.76 (0.68 - 0.82) 0.77 (0.68 - 0.81)
ECG(XB3) 0.66 (0.52 - 0.75) 0.44 (0.35 - 0.63)
ECG(XB4) 0.52 (0.42 - 0.68) 0.56 (0.43 - 0.82)
ECG(XB5) 0.74 (0.64 - 0.79) 0.76 (0.69 - 0.78)
ECG(XB6) 0.59 (0.48 - 0.69) 0.50 (0.41 - 0.80)
ECG(XB7) 0.42 (0.36 - 0.51) 0.41 (0.30 - 0.44)
ECG(XB8) 0.73 (0.61 - 0.79) 0.66 (0.44 - 0.76)
ECG(XB9) 0.40 (0.34 - 0.56) 0.36 (0.31 - 0.45)
PPG(XA1) 0.44 (0.38 - 0.57) 0.51 (0.34 - 0.65)
PPG(XA2) 0.41 (0.29 - 0.57) 0.37 (0.27 - 0.53)
PPG(XA3) 0.44 (0.33 - 0.61) 0.30 (0.25 - 0.40)
PPG(XA4) 0.37 (0.30 - 0.42) 0.38 (0.29 - 0.41)
PPG(XB1) 0.48 (0.35 - 0.56) 0.49 (0.36 - 0.63)
PPG(XB2) 0.48 (0.39 - 0.57) 0.47 (0.35 - 0.57)
PPG(XB3) 0.64 (0.50 - 0.73) 0.38 (0.32 - 0.55) *Young >Elderly
PPG(XB4) 0.45 (0.30 - 0.54) 0.48 (0.28 - 0.55)
PPG(XB5) 0.46 (0.35 - 0.54) 0.51 (0.34 - 0.58)
PPG(XB6) 0.55 (0.44 - 0.61) 0.54 (0.41 - 0.63)
PPG(XB9) 0.41 (0.33 - 0.48) 0.32 (0.28 - 0.52)
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Table A.5: Comparison of qualities of respiratory signals obtained from young and elderly
subjects in the Fantasia dataset: Subject-specific correlation coefficients (CCs) for young and
elderly subjects, expressed as median (lower - upper quartiles). There were no significant





ECG(XA1) 0.54 (0.46 - 0.64) 0.58 (0.45 - 0.66)
ECG(XB1) 0.55 (0.48 - 0.67) 0.55 (0.44 - 0.66)
ECG(XB2) 0.68 (0.47 - 0.73) 0.67 (0.43 - 0.78)
ECG(XB3) 0.72 (0.65 - 0.79) 0.59 (0.42 - 0.74)
ECG(XB4) 0.52 (0.41 - 0.57) 0.51 (0.42 - 0.59)
ECG(XB5) 0.56 (0.50 - 0.74) 0.69 (0.43 - 0.74)
ECG(XB6) 0.55 (0.45 - 0.65) 0.46 (0.38 - 0.59)
ECG(XB7) 0.35 (0.33 - 0.40) 0.34 (0.31 - 0.40)
ECG(XB8) 0.49 (0.41 - 0.70) 0.53 (0.44 - 0.68)
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A.2 Results Relating to Chapter 6
The performances of RR algorithms were assessed in healthy subjects and hospitalised patients
in this chapter. The following additional results tables are provided:
• Comparison of ECG and PPG input signals: Tables A.6 and A.7 show how the
performances of RR algorithms varied with the use of ECG or PPG as the input signal
in healthy and hospitalised subjects respectively (referenced in Sections 6.3.4 and 6.3.5
respectively).
• Comparison between age groups: Table A.8 shows how RR algorithms’ performances
varied between young and elderly healthy subjects (referenced in Section 6.3.4).
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Table A.6: Comparison of RR algorithm performances when using the ECG or PPG as the
input signal in health. Significant differences are annotated by *, with the input signal providing
improved performance labelled.
Algorithm performance, med (quartiles)
Dataset Statistic ECG PPG
RRest-healthy
C 4.1 (1.8 - 6.3) 1.0 (0.7 - 1.3) *ECG
2SD 7.9 (5.9 - 8.8) 10.5 (9.5 - 11.9) *ECG
bias -1.2 (-1.9 - -0.4) -4.5 (-5.5 - -2.3) *ECG
CP2 61.1 (47.8 - 67.3) 36.5 (33.0 - 41.7) *ECG
iCP5 15.9 (10.4 - 26.0) 38.7 (30.7 - 48.2) *ECG
TDI95 9.6 (7.0 - 11.9) 15.7 (11.6 - 16.5) *ECG
prop 100.0 (97.5 - 100.0) 100.0 (89.5 - 100.0) *PPG
Table A.7: Comparison of algorithm performances when using the ECG or PPG as the input
signal in hospitalised patients. Significant differences are annotated by *, with the input signal
providing improved performance labelled.
Algorithm performance, med (quartiles)
Dataset Statistic ECG PPG
CapnoBase
C 4.4 (2.3 - 11.5) 4.4 (1.7 - 6.4)
2SD 9.6 (7.9 - 11.3) 9.9 (7.4 - 11.5)
bias -0.1 (-1.0 - 1.3) 1.0 (0.2 - 2.7)
CP2 65.2 (50.1 - 84.5) 73.7 (46.8 - 80.6)
iCP5 14.9 (7.5 - 23.5) 17.2 (12.3 - 28.7)
TDI95 10.3 (7.6 - 13.6) 12.5 (9.7 - 15.8) *ECG
prop 98.7 (94.7 - 98.7) 98.7 (88.1 - 98.7) *PPG
MIMIC-II
C 1.7 (1.1 - 2.5) 1.3 (0.8 - 2.0) *ECG
2SD 11.5 (8.9 - 13.7) 12.4 (9.9 - 13.8)
bias -1.2 (-2.4 - 0.9) -3.0 (-4.5 - -1.7) *ECG
CP2 46.8 (37.0 - 57.1) 47.8 (33.7 - 52.0)
iCP5 29.2 (21.5 - 37.5) 38.3 (24.2 - 46.1) *ECG
TDI95 14.9 (11.3 - 17.3) 16.8 (11.1 - 18.7)
prop 100.0 (97.6 - 100.0) 98.9 (72.6 - 100.0)
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Table A.8: Comparison of RR algorithm performances between young and elderly subjects in
health. Significant differences are annotated by *, with the cohort providing improved perfor-
mance labelled.






C 4.5 (1.9 - 7.5) 3.3 (2.0 - 4.4) *young
2SD 7.7 (5.6 - 8.8) 7.7 (6.5 - 9.6) *young
bias -0.9 (-1.8 - -0.0) -2.0 (-2.7 - -1.2) *young
CP2 63.4 (50.5 - 69.9) 56.2 (46.3 - 61.4) *young
iCP5 14.4 (9.1 - 26.1) 16.8 (13.6 - 25.1) *young
TDI95 9.4 (6.6 - 11.5) 9.9 (7.7 - 11.9) *young
prop 100.0 (97.6 - 100.0) 100.0 (96.8 - 100.0) *elderly
ECG Fantasia
C 2.2 (1.3 - 3.5) 2.9 (1.4 - 5.5) *elderly
2SD 7.8 (6.8 - 10.1) 7.2 (6.2 - 9.1) *elderly
bias -2.4 (-3.8 - -1.2) -1.9 (-3.1 - -1.0) *elderly
CP2 50.5 (44.8 - 61.4) 54.8 (46.4 - 69.5) *elderly
iCP5 22.3 (16.1 - 37.5) 19.2 (12.4 - 35.2) *elderly
TDI95 10.6 (8.0 - 13.0) 9.8 (7.7 - 11.7) *elderly
prop 100.0 (98.1 - 100.0) 100.0 (98.1 - 100.0) *young
PPG RRest-
healthy
C 1.0 (0.7 - 1.4) 0.85 (0.7 - 1.1) *young
2SD 10.5 (9.3 - 11.8) 10.8 (9.7 - 12.1) *young
bias -4.0 (-5.3 - -2.1) -5.1 (-6.0 - -2.7) *young
CP2 36.7 (32.6 - 43.5) 34.9 (30.0 - 38.7) *young
iCP5 36.7 (30.4 - 49.2) 42.3 (32.8 - 48.2) *young
TDI95 15.4 (11.3 - 16.4) 15.8 (11.8 - 16.5) *young
prop 100.0 (89.9 - 100.0) 100.0 (89.1 - 100.0) *young
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[298] E. Gil, J. Maŕıa Vergara, and P. Laguna, “Detection of decreases in the amplitude fluc-
tuation of pulse photoplethysmography signal as indication of obstructive sleep apnea
syndrome in children,” Biomedical Signal Processing and Control, vol. 3, no. 3, pp. 267–
277, 2008.
[299] M. Saeed et al., “Multiparameter Intelligent Monitoring in Intensive Care II: a public-
access intensive care unit database,” Critical Care Medicine, vol. 39, no. 5, pp. 952–60,
2011.
[300] J. Welch et al., “The Massachusetts General Hospital-Marquette Foundation Hemody-
namic and Electrocardiographic Database – Comprehensive collection of critical care wave-
forms,” Journal of Clinical Monitoring, vol. 7, no. 1, pp. 96–7, 1991.
[301] G. Moody and R. Mark, “A database to support development and evaluation of intelligent
intensive care monitoring,” in Proc CinC. IEEE, 1996, pp. 657–60.
[302] N. Iyengar et al., “Age-related alterations in the fractal scaling of cardiac interbeat interval
dynamics,” The American Journal of Physiology, vol. 271, no. 4 Pt 2, pp. R1078–84, 1996.
[303] A. L. Goldberger et al., “PhysioBank, PhysioToolkit, and PhysioNet: components of a
new research resource for complex physiologic signals,” Circulation, vol. 101, no. 23, pp.
E215–20, 2000.
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[339] Z. Šidák, “Rectangular confidence regions for the means of multivariate normal distri-
butions,” Journal of the American Statistical Association, vol. 62, no. 318, pp. 626–33,
1967.
[340] A. I. Vinik and D. Ziegler, “Diabetic cardiovascular autonomic neuropathy,” Circulation,
vol. 115, no. 3, pp. 387–97, 2007.
[341] M. A. Pimentel et al., “Towards a robust estimation of respiratory rate from pulse oxime-
ters,” IEEE Transactions on Biomedical Engineering [in press], 2016.
[342] N. a. Obuchowski et al., “Quantitative imaging biomarkers: A review of statistical meth-
ods for computer algorithm comparisons,” Statistical Methods in Medical Research, vol. 24,
no. 1, pp. 68–106, 2015.
Bibliography 240
[343] J. M. Bland and D. G. Altman, “Agreement between methods of measurement with
multiple observations per individual,” Journal of Biopharmaceutical Statistics, vol. 17,
no. 4, pp. 571–82, 2007.
[344] H. X. Barnhart, M. J. Haber, and L. I. Lin, “An overview on assessing agreement with
continuous measurements,” Journal of Biopharmaceutical Statistics, vol. 17, no. 4, pp.
529–69, 2007.
[345] R. Bailon et al., “Robust electrocardiogram derived respiration from stress test recordings:
validation with respiration recordings,” in Conf Proc CinC. IEEE, 2004, pp. 293–6.
[346] L. Nilsson, A. Johansson, and S. Kalman, “Respiration can be monitored by photoplethys-
mography with high sensitivity and specificity regardless of anaesthesia and ventilatory
mode.” Acta Anaesthesiologica Scandinavica, vol. 49, no. 8, pp. 1157–62, 2005.
[347] G. Hackmann et al., “Toward a two-tier clinical warning system for hospitalized patients,”
in AMIA Annual Symposium Proceedings, 2011, pp. 511–9.
[348] L. Clifton et al., “Predictive monitoring of mobile patients by combining clinical ob-
servations with data from wearable sensors,” IEEE Journal of Biomedical and Health
Informatics, vol. 18, no. 3, pp. 722–30, 2014.
[349] M. R. Pinsky, “Hemodynamic evaluation and monitoring in the ICU,” Chest, vol. 132,
no. 6, pp. 2020–9, 2007.
[350] Philips Healthcare, “Wireless Biosensor webpage.”
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